data_1suh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1suh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.62 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.539 ' N ' ' HG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.665 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.665 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.55 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.515 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.515 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.486 HD21 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.752 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 9' ' ' CYS . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.421 ' HG1' ' HG ' ' A' ' 8' ' ' SER . 8.7 m . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.485 ' CE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.206 -1.185 0 CA-C-O 120.65 0.262 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HG2' ' HZ3' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HZ3' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG23 ' CE2' ' A' ' 36' ' ' TYR . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.504 ' H ' ' HH ' ' A' ' 36' ' ' TYR . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.639 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 27' ' ' ASN . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.639 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.48 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' HZ1' ' A' ' 33' ' ' LYS . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.504 ' HH ' ' H ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.458 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG13 ' CE2' ' A' ' 51' ' ' PHE . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 50' ' ' VAL . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.475 ' HG1' ' HB2' ' A' ' 59' ' ' TRP . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.475 ' HB2' ' HG1' ' A' ' 57' ' ' THR . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 59' ' ' TRP . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD22 ' CE1' ' A' ' 74' ' ' TYR . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.446 HD11 ' CE2' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.653 ' HG ' ' CG ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.653 ' CG ' ' HG ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 82' ' ' SER . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG23 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.636 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 . . . . . 0 C--O 1.21 -1.016 0 CA-C-O 120.803 0.335 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' HG22 ' A' ' 96' ' ' ILE . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 23' ' ' GLN . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' N ' HG21 ' A' ' 22' ' ' VAL . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.656 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 38' ' ' ILE . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.47 HG23 ' NE2' ' A' ' 79' ' ' HIS . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 1.6 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' CD2' HG11 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' HD11 ' A' ' 53' ' ' ILE . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.427 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG11 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HG1' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.653 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.747 ' CG2' ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.747 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' H ' HG23 ' A' ' 71' ' ' ILE . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.624 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 82' ' ' SER . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.461 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' HG23 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.617 ' C ' ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.617 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.647 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.51 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.471 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.494 HD22 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.522 ' CE1' ' CG2' ' A' ' 71' ' ' ILE . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.402 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 4.6 m-70 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.712 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 82' ' ' SER . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 82' ' ' SER . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.456 HG23 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.515 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.0 m0 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.484 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' CD1' ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 ' CD1' ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 HG23 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CZ ' HG23 ' A' ' 24' ' ' ILE . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.827 ' N ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.495 ' HG1' ' H ' ' A' ' 59' ' ' TRP . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.495 ' H ' ' HG1' ' A' ' 57' ' ' THR . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HZ3' ' HG2' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 63' ' ' THR . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.465 ' N ' HG21 ' A' ' 62' ' ' VAL . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD12 HE22 ' A' ' 41' ' ' GLN . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.64 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.635 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.533 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.414 ' N ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 96' ' ' ILE . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.724 HD21 ' H ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.637 ' CA ' ' HH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.479 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.554 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.448 ' CD1' HG13 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.56 ' CD1' ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 HG23 ' CE1' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.554 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.677 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.638 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.634 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HB2' HD22 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.437 HG22 ' SG ' ' A' ' 9' ' ' CYS . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.545 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.5 m0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.419 ' N ' HG23 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HG ' HD22 ' A' ' 66' ' ' LEU . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 24' ' ' ILE . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.702 ' HG ' ' N ' ' A' ' 27' ' ' ASN . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.702 ' N ' ' HG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.661 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.661 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.448 ' N ' HG12 ' A' ' 38' ' ' ILE . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.479 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 51' ' ' PHE . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' CD1' HG13 ' A' ' 50' ' ' VAL . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.674 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 41' ' ' GLN . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.605 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.452 ' HG2' ' ND2' ' A' ' 84' ' ' ASN . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.605 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.638 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.746 0.308 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.567 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' CD ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.486 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.569 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' ' HH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 18.4 m120 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.658 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.501 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HG2' ' HG ' ' A' ' 83' ' ' SER . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HH ' ' N ' ' A' ' 26' ' ' SER . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.503 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' N ' HG21 ' A' ' 48' ' ' VAL . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 51' ' ' PHE . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.513 ' CD1' ' C ' ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' N ' HD22 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 51' ' ' PHE . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 74' ' ' TYR . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.61 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.487 HG21 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.487 ' H ' HG21 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CD1' HD22 ' A' ' 66' ' ' LEU . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.814 HD21 ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.814 ' N ' HD21 ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.812 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.552 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 24' ' ' ILE . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 HG23 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.571 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.7 m0 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.511 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.476 ' HG ' ' CD2' ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.512 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.625 ' H ' ' HG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.649 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' H ' HG11 ' A' ' 34' ' ' VAL . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.492 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.42 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HZ3' ' A' ' 61' ' ' LYS . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' GLU . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.63 ' OG1' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.63 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 2.8 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' HB ' ' CE1' ' A' ' 74' ' ' TYR . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.655 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' SG ' ' A' ' 9' ' ' CYS . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.817 0.341 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.43 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' H ' HG21 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.687 ' CB ' ' HH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' HH ' ' CB ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.496 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.461 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HG ' ' SG ' ' A' ' 9' ' ' CYS . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 41' ' ' GLN . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.577 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.767 ' HG ' ' ND2' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.767 ' ND2' ' HG ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HB2' HD22 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 99' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.209 -1.076 0 CA-C-O 121.077 0.465 . . . . 0.0 110.946 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.558 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HZ1' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.478 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' CB ' HD13 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.652 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.634 ' N ' ' HG1' ' A' ' 39' ' ' THR . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' CD1' HG13 ' A' ' 50' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HE2' ' ND2' ' A' ' 20' ' ' ASN . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 66' ' ' LEU . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.577 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.636 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 84' ' ' ASN . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.444 HG23 ' SG ' ' A' ' 9' ' ' CYS . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.639 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 14.5 p-10 -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.493 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG1' ' CE1' ' A' ' 51' ' ' PHE . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 24' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.572 ' CD1' ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CE1' ' CD1' ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.59 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.621 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.59 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 HG21 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.647 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' HG23 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 20' ' ' ASN . 2.2 m120 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.635 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.647 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.485 ' HG1' ' N ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' ' HG1' ' A' ' 39' ' ' THR . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.544 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' N ' HG21 ' A' ' 62' ' ' VAL . 17.7 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CE1' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.422 ' NE2' HG23 ' A' ' 39' ' ' THR . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.553 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.799 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.537 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.799 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.437 HG23 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 . . . . . 0 C--O 1.209 -1.052 0 CA-C-O 120.902 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.57 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' NZ ' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.71 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.71 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.451 HD22 ' HD3' ' A' ' 61' ' ' LYS . 1.4 m-80 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 29' ' ' ASP . 29.4 t30 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.652 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.49 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.437 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HD3' HD22 ' A' ' 20' ' ' ASN . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.677 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.104 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' HG22 ' A' ' 96' ' ' ILE . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.698 ' HZ3' ' CD2' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.698 ' CD2' ' HZ3' ' A' ' 19' ' ' LYS . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.564 HE21 ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.633 ' CA ' ' HH ' ' A' ' 36' ' ' TYR . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.471 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.677 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.564 ' C ' HE21 ' A' ' 23' ' ' GLN . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.553 ' CB ' HH21 ' A' ' 28' ' ' ARG . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.739 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' H ' ' HG ' ' A' ' 82' ' ' SER . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.453 HG22 ' SG ' ' A' ' 9' ' ' CYS . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.556 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.489 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 96' ' ' ILE . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 29.5 m-80 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.553 ' HZ1' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.553 ' N ' ' HZ1' ' A' ' 14' ' ' LYS . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.517 HG23 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.635 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.581 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' HG11 ' A' ' 50' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 74' ' ' TYR . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.424 ' HE3' ' CG1' ' A' ' 95' ' ' VAL . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' HD22 ' A' ' 66' ' ' LEU . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.44 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.595 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.087 0.47 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.534 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.552 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.487 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' HZ1' ' A' ' 19' ' ' LYS . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.496 HD22 ' HE2' ' A' ' 61' ' ' LYS . 5.4 m-80 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.444 HD12 ' SG ' ' A' ' 9' ' ' CYS . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.453 ' H ' HG11 ' A' ' 34' ' ' VAL . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.456 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 42' ' ' GLY . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HE2' HD22 ' A' ' 20' ' ' ASN . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HB ' ' HH ' ' A' ' 74' ' ' TYR . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.487 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.613 0.244 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' CD ' ' ND2' ' A' ' 12' ' ' ASN . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' ND2' ' CD ' ' A' ' 11' ' ' GLU . 62.3 m-20 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.468 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' CD1' HG13 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.483 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.474 ' HA ' ' H ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.61 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 82' ' ' SER . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.21 -1.0 0 CA-C-O 120.848 0.356 . . . . 0.0 111.628 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.553 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.52 HG23 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB3' ' CA ' ' A' ' 2' ' ' TRP . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.67 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 HG23 ' NE2' ' A' ' 79' ' ' HIS . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.5 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.419 ' N ' HG21 ' A' ' 50' ' ' VAL . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.424 ' HG1' ' HB3' ' A' ' 54' ' ' GLU . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' ND2' ' A' ' 20' ' ' ASN . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HB ' ' CE1' ' A' ' 74' ' ' TYR . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 82' ' ' SER . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TRP . . . . . 0.693 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.548 0.214 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.431 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 96' ' ' ILE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HZ1' ' HG2' ' A' ' 13' ' ' GLU . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.785 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' CD1' ' CG1' ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 23' ' ' GLN . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.41 ' H ' HG21 ' A' ' 22' ' ' VAL . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.693 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.44 ' HG ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.532 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD22 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.485 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 74' ' ' TYR . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.739 ' CG2' ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.739 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.532 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.746 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.819 ' HG ' ' ND2' ' A' ' 84' ' ' ASN . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.524 ' H ' ' HG ' ' A' ' 83' ' ' SER . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.819 ' ND2' ' HG ' ' A' ' 82' ' ' SER . 1.1 p-10 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.746 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.929 0.395 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.62 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 -81.34 90.27 6.14 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' HG22 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.539 ' N ' ' HG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.665 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.665 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.55 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.515 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.486 HD21 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.63 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.752 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.464 HG22 ' SG ' ' A' ' 9' ' ' CYS . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.421 ' HG1' ' HG ' ' A' ' 8' ' ' SER . 8.7 m -136.09 149.43 48.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 131.78 32.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.789 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 1.2 pm0 -53.7 173.68 0.06 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.92 -5.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 101' ' ' GLN . 68.7 m-20 -91.17 115.08 27.73 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.86 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.701 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.472 0.653 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' CE3' ' HA ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -79.36 96.26 5.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HG2' ' HZ3' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HZ3' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG23 ' CE2' ' A' ' 36' ' ' TYR . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.504 ' H ' ' HH ' ' A' ' 36' ' ' TYR . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.639 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 27' ' ' ASN . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.639 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.48 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' HZ1' ' A' ' 33' ' ' LYS . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.504 ' HH ' ' H ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.458 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG13 ' CE2' ' A' ' 51' ' ' PHE . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 50' ' ' VAL . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.475 ' HG1' ' HB2' ' A' ' 59' ' ' TRP . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.475 ' HB2' ' HG1' ' A' ' 57' ' ' THR . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HZ2' ' HB3' ' A' ' 59' ' ' TRP . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD22 ' CE1' ' A' ' 74' ' ' TYR . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.446 HD11 ' CE2' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.653 ' HG ' ' CG ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.653 ' CG ' ' HG ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 82' ' ' SER . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG23 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m -110.26 143.05 41.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 1.5 m-20 -73.19 115.53 12.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.643 ' NE2' HD22 ' A' ' 102' ' ' ASN . 0.0 OUTLIER -43.8 -53.66 5.79 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.941 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.643 HD22 ' NE2' ' A' ' 101' ' ' GLN . 1.9 p30 -177.57 -117.99 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.69 123.86 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.957 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.782 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.114 0.483 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.636 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 -78.87 97.3 5.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' HG22 ' A' ' 96' ' ' ILE . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 23' ' ' GLN . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' N ' HG21 ' A' ' 22' ' ' VAL . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.656 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 38' ' ' ILE . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.47 HG23 ' NE2' ' A' ' 79' ' ' HIS . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 1.6 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' CD2' HG11 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' N ' HD11 ' A' ' 53' ' ' ILE . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.427 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG11 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HG1' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD11 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.653 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.747 ' CG2' ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.747 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' H ' HG23 ' A' ' 71' ' ' ILE . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.624 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 82' ' ' SER . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.61 148.69 52.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' A' ' 101' ' ' GLN . 33.6 t0 -70.79 -165.16 0.1 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.779 ' NE2' ' H ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -151.97 171.42 17.84 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.786 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.779 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 0.9 OUTLIER -91.52 75.49 5.9 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.769 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.07 154.71 41.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 25.0 t30 . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 -81.52 87.1 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.84 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.461 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' HG23 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.617 ' C ' ' H ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.617 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.647 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.51 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.451 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.471 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.494 HD22 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' CE1' ' CG2' ' A' ' 71' ' ' ILE . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.467 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.402 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 4.6 m-70 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.712 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 82' ' ' SER . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 82' ' ' SER . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.456 HG23 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.25 132.76 51.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.76 166.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.98 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -144.63 -167.26 2.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 103' ' ' ASP . 4.5 t30 -148.7 -152.28 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.702 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -174.92 138.21 0.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.917 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' A' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.748 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 2' ' ' TRP . 3.4 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.373 0.606 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.515 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.0 m0 -79.75 107.23 12.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' CD1' ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HZ1' ' H ' ' A' ' 104' ' ' ASN . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.406 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 ' CD1' ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 HG23 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.55 ' CZ ' HG23 ' A' ' 24' ' ' ILE . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.827 ' N ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.495 ' HG1' ' H ' ' A' ' 59' ' ' TRP . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.495 ' H ' ' HG1' ' A' ' 57' ' ' THR . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HZ3' ' HG2' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.465 HG21 ' N ' ' A' ' 63' ' ' THR . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.465 ' N ' HG21 ' A' ' 62' ' ' VAL . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD12 HE22 ' A' ' 41' ' ' GLN . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.64 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.635 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.533 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 ' N ' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -143.85 138.57 28.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 101' ' ' GLN . 6.9 t70 -48.41 157.67 0.32 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -103.28 172.77 6.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.216 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.0 75.93 1.53 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.17 135.22 2.6 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.284 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.478 ' H ' ' HZ1' ' A' ' 14' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 116.388 -1.768 . . . . 0.0 110.467 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.56 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 18.4 p-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 -79.61 89.7 5.12 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 96' ' ' ILE . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.724 HD21 ' H ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.621 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.637 ' CA ' ' HH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.554 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' CD1' HG13 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.56 ' CD1' ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 HG23 ' CE1' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.554 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.677 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.638 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.634 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' HB2' HD22 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.437 HG22 ' SG ' ' A' ' 9' ' ' CYS . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 143.64 45.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 3.3 m-20 -52.63 168.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.063 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.411 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -118.7 -16.39 9.39 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.121 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.9 t30 60.28 80.81 0.2 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.164 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -95.0 149.47 21.22 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.716 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.42 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.545 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.5 m0 -84.85 86.95 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.14 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.419 ' N ' HG23 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HG ' HD22 ' A' ' 66' ' ' LEU . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.519 ' N ' HG21 ' A' ' 24' ' ' ILE . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.702 ' HG ' ' N ' ' A' ' 27' ' ' ASN . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' N ' ' HG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.661 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.661 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.448 ' N ' HG12 ' A' ' 38' ' ' ILE . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.479 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 51' ' ' PHE . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' CD1' HG13 ' A' ' 50' ' ' VAL . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.674 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 41' ' ' GLN . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.605 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.452 ' HG2' ' ND2' ' A' ' 84' ' ' ASN . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.66 142.85 46.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.54 -162.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -138.11 179.81 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -145.69 6.12 1.06 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.42 ' HB2' HE22 ' A' ' 101' ' ' GLN . 3.9 t0 -86.05 -174.54 5.14 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.541 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.068 0.461 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.638 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 -78.9 100.17 7.11 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.025 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.567 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' CD ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.569 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.844 ' N ' ' HH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 18.4 m120 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.658 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.501 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HG2' ' HG ' ' A' ' 83' ' ' SER . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.844 ' HH ' ' N ' ' A' ' 26' ' ' SER . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.503 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' N ' HG21 ' A' ' 48' ' ' VAL . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 51' ' ' PHE . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.471 ' CD1' HG13 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' CD1' ' C ' ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' N ' HD22 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 51' ' ' PHE . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 74' ' ' TYR . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.61 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.487 HG21 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.487 ' H ' HG21 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CD1' HD22 ' A' ' 66' ' ' LEU . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.814 HD21 ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.814 ' N ' HD21 ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.812 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.552 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 24' ' ' ILE . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 HG23 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -112.49 136.81 51.56 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 7.2 t70 -58.0 162.61 3.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.089 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -177.69 178.37 1.01 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.755 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -44.17 98.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 101' ' ' GLN . 33.4 t70 -90.37 147.74 23.27 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.719 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.544 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 116.277 -1.82 . . . . 0.0 110.674 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.571 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.7 m0 -85.47 88.7 7.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.205 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.511 ' CG2' ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.511 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.476 ' HG ' ' CD2' ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.512 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.625 ' H ' ' HG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.649 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' H ' HG11 ' A' ' 34' ' ' VAL . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.492 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 ' HZ3' ' A' ' 61' ' ' LYS . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' GLU . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.63 ' OG1' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.63 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 2.8 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' HB ' ' CE1' ' A' ' 74' ' ' TYR . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.655 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.466 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' SG ' ' A' ' 9' ' ' CYS . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 149.93 51.75 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -45.07 158.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.723 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -86.52 -167.34 1.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.043 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.56 40.07 1.49 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.4 -52.59 52.4 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 104' ' ' ASN . 5.6 t-20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 116.327 -1.796 . . . . 0.0 110.711 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.634 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 -79.67 101.89 8.64 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.43 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' H ' HG21 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.687 ' CB ' ' HH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.669 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.449 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' HH ' ' CB ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.461 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HG ' ' SG ' ' A' ' 9' ' ' CYS . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.582 HH21 ' H ' ' A' ' 100' ' ' ASP . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE1' HD11 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 41' ' ' GLN . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.577 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.767 ' HG ' ' ND2' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.449 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.767 ' ND2' ' HG ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HB2' HD22 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 99' ' ' THR . 0.8 OUTLIER -108.55 126.73 53.26 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.582 ' H ' HH21 ' A' ' 68' ' ' ARG . 10.2 p-10 -57.64 162.74 2.85 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.463 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -138.72 -133.78 0.12 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.43 -85.12 0.19 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -44.95 116.99 1.2 Allowed 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.783 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.744 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.971 0.415 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -78.75 88.93 4.61 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.946 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HZ1' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.478 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' CB ' HD13 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.695 HD21 ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.652 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.477 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.634 ' N ' ' HG1' ' A' ' 39' ' ' THR . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' CD1' HG13 ' A' ' 50' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HE2' ' ND2' ' A' ' 20' ' ' ASN . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 66' ' ' LEU . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.577 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.636 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' HB2' HD22 ' A' ' 84' ' ' ASN . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.444 HG23 ' SG ' ' A' ' 9' ' ' CYS . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.18 148.35 22.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 32.5 p-10 -90.19 137.57 32.24 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.505 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -102.65 -85.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.0 80.81 0.85 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 104' ' ' ASN . 13.8 t70 -71.58 178.92 3.27 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 16.3 m120 . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.846 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.941 0.4 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.639 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 -88.65 88.56 7.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.623 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.716 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 14.5 p-10 -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.493 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG1' ' CE1' ' A' ' 51' ' ' PHE . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.437 HD12 ' CD1' ' A' ' 24' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.572 ' CD1' ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.572 ' CE1' ' CD1' ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.621 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.59 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 HG21 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.63 109.05 19.18 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -47.53 161.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.788 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' OE1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -103.94 -15.52 15.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.874 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' N ' ' OE1' ' A' ' 101' ' ' GLN . 3.5 t-20 52.28 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -167.75 37.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.647 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 -78.99 88.38 4.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' SG ' HG23 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 20' ' ' ASN . 2.2 m120 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.635 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.635 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.553 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.647 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.485 ' HG1' ' N ' ' A' ' 40' ' ' GLY . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.485 ' N ' ' HG1' ' A' ' 39' ' ' THR . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.544 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' N ' HG21 ' A' ' 62' ' ' VAL . 17.7 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CE1' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.422 ' NE2' HG23 ' A' ' 39' ' ' THR . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.623 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.553 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.799 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.537 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.799 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.437 HG23 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.28 145.42 43.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 5.0 p30 -69.79 72.99 0.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 100' ' ' ASP . 4.7 tt0 37.21 -141.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.514 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -143.72 -1.92 0.97 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.485 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 104' ' ' ASN . 25.6 t70 -78.5 174.87 10.87 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.971 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.473 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.375 -1.774 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.127 0.489 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 -79.49 88.83 5.04 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.194 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.57 ' CG2' ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.57 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' NZ ' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.71 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.419 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.71 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.451 HD22 ' HD3' ' A' ' 61' ' ' LYS . 1.4 m-80 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 29' ' ' ASP . 29.4 t30 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.652 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.49 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.652 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.437 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HD3' HD22 ' A' ' 20' ' ' ASN . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.68 149.68 48.27 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.63 169.89 2.82 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.311 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' C ' ' CG ' ' A' ' 102' ' ' ASN . 8.2 tt0 -151.84 -59.15 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.622 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' CG ' ' C ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER 44.53 87.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.113 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -16.86 24.2 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.841 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 3.0 p30 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.097 0.475 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.677 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -78.49 93.88 4.85 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.026 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.518 ' CG2' ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.518 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' HG22 ' A' ' 96' ' ' ILE . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.698 ' HZ3' ' CD2' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.698 ' CD2' ' HZ3' ' A' ' 19' ' ' LYS . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.564 HE21 ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.633 ' CA ' ' HH ' ' A' ' 36' ' ' TYR . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.471 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.677 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.431 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.564 ' C ' HE21 ' A' ' 23' ' ' GLN . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 HD11 ' CE1' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CE1' HD11 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.553 ' CB ' HH21 ' A' ' 28' ' ' ARG . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.739 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' H ' ' HG ' ' A' ' 82' ' ' SER . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.453 HG22 ' SG ' ' A' ' 9' ' ' CYS . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m -146.72 149.05 32.67 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.97 150.03 5.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.444 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.422 ' CG ' ' H ' ' A' ' 102' ' ' ASN . 2.3 pt20 -56.02 -94.49 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.931 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' H ' ' CG ' ' A' ' 101' ' ' GLN . 9.0 p30 -172.42 53.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.716 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -93.8 105.74 17.75 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 17.4 t30 . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.85 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.556 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 -80.03 101.14 8.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.006 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 96' ' ' ILE . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 29.5 m-80 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.507 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.553 ' HZ1' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.553 ' N ' ' HZ1' ' A' ' 14' ' ' LYS . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.517 HG23 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.635 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.581 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.415 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 HG11 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.478 ' CD1' HG11 ' A' ' 50' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' N ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.507 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 74' ' ' TYR . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.424 ' HE3' ' CG1' ' A' ' 95' ' ' VAL . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' HD22 ' A' ' 66' ' ' LEU . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.581 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.44 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.42 150.01 23.79 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.51 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.951 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.757 ' NE2' ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -172.62 -155.43 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.757 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 10.5 m-20 -66.75 -117.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.017 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' CG ' ' H ' ' A' ' 104' ' ' ASN . 38.0 t0 49.61 -157.45 0.08 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.659 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.621 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 2' ' ' TRP . 37.9 t70 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.595 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 -79.16 87.35 4.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.534 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.552 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.487 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.488 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' HZ1' ' A' ' 19' ' ' LYS . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.496 HD22 ' HE2' ' A' ' 61' ' ' LYS . 5.4 m-80 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.444 HD12 ' SG ' ' A' ' 9' ' ' CYS . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.453 ' H ' HG11 ' A' ' 34' ' ' VAL . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 42' ' ' GLY . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HE2' HD22 ' A' ' 20' ' ' ASN . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HB ' ' HH ' ' A' ' 74' ' ' TYR . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.642 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.487 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 149.18 49.72 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.56 174.41 0.44 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.021 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.628 ' CD ' ' H ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -91.48 -138.63 0.16 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.418 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.628 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 4.1 t-20 -122.46 17.77 10.51 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.27 97.76 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.631 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 p30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.239 -1.839 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 -82.4 91.75 6.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.52 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' CD ' ' ND2' ' A' ' 12' ' ' ASN . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' ND2' ' CD ' ' A' ' 11' ' ' GLU . 62.3 m-20 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.428 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.468 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' CD1' HG13 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.483 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CE1' HD11 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.474 ' HA ' ' H ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.61 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 82' ' ' SER . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m -120.23 123.98 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.78 159.75 5.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.747 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -136.17 -17.18 1.6 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.966 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -130.66 74.32 1.59 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.805 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -167.46 -27.47 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.3 m120 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 110.839 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 27.2 p-10 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.162 0.506 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -78.55 103.18 8.32 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.628 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 2' ' ' TRP . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.553 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.52 HG23 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB3' ' CA ' ' A' ' 2' ' ' TRP . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.67 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 HG23 ' NE2' ' A' ' 79' ' ' HIS . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.5 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.419 ' N ' HG21 ' A' ' 50' ' ' VAL . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.424 ' HG1' ' HB3' ' A' ' 54' ' ' GLU . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HD2' ' ND2' ' A' ' 20' ' ' ASN . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 69' ' ' GLU . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' HB ' ' CE1' ' A' ' 74' ' ' TYR . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 82' ' ' SER . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.33 122.72 28.43 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -146.31 33.34 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.549 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 101' ' ' GLN . 7.0 t-20 74.35 24.4 1.85 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.443 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.7 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.794 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.977 0.418 . . . . 0.0 111.407 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.693 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 -79.29 88.84 4.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.667 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.431 ' N ' HG23 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 96' ' ' ILE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.401 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HZ1' ' HG2' ' A' ' 13' ' ' GLU . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.785 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' CD1' ' CG1' ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 23' ' ' GLN . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.41 ' H ' HG21 ' A' ' 22' ' ' VAL . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.481 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.693 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.44 ' HG ' ' HB2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 ' CD1' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 ' CD2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.532 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.532 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD22 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.485 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 74' ' ' TYR . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.739 ' CG2' ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.739 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 66' ' ' LEU . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.746 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.819 ' HG ' ' ND2' ' A' ' 84' ' ' ASN . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.524 ' H ' ' HG ' ' A' ' 83' ' ' SER . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.819 ' ND2' ' HG ' ' A' ' 82' ' ' SER . 1.1 p-10 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.746 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.448 HG22 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.01 147.96 36.1 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.75 149.94 41.46 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.437 ' NE2' ' O ' ' A' ' 12' ' ' ASN . 1.6 tt0 -168.78 50.25 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.184 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.58 102.95 0.78 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 50.8 t0 -172.19 -56.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.915 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.515 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.75 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.587 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG21 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD2' HD22 ' A' ' 21' ' ' LEU . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.589 HD12 ' CG1' ' A' ' 62' ' ' VAL . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.652 HG21 ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.589 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HB2' HG13 ' A' ' 50' ' ' VAL . 80.2 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' CD1' ' A' ' 96' ' ' ILE . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.652 ' NE2' HG21 ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 9.0 p30 -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' HB2' HD22 ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.575 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 76' ' ' LEU . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.679 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.206 -1.185 0 CA-C-O 120.65 0.262 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 8' ' ' SER . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' NZ ' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.731 HD11 ' CG1' ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' N ' HG22 ' A' ' 22' ' ' VAL . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 25' ' ' LYS . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 32' ' ' THR . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.407 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 42' ' ' GLY . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 52' ' ' ILE . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 53' ' ' ILE . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' N ' HD23 ' A' ' 60' ' ' LEU . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.731 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.555 ' C ' HD22 ' A' ' 76' ' ' LEU . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.562 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 . . . . . 0 C--O 1.21 -1.016 0 CA-C-O 120.803 0.335 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 2' ' ' TRP . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' CB ' HD11 ' A' ' 66' ' ' LEU . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.9 m-20 -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 62' ' ' VAL . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.62 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 76' ' ' LEU . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 15.7 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.544 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 47' ' ' PRO . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.44 ' CD2' HG12 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 57' ' ' THR . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 66' ' ' LEU . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.692 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.033 HG22 ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.033 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.643 ' HE2' HG13 ' A' ' 95' ' ' VAL . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.612 ' CZ ' HD12 ' A' ' 71' ' ' ILE . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' HD21 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.643 HG13 ' HE2' ' A' ' 73' ' ' LYS . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.505 HG22 ' C ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.636 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.823 ' SG ' HG22 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.658 ' C ' HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 3.9 t30 -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG21 ' HB1' ' A' ' 80' ' ' ALA . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.556 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HZ ' HD21 ' A' ' 66' ' ' LEU . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD23 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.792 ' CE1' HD23 ' A' ' 66' ' ' LEU . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.617 ' C ' HD22 ' A' ' 76' ' ' LEU . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 ' C ' ' A' ' 75' ' ' ILE . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.605 ' H ' ' C ' ' A' ' 82' ' ' SER . 6.5 p30 -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' HD22 ' A' ' 84' ' ' ASN . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.823 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' HD2' ' A' ' 25' ' ' LYS . 7.0 m0 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 2' ' ' TRP . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.81 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.595 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD13 ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 82' ' ' SER . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 26' ' ' SER . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 39' ' ' THR . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 47' ' ' PRO . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.063 HD13 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 1.063 ' N ' HD13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.766 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 66' ' ' LEU . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.647 ' C ' HD22 ' A' ' 76' ' ' LEU . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.647 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.613 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 2' ' ' TRP . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.698 HG22 ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.698 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.74 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.574 ' C ' HD22 ' A' ' 21' ' ' LEU . 3.1 m120 -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 20' ' ' ASN . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' GLN . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' VAL . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 53' ' ' ILE . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.621 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.883 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.566 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.609 HG22 ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.831 HD11 HG13 ' A' ' 24' ' ' ILE . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 21' ' ' LEU . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.407 ' CG ' HG11 ' A' ' 98' ' ' VAL . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 75' ' ' ILE . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.609 ' NE2' HG22 ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.883 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.625 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.9 p30 -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.625 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' GLU . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.694 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' CG ' ' A' ' 68' ' ' ARG . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.5 m0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' TRP . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 96' ' ' ILE . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 52' ' ' ILE . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.818 ' C ' HD22 ' A' ' 21' ' ' LEU . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.736 HG21 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 2' ' ' TRP . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.562 ' N ' ' OG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.646 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.646 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.45 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.736 ' CD1' HG21 ' A' ' 24' ' ' ILE . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.6 HG21 HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 79' ' ' HIS . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.512 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 44' ' ' ASP . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 18' ' ' PRO . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 HG21 ' A' ' 38' ' ' ILE . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 21' ' ' LEU . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.674 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 75' ' ' ILE . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 39' ' ' THR . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 88' ' ' VAL . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.626 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.633 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.746 0.308 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' TRP . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.734 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.67 ' H ' ' CD ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 21' ' ' LEU . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 23' ' ' GLN . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.507 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG21 ' CD2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.623 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 80.9 m-20 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.637 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.633 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 50' ' ' VAL . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.543 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 47' ' ' PRO . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.744 ' C ' HD12 ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.004 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.651 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 76' ' ' LEU . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 82' ' ' SER . 26.7 p30 -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.584 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG21 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.004 HG22 HD23 ' A' ' 66' ' ' LEU . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.7 m0 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.688 HG22 ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.688 ' N ' HG22 ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.718 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.718 HD12 ' C ' ' A' ' 20' ' ' ASN . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' N ' ' OG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.76 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.651 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 48' ' ' VAL . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 48' ' ' VAL . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.478 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.531 ' C ' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.531 ' NE2' ' C ' ' A' ' 63' ' ' THR . 1.6 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.562 ' O ' HG21 ' A' ' 98' ' ' VAL . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 71' ' ' ILE . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.63 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.817 0.341 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 21' ' ' LEU . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.642 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.667 HD11 HD13 ' A' ' 76' ' ' LEU . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.534 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 64' ' ' GLN . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 60' ' ' LEU . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.465 HG23 ' CD1' ' A' ' 52' ' ' ILE . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.689 ' HB2' HG13 ' A' ' 50' ' ' VAL . 6.2 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.702 HD12 HG22 ' A' ' 98' ' ' VAL . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 73' ' ' LYS . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 71' ' ' ILE . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CE1' HD13 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 38' ' ' ILE . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 94' ' ' ILE . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.6 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' HD21 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.6 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 78' ' ' SER . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 HD12 ' A' ' 66' ' ' LEU . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.209 -1.076 0 CA-C-O 121.077 0.465 . . . . 0.0 110.946 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 8' ' ' SER . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.622 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.403 HD22 ' HE3' ' A' ' 61' ' ' LYS . 2.6 m120 -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 9' ' ' CYS . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.401 ' CD2' HG12 ' A' ' 62' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.622 HD11 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.474 ' CD1' HD12 ' A' ' 24' ' ' ILE . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.59 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 60' ' ' LEU . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 98' ' ' VAL . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.6 p30 -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.697 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.483 HD12 HD23 ' A' ' 76' ' ' LEU . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG22 HD12 ' A' ' 66' ' ' LEU . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.632 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 2.1 m120 -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 21' ' ' LEU . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 23' ' ' GLN . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' PRO . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 ' HB ' ' A' ' 38' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 21' ' ' LEU . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' H ' HG22 ' A' ' 71' ' ' ILE . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 38' ' ' ILE . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.618 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.637 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' O ' HD13 ' A' ' 7' ' ' ILE . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 6' ' ' PRO . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.584 ' H ' HG22 ' A' ' 7' ' ' ILE . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 62' ' ' VAL . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' N ' HG22 ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.662 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 48' ' ' VAL . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 50' ' ' VAL . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.741 HD12 ' HB ' ' A' ' 38' ' ' ILE . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.4 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 62' ' ' VAL . 55.6 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 75' ' ' ILE . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.64 HD22 ' HB2' ' A' ' 86' ' ' GLU . 15.4 p30 -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' HD22 ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 72' ' ' ALA . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 . . . . . 0 C--O 1.209 -1.052 0 CA-C-O 120.902 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.696 HG22 ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.696 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.597 ' HA3' ' HZ2' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.697 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.445 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.697 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.49 HD22 ' HE2' ' A' ' 61' ' ' LYS . 3.0 m120 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' CG1' ' A' ' 62' ' ' VAL . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 29' ' ' ASP . 6.3 t-20 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.742 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 64' ' ' GLN . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.496 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.503 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.478 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 60' ' ' LEU . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.628 ' HB2' HG13 ' A' ' 50' ' ' VAL . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HB3' ' N ' ' A' ' 13' ' ' GLU . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 88' ' ' VAL . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 93' ' ' GLU . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.663 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.104 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.71 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.626 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HZ1' ' HG ' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 62' ' ' VAL . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 23' ' ' GLN . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.449 ' N ' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 26' ' ' SER . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.846 HD11 HD13 ' A' ' 76' ' ' LEU . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 52' ' ' ILE . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.634 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 73' ' ' LYS . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 38' ' ' ILE . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.8 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.64 HD22 ' HB2' ' A' ' 86' ' ' GLU . 4.2 p30 -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' HD22 ' A' ' 84' ' ' ASN . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.572 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 73' ' ' LYS . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 76' ' ' LEU . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.536 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 2' ' ' TRP . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.67 HG22 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.67 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.555 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 15.7 m120 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' ND2' ' HE2' ' A' ' 61' ' ' LYS . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' OE1' ' A' ' 13' ' ' GLU . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 76' ' ' LEU . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.553 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 62' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 53' ' ' ILE . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.555 ' HB2' ' H ' ' A' ' 12' ' ' ASN . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 98' ' ' VAL . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 73' ' ' LYS . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.45 ' NE2' HG22 ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.582 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 76' ' ' LEU . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.563 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.087 0.47 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 2' ' ' TRP . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.628 ' N ' HG22 ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.607 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 52' ' ' ILE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.41 HD22 ' HE2' ' A' ' 61' ' ' LYS . 5.5 m120 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 21' ' ' LEU . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.619 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' ILE . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.446 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 51' ' ' PHE . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 50' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' CB ' ' A' ' 18' ' ' PRO . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.557 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.508 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' LYS . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' C ' HD22 ' A' ' 76' ' ' LEU . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.728 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.528 HD11 ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.613 0.244 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 21' ' ' LEU . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLU . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m120 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 10' ' ' PRO . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 48' ' ' VAL . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CD1' HG12 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 HG22 ' CG2' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 81' ' ' VAL . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.569 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.452 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 71' ' ' ILE . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.21 -1.0 0 CA-C-O 120.848 0.356 . . . . 0.0 111.628 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' VAL . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.761 ' N ' HG22 ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.571 ' SG ' HD13 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 61' ' ' LYS . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HG22 ' A' ' 4' ' ' ILE . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.708 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 38' ' ' ILE . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 3.4 pt20 -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' N ' ' A' ' 41' ' ' GLN . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.535 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 53' ' ' ILE . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 59' ' ' TRP . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 60' ' ' LEU . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.41 HG13 HD12 ' A' ' 21' ' ' LEU . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 73' ' ' LYS . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 71' ' ' ILE . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.601 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.681 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.54 HG21 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TRP . . . . . 0.672 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.548 0.214 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.618 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.565 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.824 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD11 HG11 ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' ASP . 9.4 t-20 -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 80' ' ' ALA . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.672 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.781 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.592 ' HE1' ' HG ' ' A' ' 9' ' ' CYS . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.633 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.718 ' N ' HD23 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.7 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.03 HG22 ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.03 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.652 ' H ' HG22 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 94' ' ' ILE . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.571 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.781 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 32' ' ' THR . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.0 p30 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.48 ' HB2' ' HG ' ' A' ' 82' ' ' SER . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.781 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 66' ' ' LEU . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.929 0.395 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.587 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 -81.34 90.27 6.14 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG21 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD2' HD22 ' A' ' 21' ' ' LEU . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.589 HD12 ' CG1' ' A' ' 62' ' ' VAL . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.652 HG21 ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.589 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HB2' HG13 ' A' ' 50' ' ' VAL . 80.2 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' CD1' ' A' ' 96' ' ' ILE . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.652 ' NE2' HG21 ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 9.0 p30 -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' HB2' HD22 ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.575 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 76' ' ' LEU . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 m -136.09 149.43 48.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 131.78 32.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.816 ' NE2' ' H ' ' A' ' 101' ' ' GLN . 1.2 pm0 -53.7 173.68 0.06 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -60.92 -5.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 101' ' ' GLN . 68.7 m-20 -91.17 115.08 27.73 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.86 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.701 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.472 0.653 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.679 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -79.36 96.26 5.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 8' ' ' SER . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' NZ ' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.731 HD11 ' CG1' ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' N ' HG22 ' A' ' 22' ' ' VAL . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 25' ' ' LYS . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 32' ' ' THR . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.407 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 42' ' ' GLY . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 52' ' ' ILE . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 53' ' ' ILE . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' N ' HD23 ' A' ' 60' ' ' LEU . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.731 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.555 ' C ' HD22 ' A' ' 76' ' ' LEU . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m -110.26 143.05 41.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 1.5 m-20 -73.19 115.53 12.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' CD ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -43.8 -53.66 5.79 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.941 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' CD ' ' A' ' 101' ' ' GLN . 1.9 p30 -177.57 -117.99 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.69 123.86 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.957 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.782 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.114 0.483 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.562 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 -78.87 97.3 5.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 2' ' ' TRP . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' CB ' HD11 ' A' ' 66' ' ' LEU . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.9 m-20 -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 62' ' ' VAL . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.62 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 76' ' ' LEU . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 15.7 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 47' ' ' PRO . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.44 ' CD2' HG12 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 57' ' ' THR . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 66' ' ' LEU . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.692 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.033 HG22 ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.033 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.643 ' HE2' HG13 ' A' ' 95' ' ' VAL . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.612 ' CZ ' HD12 ' A' ' 71' ' ' ILE . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' HD21 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.643 HG13 ' HE2' ' A' ' 73' ' ' LYS . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.61 148.69 52.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 101' ' ' GLN . 33.6 t0 -70.79 -165.16 0.1 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -151.97 171.42 17.84 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.786 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.605 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 4.7 m-20 -91.52 75.49 5.9 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.769 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.07 154.71 41.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.788 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 -81.52 87.1 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.84 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.505 HG22 ' C ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.636 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.823 ' SG ' HG22 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.658 ' C ' HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 3.9 t30 -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG21 ' HB1' ' A' ' 80' ' ' ALA . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.556 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HZ ' HD21 ' A' ' 66' ' ' LEU . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD23 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.792 ' CE1' HD23 ' A' ' 66' ' ' LEU . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.617 ' C ' HD22 ' A' ' 76' ' ' LEU . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 ' C ' ' A' ' 75' ' ' ILE . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.605 ' H ' ' C ' ' A' ' 82' ' ' SER . 6.5 p30 -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' HD22 ' A' ' 84' ' ' ASN . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.823 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.25 132.76 51.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.76 166.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.98 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -144.63 -167.26 2.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -148.7 -152.28 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.92 138.21 0.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.748 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 2' ' ' TRP . 3.4 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.373 0.606 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' HD2' ' A' ' 25' ' ' LYS . 7.0 m0 -79.75 107.23 12.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 2' ' ' TRP . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.81 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.595 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' NZ ' ' H ' ' A' ' 104' ' ' ASN . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD13 ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 82' ' ' SER . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 26' ' ' SER . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 39' ' ' THR . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 47' ' ' PRO . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.063 HD13 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 1.063 ' N ' HD13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.766 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 66' ' ' LEU . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.647 ' C ' HD22 ' A' ' 76' ' ' LEU . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.647 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.613 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.85 138.57 28.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 101' ' ' GLN . 6.9 t70 -48.41 157.67 0.32 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -103.28 172.77 6.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.216 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.0 75.93 1.53 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.17 135.22 2.6 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.284 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.405 ' H ' ' NZ ' ' A' ' 14' ' ' LYS . 57.1 t-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 116.388 -1.768 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 18.4 p-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 -79.61 89.7 5.12 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 2' ' ' TRP . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.698 HG22 ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.698 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.74 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.574 ' C ' HD22 ' A' ' 21' ' ' LEU . 3.1 m120 -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 20' ' ' ASN . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' GLN . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' VAL . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 53' ' ' ILE . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.621 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.883 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.566 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.609 HG22 ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.831 HD11 HG13 ' A' ' 24' ' ' ILE . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 21' ' ' LEU . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.407 ' CG ' HG11 ' A' ' 98' ' ' VAL . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 75' ' ' ILE . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.609 ' NE2' HG22 ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.883 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.625 ' HG ' ' H ' ' A' ' 86' ' ' GLU . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.9 p30 -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.625 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' GLU . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.694 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' CG ' ' A' ' 68' ' ' ARG . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 143.64 45.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 3.3 m-20 -52.63 168.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.063 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.411 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 6.3 tm0? -118.7 -16.39 9.39 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.121 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.9 t30 60.28 80.81 0.2 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.164 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -95.0 149.47 21.22 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.716 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.42 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.5 m0 -84.85 86.95 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.14 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' TRP . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 96' ' ' ILE . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 52' ' ' ILE . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.818 ' C ' HD22 ' A' ' 21' ' ' LEU . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.736 HG21 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 2' ' ' TRP . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.562 ' N ' ' OG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.646 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.646 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.45 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.736 ' CD1' HG21 ' A' ' 24' ' ' ILE . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.6 HG21 HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 79' ' ' HIS . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.512 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 44' ' ' ASP . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 18' ' ' PRO . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 HG21 ' A' ' 38' ' ' ILE . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 21' ' ' LEU . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.674 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 75' ' ' ILE . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 39' ' ' THR . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 88' ' ' VAL . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.626 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.66 142.85 46.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.54 -162.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -138.11 179.81 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -145.69 6.12 1.06 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB2' HE22 ' A' ' 101' ' ' GLN . 3.9 t0 -86.05 -174.54 5.14 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.541 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.068 0.461 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.633 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 -78.9 100.17 7.11 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.025 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' TRP . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.734 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.67 ' H ' ' CD ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 21' ' ' LEU . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 23' ' ' GLN . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.507 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG21 ' CD2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.623 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 80.9 m-20 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.637 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.633 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 50' ' ' VAL . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.543 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 47' ' ' PRO . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.744 ' C ' HD12 ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.004 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.651 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 76' ' ' LEU . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' H ' ' C ' ' A' ' 82' ' ' SER . 26.7 p30 -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.584 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG21 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.004 HG22 HD23 ' A' ' 66' ' ' LEU . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -112.49 136.81 51.56 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 7.2 t70 -58.0 162.61 3.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.089 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -177.69 178.37 1.01 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.755 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -44.17 98.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 101' ' ' GLN . 33.4 t70 -90.37 147.74 23.27 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.719 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.434 ' OD1' ' C ' ' A' ' 104' ' ' ASN . 5.9 t30 . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 116.277 -1.82 . . . . 0.0 110.674 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.7 m0 -85.47 88.7 7.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.205 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.688 HG22 ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.688 ' N ' HG22 ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.718 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.718 HD12 ' C ' ' A' ' 20' ' ' ASN . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' N ' ' OG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.76 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.651 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 48' ' ' VAL . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 48' ' ' VAL . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.478 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.531 ' C ' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.531 ' NE2' ' C ' ' A' ' 63' ' ' THR . 1.6 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.562 ' O ' HG21 ' A' ' 98' ' ' VAL . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 71' ' ' ILE . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 149.93 51.75 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -45.07 158.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.723 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -86.52 -167.34 1.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.043 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.56 40.07 1.49 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.4 -52.59 52.4 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 104' ' ' ASN . 31.2 t30 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 116.327 -1.796 . . . . 0.0 110.711 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.63 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 -79.67 101.89 8.64 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 21' ' ' LEU . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.642 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.667 HD11 HD13 ' A' ' 76' ' ' LEU . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 64' ' ' GLN . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 60' ' ' LEU . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.465 HG23 ' CD1' ' A' ' 52' ' ' ILE . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.689 ' HB2' HG13 ' A' ' 50' ' ' VAL . 6.2 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.702 HD12 HG22 ' A' ' 98' ' ' VAL . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.651 HH21 ' H ' ' A' ' 100' ' ' ASP . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 73' ' ' LYS . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 71' ' ' ILE . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CE1' HD13 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 38' ' ' ILE . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 94' ' ' ILE . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.6 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' HD21 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.6 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 78' ' ' SER . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 HD12 ' A' ' 66' ' ' LEU . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.55 126.73 53.26 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HH21 ' A' ' 68' ' ' ARG . 10.2 p-10 -57.64 162.74 2.85 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.463 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -138.72 -133.78 0.12 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.43 -85.12 0.19 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -44.95 116.99 1.2 Allowed 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.783 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.744 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.971 0.415 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -78.75 88.93 4.61 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.946 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 8' ' ' SER . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.622 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.403 HD22 ' HE3' ' A' ' 61' ' ' LYS . 2.6 m120 -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 9' ' ' CYS . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.401 ' CD2' HG12 ' A' ' 62' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD11 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.474 ' CD1' HD12 ' A' ' 24' ' ' ILE . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' N ' HD23 ' A' ' 60' ' ' LEU . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 98' ' ' VAL . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.6 p30 -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.697 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.483 HD12 HD23 ' A' ' 76' ' ' LEU . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG22 HD12 ' A' ' 66' ' ' LEU . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.18 148.35 22.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 32.5 p-10 -90.19 137.57 32.24 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.505 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -102.65 -85.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.0 80.81 0.85 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.58 178.92 3.27 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.846 179.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.941 0.4 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.632 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 -88.65 88.56 7.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.623 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 2.1 m120 -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 21' ' ' LEU . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 23' ' ' GLN . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' PRO . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 ' HB ' ' A' ' 38' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 21' ' ' LEU . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' H ' HG22 ' A' ' 71' ' ' ILE . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 38' ' ' ILE . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.618 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.63 109.05 19.18 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -47.53 161.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.788 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' OE1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -103.94 -15.52 15.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.874 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' N ' ' OE1' ' A' ' 101' ' ' GLN . 58.5 t30 52.28 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -167.75 37.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.637 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 -78.99 88.38 4.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' O ' HD13 ' A' ' 7' ' ' ILE . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 6' ' ' PRO . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.584 ' H ' HG22 ' A' ' 7' ' ' ILE . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 62' ' ' VAL . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' N ' HG22 ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.662 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 48' ' ' VAL . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 50' ' ' VAL . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.741 HD12 ' HB ' ' A' ' 38' ' ' ILE . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.4 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 62' ' ' VAL . 55.6 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 75' ' ' ILE . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.64 HD22 ' HB2' ' A' ' 86' ' ' GLU . 15.4 p30 -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' HD22 ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 72' ' ' ALA . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.28 145.42 43.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 5.0 p30 -69.79 72.99 0.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 100' ' ' ASP . 4.7 tt0 37.21 -141.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.514 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -143.72 -1.92 0.97 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.485 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.468 ' CG ' ' N ' ' A' ' 104' ' ' ASN . 25.6 t70 -78.5 174.87 10.87 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.971 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.468 ' N ' ' CG ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.375 -1.774 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.127 0.489 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 -79.49 88.83 5.04 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.194 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.696 HG22 ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.696 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.597 ' HA3' ' HZ2' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.697 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.445 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.697 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.49 HD22 ' HE2' ' A' ' 61' ' ' LYS . 3.0 m120 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' CG1' ' A' ' 62' ' ' VAL . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 29' ' ' ASP . 6.3 t-20 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.742 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 64' ' ' GLN . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.496 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.503 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.478 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 60' ' ' LEU . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.628 ' HB2' HG13 ' A' ' 50' ' ' VAL . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HB3' ' N ' ' A' ' 13' ' ' GLU . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 88' ' ' VAL . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 93' ' ' GLU . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.68 149.68 48.27 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' HB3' HD21 ' A' ' 102' ' ' ASN . 6.0 m-20 -62.63 169.89 2.82 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' C ' ' CG ' ' A' ' 102' ' ' ASN . 3.9 tt0 -151.84 -59.15 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.622 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' CG ' ' C ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER 44.53 87.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.113 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -16.86 24.2 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.841 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 3.0 p30 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.097 0.475 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.663 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.49 93.88 4.85 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.026 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.71 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.626 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HZ1' ' HG ' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 62' ' ' VAL . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 23' ' ' GLN . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' N ' HG22 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 26' ' ' SER . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.846 HD11 HD13 ' A' ' 76' ' ' LEU . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 52' ' ' ILE . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 73' ' ' LYS . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 38' ' ' ILE . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.8 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.64 HD22 ' HB2' ' A' ' 86' ' ' GLU . 4.2 p30 -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' HD22 ' A' ' 84' ' ' ASN . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.572 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 73' ' ' LYS . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 76' ' ' LEU . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m -146.72 149.05 32.67 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.97 150.03 5.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.444 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 103' ' ' ASP . 2.3 pt20 -56.02 -94.49 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.931 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -172.42 53.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.716 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HE21 ' A' ' 101' ' ' GLN . 11.0 t0 -93.8 105.74 17.75 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' CG ' ' O ' ' A' ' 104' ' ' ASN . 22.0 t-20 . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.85 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.536 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 -80.03 101.14 8.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.006 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 2' ' ' TRP . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.67 HG22 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.67 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.555 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 15.7 m120 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' ND2' ' HE2' ' A' ' 61' ' ' LYS . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' OE1' ' A' ' 13' ' ' GLU . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 76' ' ' LEU . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.553 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 62' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 53' ' ' ILE . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.555 ' HB2' ' H ' ' A' ' 12' ' ' ASN . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 98' ' ' VAL . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 73' ' ' LYS . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.45 ' NE2' HG22 ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.582 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 76' ' ' LEU . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.42 150.01 23.79 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.51 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.951 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -172.62 -155.43 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.79 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -66.75 -117.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.017 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 104' ' ' ASN . 38.0 t0 49.61 -157.45 0.08 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.659 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.6 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 17.1 p-10 . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.797 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 2' ' ' TRP . 37.9 t70 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.563 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 -79.16 87.35 4.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 2' ' ' TRP . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.628 ' N ' HG22 ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.607 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 52' ' ' ILE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.41 HD22 ' HE2' ' A' ' 61' ' ' LYS . 5.5 m120 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 21' ' ' LEU . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' ILE . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.446 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 51' ' ' PHE . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 50' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' CB ' ' A' ' 18' ' ' PRO . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.557 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.508 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' LYS . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' C ' HD22 ' A' ' 76' ' ' LEU . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.728 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.528 HD11 ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 149.18 49.72 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.56 174.41 0.44 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.021 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.633 ' CD ' ' H ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -91.48 -138.63 0.16 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.418 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.633 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 34.7 t30 -122.46 17.77 10.51 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.27 97.76 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.631 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 p30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.239 -1.839 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 -82.4 91.75 6.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.52 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 21' ' ' LEU . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLU . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.0 m120 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 10' ' ' PRO . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 48' ' ' VAL . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CD1' HG12 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 HG22 ' CG2' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 81' ' ' VAL . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.569 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.452 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 71' ' ' ILE . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m -120.23 123.98 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.78 159.75 5.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.747 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -136.17 -17.18 1.6 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.966 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -130.66 74.32 1.59 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.805 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -167.46 -27.47 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 110.839 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 27.2 p-10 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.162 0.506 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -78.55 103.18 8.32 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.628 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 3' ' ' VAL . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.761 ' N ' HG22 ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.571 ' SG ' HD13 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 61' ' ' LYS . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HG22 ' A' ' 4' ' ' ILE . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.708 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 38' ' ' ILE . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 3.4 pt20 -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' N ' ' A' ' 41' ' ' GLN . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.535 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 53' ' ' ILE . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 59' ' ' TRP . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 60' ' ' LEU . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.41 HG13 HD12 ' A' ' 21' ' ' LEU . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 73' ' ' LYS . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 71' ' ' ILE . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.601 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 88' ' ' VAL . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.681 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.54 HG21 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.33 122.72 28.43 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -146.31 33.34 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.549 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 101' ' ' GLN . 7.0 t-20 74.35 24.4 1.85 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.443 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.7 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.2 t30 . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.794 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.977 0.418 . . . . 0.0 111.407 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.672 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 -79.29 88.84 4.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.667 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.618 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.434 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.824 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD11 HG11 ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' ASP . 9.4 t-20 -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 80' ' ' ALA . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.672 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.781 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.592 ' HE1' ' HG ' ' A' ' 9' ' ' CYS . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.633 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.718 ' N ' HD23 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.7 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.03 HG22 ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.03 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' H ' HG22 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 94' ' ' ILE . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.571 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.781 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 32' ' ' THR . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 82' ' ' SER . 2.0 p30 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' HB2' ' HG ' ' A' ' 82' ' ' SER . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.781 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 66' ' ' LEU . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.01 147.96 36.1 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.75 149.94 41.46 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 12' ' ' ASN . 1.6 tt0 -168.78 50.25 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.184 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.58 102.95 0.78 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 50.8 t0 -172.19 -56.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.915 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.75 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.587 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG21 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD2' HD22 ' A' ' 21' ' ' LEU . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.589 HD12 ' CG1' ' A' ' 62' ' ' VAL . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.652 HG21 ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.589 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HB2' HG13 ' A' ' 50' ' ' VAL . 19.9 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' CD1' ' A' ' 96' ' ' ILE . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.652 ' NE2' HG21 ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.749 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.749 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.575 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 76' ' ' LEU . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.679 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.206 -1.185 0 CA-C-O 120.65 0.262 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 8' ' ' SER . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' NZ ' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.731 HD11 ' CG1' ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' N ' HG22 ' A' ' 22' ' ' VAL . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 25' ' ' LYS . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.615 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 32' ' ' THR . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.407 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 42' ' ' GLY . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 52' ' ' ILE . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 53' ' ' ILE . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' N ' HD23 ' A' ' 60' ' ' LEU . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.731 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.555 ' C ' HD22 ' A' ' 76' ' ' LEU . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.562 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 . . . . . 0 C--O 1.21 -1.016 0 CA-C-O 120.803 0.335 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 2' ' ' TRP . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' CB ' HD11 ' A' ' 66' ' ' LEU . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 62' ' ' VAL . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.62 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 76' ' ' LEU . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 1.6 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.544 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 47' ' ' PRO . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.44 ' CD2' HG12 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 57' ' ' THR . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 66' ' ' LEU . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.692 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.033 HG22 ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.033 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.643 ' HE2' HG13 ' A' ' 95' ' ' VAL . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.612 ' CZ ' HD12 ' A' ' 71' ' ' ILE . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' HD21 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.643 HG13 ' HE2' ' A' ' 73' ' ' LYS . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.621 0.248 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.505 HG22 ' C ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.636 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.823 ' SG ' HG22 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.658 ' C ' HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG21 ' HB1' ' A' ' 80' ' ' ALA . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.556 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HZ ' HD21 ' A' ' 66' ' ' LEU . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD23 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.792 ' CE1' HD23 ' A' ' 66' ' ' LEU . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.617 ' C ' HD22 ' A' ' 76' ' ' LEU . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 ' C ' ' A' ' 75' ' ' ILE . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.402 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 4.6 m-70 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.712 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 88' ' ' VAL . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.823 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' HD2' ' A' ' 25' ' ' LYS . 7.0 m0 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 2' ' ' TRP . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.81 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.595 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD13 ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 82' ' ' SER . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 26' ' ' SER . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 39' ' ' THR . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.856 ' N ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 47' ' ' PRO . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.063 HD13 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 1.063 ' N ' HD13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.766 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 66' ' ' LEU . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.647 ' C ' HD22 ' A' ' 76' ' ' LEU . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.647 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.613 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 2' ' ' TRP . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.698 HG22 ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.698 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.74 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.783 ' H ' HD22 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 20' ' ' ASN . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' GLN . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' VAL . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 53' ' ' ILE . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.621 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.883 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.566 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.609 HG22 ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.831 HD11 HG13 ' A' ' 24' ' ' ILE . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 21' ' ' LEU . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.407 ' CG ' HG11 ' A' ' 98' ' ' VAL . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 75' ' ' ILE . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.609 ' NE2' HG22 ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.883 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.638 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' HD21 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' GLU . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.694 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' CG ' ' A' ' 68' ' ' ARG . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.5 m0 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' TRP . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 96' ' ' ILE . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 52' ' ' ILE . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.818 ' C ' HD22 ' A' ' 21' ' ' LEU . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.736 HG21 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 2' ' ' TRP . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.562 ' N ' ' OG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.646 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.646 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.45 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.736 ' CD1' HG21 ' A' ' 24' ' ' ILE . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.6 HG21 HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 79' ' ' HIS . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.512 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 44' ' ' ASP . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 18' ' ' PRO . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 HG21 ' A' ' 38' ' ' ILE . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 21' ' ' LEU . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.674 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 75' ' ' ILE . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 76' ' ' LEU . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 39' ' ' THR . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 88' ' ' VAL . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.626 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.633 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.746 0.308 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' TRP . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.734 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 21' ' ' LEU . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 23' ' ' GLN . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.507 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.615 HG21 ' CD2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.623 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 18.4 m120 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.637 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.633 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 50' ' ' VAL . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.543 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 47' ' ' PRO . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.004 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.651 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 76' ' ' LEU . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.852 HD22 ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.852 ' N ' HD22 ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.827 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.584 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG21 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.004 HG22 HD23 ' A' ' 66' ' ' LEU . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.7 m0 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.884 0.373 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.688 HG22 ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.688 ' N ' HG22 ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.718 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.718 HD12 ' C ' ' A' ' 20' ' ' ASN . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' N ' ' OG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.76 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.651 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 48' ' ' VAL . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 48' ' ' VAL . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.478 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.63 ' OG1' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.63 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 2.8 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.562 ' O ' HG21 ' A' ' 98' ' ' VAL . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 71' ' ' ILE . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.63 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.817 0.341 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 21' ' ' LEU . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.642 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.667 HD11 HD13 ' A' ' 76' ' ' LEU . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.534 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 64' ' ' GLN . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 60' ' ' LEU . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.465 HG23 ' CD1' ' A' ' 52' ' ' ILE . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.689 ' HB2' HG13 ' A' ' 50' ' ' VAL . 5.0 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.702 HD12 HG22 ' A' ' 98' ' ' VAL . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 73' ' ' LYS . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 71' ' ' ILE . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CE1' HD13 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 38' ' ' ILE . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 94' ' ' ILE . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.6 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' HD21 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.6 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 78' ' ' SER . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 HD12 ' A' ' 66' ' ' LEU . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.209 -1.076 0 CA-C-O 121.077 0.465 . . . . 0.0 110.946 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 8' ' ' SER . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.622 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.756 ' H ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 9' ' ' CYS . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.401 ' CD2' HG12 ' A' ' 62' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.622 HD11 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.474 ' CD1' HD12 ' A' ' 24' ' ' ILE . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.59 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HE2' ' ND2' ' A' ' 20' ' ' ASN . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 98' ' ' VAL . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.636 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HB2' HD21 ' A' ' 84' ' ' ASN . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.483 HD12 HD23 ' A' ' 76' ' ' LEU . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.626 HG22 HD12 ' A' ' 66' ' ' LEU . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.632 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.736 ' N ' HD22 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 21' ' ' LEU . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 23' ' ' GLN . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 14.5 p-10 -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' PRO . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 ' HB ' ' A' ' 38' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 21' ' ' LEU . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' H ' HG22 ' A' ' 71' ' ' ILE . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 38' ' ' ILE . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.618 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.637 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' O ' HD13 ' A' ' 7' ' ' ILE . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 6' ' ' PRO . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.584 ' H ' HG22 ' A' ' 7' ' ' ILE . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' N ' HD22 ' A' ' 20' ' ' ASN . 2.2 m120 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 62' ' ' VAL . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' N ' HG22 ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.608 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.662 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 48' ' ' VAL . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 50' ' ' VAL . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.741 HD12 ' HB ' ' A' ' 38' ' ' ILE . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.4 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 62' ' ' VAL . 17.7 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 75' ' ' ILE . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.801 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.537 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.801 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 72' ' ' ALA . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 . . . . . 0 C--O 1.209 -1.052 0 CA-C-O 120.902 0.382 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.696 HG22 ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.696 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.597 ' HA3' ' HZ2' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.697 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.445 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.697 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.465 HD21 ' HD3' ' A' ' 61' ' ' LYS . 1.4 m-80 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' CG1' ' A' ' 62' ' ' VAL . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 29' ' ' ASP . 29.4 t30 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.742 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 64' ' ' GLN . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.496 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.503 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.478 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 60' ' ' LEU . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.628 ' HB2' HG13 ' A' ' 50' ' ' VAL . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HB3' ' N ' ' A' ' 13' ' ' GLU . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' VAL . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 93' ' ' GLU . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.663 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.104 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.71 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.626 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HZ1' ' HG ' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.427 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 62' ' ' VAL . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 23' ' ' GLN . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.601 HE21 ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 26' ' ' SER . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.846 HD11 HD13 ' A' ' 76' ' ' LEU . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 52' ' ' ILE . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.406 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.601 ' C ' HE21 ' A' ' 23' ' ' GLN . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.634 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 73' ' ' LYS . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.514 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 38' ' ' ILE . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.8 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.739 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 84' ' ' ASN . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.572 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 73' ' ' LYS . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 76' ' ' LEU . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.536 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 2' ' ' TRP . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.67 HG22 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.67 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.555 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 29.5 m-80 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' ND2' ' HE2' ' A' ' 61' ' ' LYS . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' OE1' ' A' ' 13' ' ' GLU . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 76' ' ' LEU . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.553 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 62' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.454 HD12 ' C ' ' A' ' 53' ' ' ILE . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.555 ' HB2' ' H ' ' A' ' 12' ' ' ASN . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 98' ' ' VAL . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 73' ' ' LYS . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.45 ' NE2' HG22 ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.582 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 76' ' ' LEU . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.563 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.087 0.47 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 2' ' ' TRP . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.628 ' N ' HG22 ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.607 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 52' ' ' ILE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.515 HD21 ' HE2' ' A' ' 61' ' ' LYS . 5.4 m-80 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 21' ' ' LEU . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.619 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' ILE . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.446 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 51' ' ' PHE . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 50' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' CB ' ' A' ' 18' ' ' PRO . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.557 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.455 HE21 HG22 ' A' ' 50' ' ' VAL . 23.0 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.508 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.509 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' LYS . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' C ' HD22 ' A' ' 76' ' ' LEU . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.728 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.528 HD11 ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.613 0.244 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 21' ' ' LEU . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' CD ' ' ND2' ' A' ' 12' ' ' ASN . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' ND2' ' CD ' ' A' ' 11' ' ' GLU . 62.3 m-20 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 10' ' ' PRO . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 48' ' ' VAL . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CD1' HG12 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 HG22 ' CG2' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 81' ' ' VAL . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.569 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.452 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 71' ' ' ILE . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.21 -1.0 0 CA-C-O 120.848 0.356 . . . . 0.0 111.628 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.761 ' N ' HG22 ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.571 ' SG ' HD13 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 61' ' ' LYS . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HG22 ' A' ' 4' ' ' ILE . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.708 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 38' ' ' ILE . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' N ' ' A' ' 41' ' ' GLN . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.535 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 53' ' ' ILE . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 59' ' ' TRP . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 60' ' ' LEU . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.41 HG13 HD12 ' A' ' 21' ' ' LEU . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 73' ' ' LYS . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 71' ' ' ILE . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.407 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.601 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.681 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.54 HG21 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TRP . . . . . 0.672 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.548 0.214 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.618 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.565 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.824 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD11 HG11 ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 80' ' ' ALA . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.672 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.781 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.592 ' HE1' ' HG ' ' A' ' 9' ' ' CYS . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.633 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.718 ' N ' HD23 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.7 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.03 HG22 ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.03 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.652 ' H ' HG22 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 94' ' ' ILE . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.571 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.781 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 32' ' ' THR . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.1 p-10 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.781 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 66' ' ' LEU . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.929 0.395 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.587 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 10.5 m0 -81.34 90.27 6.14 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -156.67 87.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.678 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.3 tp -162.33 88.97 1.4 Allowed Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.563 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.4 Cg_exo -58.67 -43.65 43.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.104 1.203 . . . . 0.0 113.214 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -74.59 145.35 33.02 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.305 1.337 . . . . 0.0 111.508 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.1 mm -139.41 169.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.936 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.643 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 7.3 t -129.38 132.83 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.026 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' SG ' HG21 ' A' ' 96' ' ' ILE . 4.4 m -130.78 120.95 18.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.668 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HD2' HD22 ' A' ' 21' ' ' LEU . 4.2 Cg_exo -61.85 166.26 12.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 121.189 1.26 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -122.92 155.63 36.32 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.246 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.07 32.37 18.13 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.489 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 15.6 mm-40 -63.98 132.6 51.15 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.76 -1.176 . . . . 0.0 110.398 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.16 138.6 54.13 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.7 -110.95 0.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -127.26 110.4 12.81 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 40.5 m-85 -97.9 147.88 33.69 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.3 Cg_endo -68.3 155.81 88.59 Favored 'Cis proline' 0 C--O 1.217 -0.539 0 C-N-CA 123.761 -1.349 . . . . 0.0 111.843 -1.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -134.37 150.04 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.406 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -75.71 154.14 36.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.808 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.589 HD12 ' CG1' ' A' ' 62' ' ' VAL . 26.0 mt -127.77 -60.32 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.261 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.86 152.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.808 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 57' ' ' THR . 4.3 tm0? -78.42 153.07 31.82 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.682 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 25' ' ' LYS . 6.0 mm -97.89 156.57 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.929 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 24' ' ' ILE . 72.0 mttt -141.73 122.09 14.01 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.483 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 10.8 t -100.28 -121.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -158.43 -47.84 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.097 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -56.44 -8.87 0.59 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.196 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.2 p-10 -65.02 17.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.791 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -109.67 3.43 20.98 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.459 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.09 -30.61 1.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.319 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -159.89 141.37 12.73 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -48.9 109.13 0.22 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.883 -1.127 . . . . 0.0 109.346 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.9 p -99.94 135.62 34.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.735 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 83' ' ' SER . 5.0 m-30 -98.16 160.25 14.42 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.634 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 26' ' ' SER . 79.7 m-85 -108.29 172.66 6.71 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.49 148.07 17.76 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.828 -1.987 . . . . 0.0 107.185 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.416 ' CG1' ' N ' ' A' ' 39' ' ' THR . 2.3 tt -132.28 150.7 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 C-N-CA 118.754 -1.179 . . . . 0.0 113.303 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.652 HG21 ' NE2' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -159.99 146.8 16.15 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.897 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.72 174.54 13.68 Favored Glycine 0 N--CA 1.504 3.167 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.605 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' H ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -53.23 130.49 34.83 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.524 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.89 -22.93 18.01 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.88 -67.93 0.95 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.926 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -105.89 -27.26 11.32 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.745 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -99.47 151.72 37.54 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.445 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.2 Cg_exo -56.88 131.05 43.12 Favored 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 121.42 1.414 . . . . 0.0 111.628 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -69.8 114.74 2.15 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 124.144 -1.19 . . . . 0.0 110.934 -2.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.1 p -80.48 134.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.426 -0.909 . . . . 0.0 111.417 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.59 69.78 1.32 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.396 -1.383 . . . . 0.0 111.322 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -138.83 -55.65 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.228 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.476 ' CZ ' HD21 ' A' ' 66' ' ' LEU . 3.2 m-85 -108.69 146.56 33.27 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.745 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 pt -141.21 145.73 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.113 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' A' ' 60' ' ' LEU . 7.7 mt -130.3 146.7 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.867 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 57' ' ' THR . 8.8 tp10 -87.01 106.91 18.16 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.86 -15.65 3.58 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.052 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 43.8 mt-10 -89.92 -69.33 0.73 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.923 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 46.2 p -79.96 -22.33 42.73 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.53 20.23 60.53 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.933 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -72.55 124.3 24.94 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.463 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' CG1' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -90.94 109.26 20.48 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.386 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.82 160.43 21.4 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.363 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.589 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -141.23 151.01 19.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 118.932 -1.107 . . . . 0.0 112.221 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.5 p -90.34 -20.74 22.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.979 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HB2' HG13 ' A' ' 50' ' ' VAL . 19.9 mt-30 -133.84 127.85 19.53 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.558 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.489 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.0 Cg_endo -65.17 179.38 1.52 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.415 1.41 . . . . 0.0 111.54 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.508 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 23.2 mt -98.35 170.51 8.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.263 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -145.3 108.42 4.57 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -55.1 -32.43 62.0 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -63.41 -27.57 69.39 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.642 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.79 -57.98 2.1 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.723 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 8.3 mt -136.66 138.91 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.625 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.74 22.38 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -155.83 122.74 5.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.477 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 9.4 m-85 -99.67 150.34 22.39 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.06 135.6 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.604 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 ' CD1' ' A' ' 96' ' ' ILE . 22.7 mt -138.3 166.08 25.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -118.82 148.58 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.1 p -138.98 160.18 40.37 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.643 -1.223 . . . . 0.0 113.103 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.652 ' NE2' HG21 ' A' ' 39' ' ' THR . 16.6 m-70 -124.74 151.49 45.0 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.22 143.21 48.39 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.845 -0.742 . . . . 0.0 112.42 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.09 151.1 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.283 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 25.8 p -87.62 123.9 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.652 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 3.9 p -55.08 1.5 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.359 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.749 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -92.46 -26.35 18.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.964 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 129.8 -5.02 6.14 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.749 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 24.3 mt-10 -99.3 125.43 44.94 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.535 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.75 135.61 48.33 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.739 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.3 m -137.91 32.14 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.575 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 13.4 pt-20 -79.02 159.75 27.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.205 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.584 ' OD2' ' NH1' ' A' ' 28' ' ' ARG . 24.3 m-20 -159.68 147.39 13.08 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.474 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.67 90.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 120.743 0.962 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 90' ' ' ASP . 49.5 mtm -107.06 127.65 53.67 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.2 114.9 29.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.094 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.12 123.88 46.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.063 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.93 122.6 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.377 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 76' ' ' LEU . 13.9 mt -116.64 112.6 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.273 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 t -93.44 150.48 20.42 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.077 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.98 150.12 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.592 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 m -136.09 149.43 48.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.054 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.07 131.78 32.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.816 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 1.2 pm0 -53.7 173.68 0.06 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.92 -5.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 101' ' ' GLN . 68.7 m-20 -91.17 115.08 27.73 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.86 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 116.209 -1.853 . . . . 0.0 110.701 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.472 0.653 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.679 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -79.36 96.26 5.95 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 2' ' ' TRP . 1.5 m -161.68 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -161.01 89.13 1.63 Allowed Pre-proline 0 CA--C 1.568 1.665 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.094 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 Cg_exo -66.28 -41.98 11.34 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 121.97 1.78 . . . . 0.0 114.972 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.2 Cg_endo -70.75 138.52 34.86 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 121.75 1.633 . . . . 0.0 112.628 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 8' ' ' SER . 7.5 mm -137.75 167.54 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.326 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.8 p -132.96 143.22 49.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.829 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.5 m -137.19 122.44 12.78 Favored Pre-proline 0 N--CA 1.49 1.537 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.249 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HG2' ' NZ ' ' A' ' 19' ' ' LYS . 4.1 Cg_exo -61.91 151.46 81.05 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 121.346 1.364 . . . . 0.0 112.184 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.88 154.16 25.59 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.553 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 58.81 60.42 2.5 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.338 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.57 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -119.23 97.29 5.59 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.518 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -102.71 132.13 49.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.68 -122.15 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.656 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -94.53 150.18 20.51 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.186 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.416 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 20.3 m-85 -140.43 155.42 69.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.166 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.2 Cg_endo -73.51 161.39 94.19 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.02 -0.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' HG2' ' A' ' 10' ' ' PRO . 13.8 ttpt -107.77 113.1 26.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.766 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -65.69 147.13 53.9 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.1 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.731 HD11 ' CG1' ' A' ' 62' ' ' VAL . 21.8 mt -121.8 -67.27 0.97 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.068 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.8 p -159.53 160.16 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.948 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' N ' HG22 ' A' ' 22' ' ' VAL . 42.3 mt-30 -81.12 157.68 25.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 25' ' ' LYS . 18.6 mm -89.91 151.17 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.124 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' CE3' ' A' ' 2' ' ' TRP . 32.5 mttt -141.16 113.22 7.87 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.7 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 23.1 t -99.41 -144.67 0.33 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.352 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.442 ' N ' ' OG ' ' A' ' 26' ' ' SER . 1.9 m120 -124.37 -46.93 1.89 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.615 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.4 mtt85 -56.75 -9.3 0.75 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.733 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -65.11 14.39 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 28' ' ' ARG . 12.4 mttm -98.33 -14.13 20.36 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.049 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -103.03 -37.26 7.85 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.886 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.7 t -160.51 152.87 20.58 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.503 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' O ' HG23 ' A' ' 32' ' ' THR . 33.5 tttm -46.49 148.38 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.812 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -140.24 142.6 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 118.461 -1.295 . . . . 0.0 113.2 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.64 161.11 13.83 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.966 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.407 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 32.0 m-85 -124.12 179.14 4.99 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -160.75 149.38 16.5 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.489 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 39' ' ' THR . 1.3 tt -126.9 149.49 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.932 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 9.9 t -160.39 161.01 32.95 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.17 -171.93 14.16 Favored Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -53.82 116.98 2.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 118.07 -16.79 11.9 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.8 -67.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.867 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -112.93 -23.72 9.93 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -99.73 150.54 36.91 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.663 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -58.27 129.82 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 121.509 1.473 . . . . 0.0 111.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.9 Cg_endo -67.53 121.81 4.4 Favored 'Cis proline' 0 C--O 1.215 -0.65 0 C-N-CA 124.074 -1.219 . . . . 0.0 111.005 -2.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.2 p -80.25 137.88 20.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.651 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.35 88.59 0.18 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.249 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 42' ' ' GLY . 12.0 t -148.94 -53.2 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -113.7 147.87 37.42 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.508 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 52' ' ' ILE . 25.4 pt -139.73 153.7 23.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 53' ' ' ILE . 5.4 mt -139.78 147.38 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.589 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' GLU . 1.0 OUTLIER -82.68 100.02 9.96 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.529 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -44.3 -20.63 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.935 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 4.5 mm-40 -92.41 -69.19 0.76 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.023 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -80.36 10.24 4.83 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.898 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.26 20.56 1.51 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.206 -1.474 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.97 113.9 6.78 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.076 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -86.27 116.49 24.48 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.314 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' N ' HD23 ' A' ' 60' ' ' LEU . 12.7 mttm -124.6 160.31 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.259 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.731 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -126.21 139.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.992 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 p -90.4 -46.76 8.16 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.626 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -100.43 132.72 22.04 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.37 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -61.32 166.82 10.46 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.118 1.212 . . . . 0.0 110.769 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.0 mp -97.65 168.62 10.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.79 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -146.37 99.82 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.615 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -53.18 -20.21 3.73 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.11 -33.92 65.85 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.998 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.42 6.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.334 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 82.8 mt -141.77 138.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.771 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -102.54 -14.68 16.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -155.72 126.12 6.74 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.3 m-85 -104.49 129.59 52.49 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.023 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.555 ' C ' HD22 ' A' ' 76' ' ' LEU . 27.5 mt -101.37 112.56 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.6 mm? -108.48 155.65 20.36 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -115.6 148.52 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 90.7 p -144.58 159.76 42.26 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.235 -1.386 . . . . 0.0 113.291 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.548 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.0 OUTLIER -127.07 151.22 48.91 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.206 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -128.63 149.13 50.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.603 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -139.75 133.04 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.758 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 84' ' ' ASN . 78.8 p -65.01 131.78 47.48 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.641 -1.224 . . . . 0.0 111.177 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 t -60.93 6.8 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 82' ' ' SER . 17.7 p30 -94.48 -19.31 20.67 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.631 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.413 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 116.23 12.6 8.9 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.556 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 80.8 mt-10 -113.03 133.68 54.86 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.772 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.32 127.91 34.39 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.034 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.6 m -137.92 27.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 2.1 pt-20 -79.88 142.81 34.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.674 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 92' ' ' MET . 94.0 m-20 -138.9 149.08 60.49 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -53.86 85.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 120.635 0.89 . . . . 0.0 110.513 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 90' ' ' ASP . 38.0 mtp -100.66 121.68 42.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.937 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.97 111.97 24.93 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.664 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.4 mt -89.15 131.81 35.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.625 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.59 110.05 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.774 -0.771 . . . . 0.0 110.654 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 9' ' ' CYS . 9.9 mt -104.54 109.86 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.13 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 t -90.17 150.07 22.16 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.288 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.535 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -89.85 131.69 36.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.441 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.0 m -110.26 143.05 41.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 1.5 m-20 -73.19 115.53 12.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.675 ' NE2' HD21 ' A' ' 102' ' ' ASN . 0.0 OUTLIER -43.8 -53.66 5.79 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.941 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.675 HD21 ' NE2' ' A' ' 101' ' ' GLN . 1.9 p30 -177.57 -117.99 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.69 123.86 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.957 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 C--N 1.305 -1.369 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.782 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.114 0.483 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.562 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.9 m0 -78.87 97.3 5.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 2' ' ' TRP . 11.6 m -158.42 89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.276 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -159.9 86.48 2.02 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.037 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 Cg_exo -65.31 -41.51 15.81 Favored 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 121.948 1.765 . . . . 0.0 114.719 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 2.1 Cg_endo -65.53 146.01 83.74 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.61 1.54 . . . . 0.0 113.2 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.646 ' CG2' ' N ' ' A' ' 8' ' ' SER . 4.4 mt -150.09 170.31 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.646 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 59.7 p -137.49 143.6 41.79 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.106 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' CB ' HD11 ' A' ' 66' ' ' LEU . 6.4 m -140.36 110.86 7.0 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.819 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.31 172.98 6.84 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.532 1.488 . . . . 0.0 113.754 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.5 tt0 -99.28 140.48 33.39 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 43.86 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 2.6 mt-10 -81.29 175.97 10.14 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.987 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -119.14 143.53 47.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.72 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.66 -158.45 17.32 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -107.97 142.17 38.49 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.593 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 73.3 m-85 -98.52 152.73 38.04 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.659 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.7 Cg_endo -71.06 142.99 74.79 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.957 -2.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -106.27 135.7 47.28 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.576 ' ND2' ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -75.29 130.36 38.95 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.759 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 62' ' ' VAL . 9.8 mt -99.31 -62.18 1.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.748 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 p -160.84 160.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.311 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -81.46 156.72 25.19 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.59 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.7 mt -99.34 163.84 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.787 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 43.7 mttt -140.42 124.58 17.58 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.97 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.67 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.7 t -102.16 -108.06 0.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.697 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -170.73 -49.22 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.303 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.62 ' C ' ' H ' ' A' ' 30' ' ' LYS . 8.7 mmt180 -59.43 -6.08 0.95 Allowed 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.246 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.8 OUTLIER -65.75 15.96 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.9 mmtm -106.11 -12.28 15.82 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.908 -0.717 . . . . 0.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.2 pt-20 -107.4 -37.81 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.259 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 1.6 t -159.21 150.84 20.45 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.149 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -49.28 108.88 0.22 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.287 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG21 ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -101.1 140.8 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.016 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.9 m-30 -99.22 160.45 14.26 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.67 ' OH ' ' N ' ' A' ' 26' ' ' SER . 37.3 m-85 -111.36 175.05 5.58 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.41 144.02 13.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.412 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 76' ' ' LEU . 1.1 tt -121.15 149.76 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.485 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -160.21 159.41 31.53 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.77 179.22 20.47 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.623 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 1.6 pt20 -50.14 136.63 19.02 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.629 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.97 -27.84 18.43 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.013 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.58 -78.86 0.59 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.374 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 44' ' ' ASP . 1.1 p30 -99.12 -24.95 14.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 mtmt -99.45 151.23 37.36 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.626 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -55.73 132.21 50.74 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.59 1.527 . . . . 0.0 111.755 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -69.12 116.84 2.74 Favored 'Cis proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.973 -1.261 . . . . 0.0 111.402 -3.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 7.8 p -80.42 135.47 25.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.5 66.9 1.48 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.24 -1.457 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 47' ' ' PRO . 93.7 t -141.17 -37.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.028 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.44 ' CD2' HG12 ' A' ' 62' ' ' VAL . 68.1 m-85 -122.47 141.3 51.78 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.887 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.34 125.84 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.61 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.663 HG22 HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -112.21 135.71 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.182 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 57' ' ' THR . 11.0 tp10 -80.23 108.64 14.0 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.827 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -58.11 -15.07 8.16 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.665 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 60.3 mt-10 -92.29 -67.31 0.86 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.66 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 29.5 p -81.07 -13.07 59.12 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.597 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.22 78.92 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.186 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 120.23 20.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 112.81 24.89 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.496 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.1 160.77 19.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.289 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG12 ' CD2' ' A' ' 51' ' ' PHE . 6.4 m -121.35 139.39 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.04 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -25.56 21.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.652 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.5 133.91 16.07 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.424 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.44 167.38 6.4 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 121.322 1.348 . . . . 0.0 111.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 66' ' ' LEU . 5.6 mt -91.41 170.43 9.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 118.929 -1.108 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 37.7 t0 -132.87 98.92 4.44 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.692 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.4 ttp180 -52.6 -32.18 40.11 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.365 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -70.1 -25.7 63.63 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.846 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.24 -39.38 12.12 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.699 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.033 HG22 ' H ' ' A' ' 72' ' ' ALA . 36.7 mt -145.02 -171.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.033 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -143.52 -19.14 0.61 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.423 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.643 ' HE2' HG13 ' A' ' 95' ' ' VAL . 16.0 tttm -155.27 124.31 6.2 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.612 ' CZ ' HD12 ' A' ' 71' ' ' ILE . 6.5 m-85 -99.43 135.97 40.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.32 142.99 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.535 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.3 tp -140.32 157.23 45.87 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.527 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -122.1 133.01 54.77 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 20.6 p -127.59 160.44 31.58 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.841 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.55 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 5.4 m-70 -133.04 150.84 52.1 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.727 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -121.18 142.69 49.65 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.038 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.01 129.25 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.074 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.0 p -59.68 124.2 19.36 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.441 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.624 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 3.7 t -56.09 0.97 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.6 p30 -88.47 -31.49 18.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.394 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.404 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 130.35 20.15 1.29 Allowed Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.903 -1.141 . . . . 0.0 110.63 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HB2' HD21 ' A' ' 84' ' ' ASN . 31.9 mm-40 -121.22 131.75 54.41 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.953 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.37 125.57 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.325 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.3 m -136.6 26.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ALA . 3.3 pt-20 -79.79 168.01 19.84 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.239 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -159.4 138.47 8.09 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.665 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -51.99 87.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 120.755 0.97 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' ASP . 59.1 mtm -107.84 126.99 53.32 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.13 113.33 26.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.672 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.6 mt -89.16 139.84 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.643 HG13 ' HE2' ' A' ' 73' ' ' LYS . 59.2 t -109.11 126.62 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.1 mt -122.5 118.69 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -92.22 150.44 20.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.382 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.93 150.58 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.224 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.61 148.69 52.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.428 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 101' ' ' GLN . 33.6 t0 -70.79 -165.16 0.1 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.791 ' NE2' ' H ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -151.97 171.42 17.84 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.786 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.791 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 0.9 OUTLIER -91.52 75.49 5.9 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.769 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.07 154.71 41.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 25.0 t30 . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.65 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 6.2 m0 -81.52 87.1 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.84 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.505 HG22 ' C ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.64 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.833 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.8 tp -162.46 88.78 1.38 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.3 -40.79 38.15 Favored 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 121.935 1.757 . . . . 0.0 114.974 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_exo -65.32 132.55 31.87 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 121.635 1.557 . . . . 0.0 113.165 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 8' ' ' SER . 11.2 mm -141.46 170.55 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.24 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.636 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.4 p -121.43 148.04 44.94 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.047 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.823 ' SG ' HG22 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -140.15 118.67 8.52 Favored Pre-proline 0 N--CA 1.495 1.809 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.516 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.03 153.93 76.21 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.467 1.444 . . . . 0.0 112.139 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.586 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -118.76 166.99 12.1 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 60.4 m-20 53.11 -1.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 11' ' ' GLU . 3.4 mm-40 -67.1 102.41 1.01 Allowed 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.14 160.18 22.0 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 140.96 -109.6 0.61 Allowed Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.281 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -95.85 143.18 27.28 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HD3' ' A' ' 65' ' ' PRO . 8.0 m-85 -143.21 160.29 52.62 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.616 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -74.09 167.0 80.95 Favored 'Cis proline' 0 C--N 1.321 -0.893 0 C-N-CA 123.511 -1.454 . . . . 0.0 111.997 -2.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -115.15 121.4 42.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.566 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.658 ' C ' HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -74.1 139.5 44.64 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.664 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.3 mm? -112.62 -68.53 0.92 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.272 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.42 160.7 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -74.58 155.2 38.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.1 mm -89.53 162.15 2.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.619 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.2 mttt -141.14 129.1 21.89 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.713 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.657 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.5 t -104.96 -111.92 0.26 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.64 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -171.86 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.803 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.6 mtt85 -69.38 5.64 1.26 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.649 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.4 OUTLIER -65.05 16.84 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.998 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.5 mttp -107.48 -11.15 15.56 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.312 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -103.39 -40.84 6.21 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.677 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -158.92 152.35 22.78 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.45 126.51 8.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.236 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG21 ' HB1' ' A' ' 80' ' ' ALA . 3.9 p -118.28 139.37 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.519 -0.872 . . . . 0.0 112.682 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.58 158.1 15.82 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.984 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 26' ' ' SER . 36.3 m-85 -110.35 159.6 17.3 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 t -148.95 138.86 22.06 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.514 -1.676 . . . . 0.0 107.717 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.83 150.43 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.424 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -159.93 159.86 32.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.202 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.04 -171.01 15.13 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.628 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.13 127.34 26.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.687 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.41 -8.91 57.19 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.686 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.05 -74.28 0.62 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.837 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -107.96 -22.23 12.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.425 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -99.55 133.07 22.15 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.408 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.556 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 12.8 Cg_exo -48.46 131.09 22.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 121.2 1.267 . . . . 0.0 111.459 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 Cg_endo -69.0 117.36 2.87 Favored 'Cis proline' 0 C--O 1.212 -0.819 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.758 -0.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.556 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -81.27 140.81 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.106 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 78.76 0.74 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.49 -43.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.416 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' HZ ' HD21 ' A' ' 66' ' ' LEU . 64.7 m-85 -117.98 149.27 41.21 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.643 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.7 pt -139.94 143.5 30.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.977 -0.689 . . . . 0.0 109.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 53' ' ' ILE . 2.6 pp -127.22 139.59 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.585 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.528 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 1.7 mm-40 -75.17 103.1 5.2 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.538 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -45.83 -27.92 0.96 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' OE1' ' CZ ' ' A' ' 35' ' ' PHE . 31.0 mm-40 -89.51 -66.91 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.573 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.4 p -79.5 -31.85 42.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.508 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 91.15 20.42 38.95 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.17 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.51 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 9.7 m95 -66.14 121.56 15.45 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.109 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -90.19 114.13 26.05 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.525 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mtpt -127.1 156.14 42.2 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.748 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.26 140.61 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.5 p -98.7 -30.17 12.6 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.804 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -122.24 136.64 26.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 17' ' ' PHE . 2.3 Cg_endo -60.1 162.18 17.35 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 121.318 1.345 . . . . 0.0 110.772 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD23 ' CE1' ' A' ' 74' ' ' TYR . 5.6 mp -106.9 169.23 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.625 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -139.15 100.94 4.14 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.704 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -54.82 -30.3 56.99 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.551 -0.859 . . . . 0.0 110.816 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -55.65 -33.38 64.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.635 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 -57.24 2.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CG2' ' CE1' ' A' ' 74' ' ' TYR . 6.8 mm -116.97 110.6 31.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.407 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.26 -9.09 51.93 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -160.28 123.09 3.38 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.455 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.792 ' CE1' HD23 ' A' ' 66' ' ' LEU . 3.4 m-85 -99.63 146.55 26.34 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.617 ' C ' HD22 ' A' ' 76' ' ' LEU . 40.5 mt -120.81 110.75 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.248 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD22 ' C ' ' A' ' 75' ' ' ILE . 3.8 mm? -106.72 161.2 14.87 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.355 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.484 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 41.9 m-85 -127.29 140.68 52.04 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.402 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 97.8 p -133.28 160.03 38.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.882 -1.127 . . . . 0.0 113.441 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 4.6 m-70 -132.23 136.23 46.85 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.977 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 89' ' ' GLU . . . -103.07 143.28 32.79 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.676 -0.809 . . . . 0.0 112.112 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -137.79 129.21 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.099 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.605 ' C ' ' H ' ' A' ' 84' ' ' ASN . 93.8 p -63.43 124.21 20.73 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.67 -1.212 . . . . 0.0 111.258 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 8.2 p -55.83 1.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.078 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -87.37 -31.13 20.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.836 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.712 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 132.41 15.07 1.48 Allowed Glycine 0 N--CA 1.496 2.694 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.037 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 88' ' ' VAL . 14.8 mm-40 -122.45 131.18 53.75 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.71 120.71 16.71 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.3 m -126.72 31.29 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 80' ' ' ALA . 4.1 pt-20 -80.12 168.08 19.57 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.718 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 92' ' ' MET . 5.3 m-20 -155.89 145.74 15.58 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.142 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.65 87.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 120.646 0.897 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' ASP . 7.6 mmt -105.28 109.49 21.49 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.966 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 77' ' ' TYR . 1.8 pt-20 -94.76 110.83 22.64 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.0 mt -88.66 131.98 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.534 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 t -102.29 135.61 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.961 -0.695 . . . . 0.0 109.853 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.823 HG22 ' SG ' ' A' ' 9' ' ' CYS . 7.1 mt -134.31 114.1 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.564 -0.855 . . . . 0.0 111.213 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.404 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 1.4 t -90.64 146.7 23.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.651 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.83 149.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.404 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.25 132.76 51.64 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.76 166.28 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.98 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -144.63 -167.26 2.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.796 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.717 ' ND2' ' H ' ' A' ' 103' ' ' ASP . 4.5 t30 -148.7 -152.28 0.43 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.717 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -174.92 138.21 0.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.917 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.548 ' H ' ' ND2' ' A' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.748 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 2' ' ' TRP . 3.4 t70 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.373 0.606 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' HD2' ' A' ' 25' ' ' LYS . 7.0 m0 -79.75 107.23 12.37 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' C ' ' A' ' 2' ' ' TRP . 76.4 t -157.81 92.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.665 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.7 tp -159.72 86.07 2.1 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.998 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.3 Cg_exo -65.34 -42.41 13.26 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.543 1.495 . . . . 0.0 114.176 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.0 Cg_endo -74.32 143.53 31.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.778 1.652 . . . . 0.0 112.759 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 8' ' ' SER . 18.3 mm -144.7 169.12 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.373 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.699 ' N ' HG22 ' A' ' 7' ' ' ILE . 36.8 t -140.05 150.94 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.81 ' SG ' HD13 ' A' ' 21' ' ' LEU . 1.3 m -136.61 131.72 18.39 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.689 -0.805 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.66 161.14 42.93 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.788 1.659 . . . . 0.0 113.093 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' CG ' ' CG1' ' A' ' 98' ' ' VAL . 28.3 mt-10 -107.16 163.89 12.62 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.015 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 42.33 42.96 2.81 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.394 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.595 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 5.3 mm-40 -39.78 140.64 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' NZ ' ' H ' ' A' ' 104' ' ' ASN . 17.2 ptmt -113.17 169.99 8.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.9 -122.09 7.06 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.547 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -141.14 149.95 42.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.63 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 67.2 m-85 -97.35 152.41 38.22 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.968 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.2 Cg_endo -72.79 174.83 47.36 Favored 'Cis proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.659 -1.392 . . . . 0.0 112.074 -1.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.57 135.38 38.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -74.14 146.85 43.17 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.264 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD13 ' SG ' ' A' ' 9' ' ' CYS . 69.8 mt -118.23 -67.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.5 p -159.25 160.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.273 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.3 tt0 -82.61 152.06 26.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 3.1 mt -97.0 152.03 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.688 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HD2' ' CD1' ' A' ' 2' ' ' TRP . 25.8 mtmt -140.35 121.15 14.43 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.688 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.583 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.0 t -116.86 175.91 5.36 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.737 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.583 ' N ' ' OG ' ' A' ' 26' ' ' SER . 22.3 t-20 -81.82 -55.89 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.185 -1.006 . . . . 0.0 112.263 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 30' ' ' LYS . 12.1 mmp_? -36.23 -27.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.34 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 27' ' ' ASN . 3.0 p-10 -60.96 12.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 28' ' ' ARG . 56.2 mttm -97.06 -2.47 43.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.969 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.42 -25.62 1.93 Allowed 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.942 -1.103 . . . . 0.0 112.698 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.511 HG21 ' HB2' ' A' ' 82' ' ' SER . 5.5 t -160.79 156.52 25.36 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.289 -1.364 . . . . 0.0 112.201 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -54.58 109.55 0.52 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.0 p -98.99 136.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.037 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.61 145.03 27.26 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.935 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.526 ' OH ' ' N ' ' A' ' 26' ' ' SER . 29.8 m-85 -99.64 164.44 12.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.444 -0.902 . . . . 0.0 113.381 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -160.57 110.46 1.75 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.881 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 39' ' ' THR . 8.2 tt -99.3 150.94 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.587 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.535 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.6 t -157.07 151.34 25.09 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.003 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.91 -179.85 18.5 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 119.501 -1.333 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.856 ' N ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -57.86 103.57 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.343 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 136.14 -22.1 3.44 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.05 -67.04 1.02 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.431 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.7 p-10 -106.36 -20.99 13.22 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.039 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 13.6 mptt -104.72 150.51 38.69 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.472 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 47' ' ' PRO . 6.1 Cg_exo -55.25 130.02 38.4 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 121.544 1.496 . . . . 0.0 111.253 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 Cg_endo -67.18 126.5 7.72 Favored 'Cis proline' 0 C--O 1.214 -0.675 0 C-N-CA 123.921 -1.283 . . . . 0.0 111.115 -1.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.2 t -78.67 124.86 37.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.438 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.28 86.37 0.82 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.745 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 42' ' ' GLY . 2.8 t -147.91 -38.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.868 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.04 128.23 51.15 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.54 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.57 140.45 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.526 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.063 HD13 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -127.84 150.32 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.97 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 1.063 ' N ' HD13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -92.64 105.08 17.3 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.981 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -54.82 -22.78 15.53 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -91.15 -65.56 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.174 -1.01 . . . . 0.0 112.332 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.7 p -79.82 -2.6 44.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.902 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.12 16.63 49.21 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.789 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -71.23 118.65 14.29 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.463 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.93 113.31 25.55 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.985 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.74 157.1 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.506 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.766 ' CG1' HD11 ' A' ' 21' ' ' LEU . 1.5 p -127.24 149.17 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.349 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.5 p -97.28 -34.33 11.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.601 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -110.57 133.81 21.05 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.505 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.0 Cg_endo -65.36 157.7 56.5 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.446 1.43 . . . . 0.0 110.7 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' CE1' ' A' ' 74' ' ' TYR . 4.0 mt -89.79 161.03 16.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.343 -1.343 . . . . 0.0 110.248 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -148.61 112.51 5.14 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.481 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -27.72 62.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.753 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.4 -26.38 66.63 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.811 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -108.08 -48.56 3.35 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.355 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 73' ' ' LYS . 37.2 mt -145.11 135.66 19.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.311 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.31 23.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.096 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -158.68 130.45 6.6 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.041 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CE1' HD13 ' A' ' 66' ' ' LEU . 3.3 m-85 -102.99 138.85 39.32 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.647 ' C ' HD22 ' A' ' 76' ' ' LEU . 74.7 mt -113.38 112.0 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.647 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.3 mm? -110.62 160.76 16.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.313 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -119.31 150.83 39.47 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.477 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 25.8 p -141.19 156.7 45.89 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.333 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 1.9 m-70 -136.54 151.14 49.08 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.997 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -132.1 149.55 52.38 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.513 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.5 139.0 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.496 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 84' ' ' ASN . 49.6 p -72.32 128.59 36.09 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.054 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.613 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -62.86 8.97 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.555 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' SER . 21.7 p30 -101.35 -7.51 22.89 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 2.93 31.7 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.103 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 7.9 mm-40 -105.1 124.51 49.66 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.072 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.93 131.75 44.18 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CD ' ' A' ' 28' ' ' ARG . 10.7 m -137.32 28.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.463 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.57 151.26 30.76 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.781 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -152.05 150.79 26.57 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.19 91.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 120.779 0.986 . . . . 0.0 110.951 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 5.8 mmm -114.17 116.38 28.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.574 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -97.08 117.5 31.4 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.312 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.0 mt -89.06 124.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.182 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -102.2 121.58 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.058 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 9' ' ' CYS . 56.7 mt -117.39 112.02 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.694 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -89.84 148.59 23.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' CG ' ' A' ' 11' ' ' GLU . 47.8 t -92.23 149.96 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.85 138.57 28.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.598 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 101' ' ' GLN . 6.9 t70 -48.41 157.67 0.32 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -103.28 172.77 6.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.216 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.0 75.93 1.53 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.183 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.17 135.22 2.6 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.284 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.405 ' H ' ' NZ ' ' A' ' 14' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 116.388 -1.768 . . . . 0.0 110.467 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 18.4 p-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.064 0.459 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.674 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.3 m0 -79.61 89.7 5.12 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 2' ' ' TRP . 73.1 t -156.45 89.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.752 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.6 tp -160.73 88.03 1.74 Allowed Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.1 Cg_exo -61.82 -41.0 40.75 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 121.451 1.434 . . . . 0.0 113.73 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -69.13 141.39 47.64 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.447 1.432 . . . . 0.0 112.37 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.698 HG22 ' N ' ' A' ' 8' ' ' SER . 11.5 mm -142.38 169.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.698 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -130.53 135.65 48.15 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.073 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.4 m -137.18 110.25 9.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 119.964 -0.695 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 160.79 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.203 1.269 . . . . 0.0 112.838 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.74 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 1.7 pm0 -99.9 163.16 12.57 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.773 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 43.46 57.95 3.67 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.214 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 75.2 tt0 -77.41 149.15 35.18 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.544 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -89.96 170.02 10.72 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.146 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.11 161.66 26.49 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.735 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 121.83 26.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 57.4 m-85 -75.09 152.9 86.44 Favored Pre-proline 0 C--N 1.306 -1.317 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.772 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.8 Cg_endo -70.83 158.27 94.36 Favored 'Cis proline' 0 C--O 1.215 -0.646 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.986 -1.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -137.08 151.28 48.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.783 ' H ' HD22 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.18 138.56 42.06 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.563 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.574 HD22 ' C ' ' A' ' 20' ' ' ASN . 3.0 mm? -107.79 -65.72 1.09 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' GLN . 7.2 p -155.63 159.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' VAL . 6.3 mt-30 -80.51 146.59 31.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.993 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.831 HG13 HD11 ' A' ' 53' ' ' ILE . 1.1 mm -96.48 165.91 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.209 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.621 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -136.32 134.5 38.0 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.801 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.647 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 5.2 t -98.62 -129.4 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.875 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 29' ' ' ASP . 5.9 t-20 -157.1 -54.44 0.08 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.147 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.634 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.5 mmm180 -63.83 -1.59 1.46 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 27' ' ' ASN . 9.1 p-10 -62.57 13.2 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 28' ' ' ARG . 49.4 mttm -93.89 -5.22 48.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -118.37 -36.87 3.44 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.217 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.8 t -159.34 152.41 22.11 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.81 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -51.25 113.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 118.846 -1.141 . . . . 0.0 108.858 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.883 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -101.15 147.9 7.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.568 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.566 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.3 m-30 -98.99 152.58 19.66 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.987 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 43.1 m-85 -100.7 163.65 12.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 t -160.8 142.32 12.1 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.232 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -136.34 150.53 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 118.743 -1.183 . . . . 0.0 113.194 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.609 HG22 ' NE2' ' A' ' 79' ' ' HIS . 2.4 t -151.66 146.54 25.87 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.651 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.25 -175.78 21.74 Favored Glycine 0 N--CA 1.5 2.91 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -58.8 111.79 1.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.532 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.64 -17.69 6.85 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -119.79 -68.83 0.88 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.974 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -109.08 -24.74 11.03 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.904 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -99.98 150.33 36.77 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.379 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -56.44 127.89 27.81 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 121.392 1.394 . . . . 0.0 111.494 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.34 118.94 2.87 Favored 'Cis proline' 0 C--O 1.214 -0.688 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.599 -2.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -81.16 113.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.893 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.72 84.57 1.8 Allowed Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.588 -1.292 . . . . 0.0 111.257 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' GLY . 55.9 t -152.05 -40.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.497 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 50' ' ' VAL . 56.8 m-85 -117.0 150.2 38.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.184 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.38 140.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.007 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.831 HD11 HG13 ' A' ' 24' ' ' ILE . 1.1 tt -119.26 149.08 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.406 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 56' ' ' GLU . 2.4 tm-20 -85.36 103.82 14.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.596 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.641 ' NH2' ' CG ' ' A' ' 56' ' ' GLU . 10.4 ttp-105 -44.6 -31.67 1.21 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.582 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.641 ' CG ' ' NH2' ' A' ' 55' ' ' ARG . 3.5 mm-40 -96.56 -65.94 0.94 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.346 -0.942 . . . . 0.0 113.103 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 59' ' ' TRP . 74.7 p -78.56 9.03 4.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.791 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 48.15 15.66 0.42 Allowed Glycine 0 N--CA 1.486 2.02 0 C-N-CA 118.784 -1.674 . . . . 0.0 110.106 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -62.7 113.63 3.12 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.646 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.93 108.8 15.73 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.709 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 160.63 17.99 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.642 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 21' ' ' LEU . 2.3 m -135.78 151.07 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.806 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -25.71 22.45 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.097 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -132.31 136.48 28.12 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.029 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.567 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -63.08 179.79 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.579 0 C-N-CA 121.185 1.257 . . . . 0.0 110.645 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.2 mm? -88.97 148.24 23.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.156 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.2 t0 -117.72 96.93 5.59 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.407 ' CG ' HG11 ' A' ' 98' ' ' VAL . 41.0 mtp180 -57.93 -26.12 61.8 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.9 -20.54 59.67 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.146 -1.021 . . . . 0.0 110.736 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.18 -54.03 2.98 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.57 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 25.1 mt -145.31 129.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.671 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.36 -4.7 55.5 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.376 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' H ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -158.62 125.43 4.78 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.521 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.8 m-85 -106.68 148.13 28.75 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.613 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 75' ' ' ILE . 31.0 mt -108.42 135.31 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.285 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 94' ' ' ILE . 4.3 tp -139.58 146.94 40.45 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.606 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 12.4 m-85 -111.35 130.07 55.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 p -116.5 155.8 28.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.609 ' NE2' HG22 ' A' ' 39' ' ' THR . 16.0 m-70 -132.48 151.15 52.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.717 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.883 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -132.04 134.21 45.28 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.574 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -129.23 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.028 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.638 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 97.7 p -55.63 135.0 51.46 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.469 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 8.9 t -60.7 9.77 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.352 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.638 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -113.8 -13.7 12.6 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.483 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.426 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . 120.02 2.78 12.38 Favored Glycine 0 N--CA 1.506 3.317 0 C-N-CA 119.3 -1.429 . . . . 0.0 111.833 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.557 ' HB2' HD21 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -98.99 121.75 41.35 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.571 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -67.36 128.98 38.45 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.729 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' GLU . 5.0 m -139.34 22.48 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.956 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.694 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -79.12 163.02 25.42 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.313 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.605 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 51.8 m-20 -152.47 133.38 7.83 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.749 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.03 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 120.673 0.916 . . . . 0.0 110.688 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 90' ' ' ASP . 17.0 mmt -113.49 124.4 52.3 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.066 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 158.67 25.51 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.16 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.481 ' N ' ' O ' ' A' ' 76' ' ' LEU . 3.1 mt -134.75 123.06 40.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.493 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -99.94 108.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.9 mt -101.27 109.48 25.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.238 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 t -91.93 145.49 24.5 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG11 ' CG ' ' A' ' 68' ' ' ARG . 42.0 t -90.05 132.35 34.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.57 143.64 45.04 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' C ' ' OE2' ' A' ' 11' ' ' GLU . 3.3 m-20 -52.63 168.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.063 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.411 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -118.7 -16.39 9.39 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.121 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.9 t30 60.28 80.81 0.2 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.164 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER -95.0 149.47 21.22 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.716 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.42 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.5 m0 -84.85 86.95 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.14 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 2' ' ' TRP . 38.4 t -161.62 96.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 120.009 -0.676 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.7 tt -160.63 87.81 1.78 Allowed Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.916 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -63.97 -41.82 21.62 Favored 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 121.659 1.573 . . . . 0.0 113.886 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.8 Cg_endo -72.8 140.76 32.64 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.837 1.691 . . . . 0.0 112.549 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 8' ' ' SER . 13.5 mm -144.09 163.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.502 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 7' ' ' ILE . 4.9 p -128.66 146.7 50.79 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.473 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB2' ' CG2' ' A' ' 96' ' ' ILE . 2.5 t -140.66 115.81 7.49 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.065 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.54 158.34 58.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.497 1.464 . . . . 0.0 112.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.532 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -116.46 170.04 8.87 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.149 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 11' ' ' GLU . 2.9 m-20 52.8 30.86 9.61 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.711 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.3 tp10 -67.04 115.72 7.06 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.773 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -93.77 169.82 10.03 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.88 -159.82 13.77 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.344 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.62 122.79 43.16 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.056 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 63' ' ' THR . 41.5 m-85 -87.78 157.33 52.12 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 52' ' ' ILE . 7.0 Cg_endo -76.07 178.97 32.7 Favored 'Cis proline' 0 C--N 1.32 -0.934 0 C-N-CA 123.469 -1.471 . . . . 0.0 112.116 -1.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 30.7 tttp -140.16 136.5 33.54 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.818 ' C ' HD22 ' A' ' 21' ' ' LEU . 1.8 m120 -75.4 140.05 42.73 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.428 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 20' ' ' ASN . 4.2 mm? -121.01 -59.15 1.76 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.108 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 4.8 p -146.2 161.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -99.34 152.21 20.2 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.438 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.736 HG21 ' CD1' ' A' ' 36' ' ' TYR . 1.5 mp -89.69 151.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.713 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 2' ' ' TRP . 44.5 mttp -140.66 136.73 32.97 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.297 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 35.4 t -116.25 -120.54 0.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.286 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.562 ' N ' ' OG ' ' A' ' 26' ' ' SER . 17.3 t-20 -159.03 -44.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.562 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.646 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.9 mmt85 -57.79 -6.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.457 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -61.93 16.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.227 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.646 ' H ' ' C ' ' A' ' 28' ' ' ARG . 23.8 mtpp -112.1 4.74 18.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.752 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -142.12 -21.88 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.964 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' CG2' ' A' ' 32' ' ' THR . 5.4 t -157.42 132.5 8.86 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.246 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -47.61 110.16 0.29 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.586 -1.246 . . . . 0.0 108.542 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.45 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 6.0 p -98.59 133.25 41.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.354 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -97.05 160.68 14.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.486 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.736 ' CD1' HG21 ' A' ' 24' ' ' ILE . 43.0 m-85 -114.72 164.2 14.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.3 152.68 32.43 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.439 -1.709 . . . . 0.0 107.887 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.6 HG21 HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -140.34 149.88 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.788 -1.165 . . . . 0.0 112.221 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 79' ' ' HIS . 9.2 t -156.15 160.3 39.76 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.35 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 116.44 -168.12 12.66 Favored Glycine 0 N--CA 1.5 2.923 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 54.6 tt0 -49.33 125.15 10.43 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.351 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.31 -9.12 45.39 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -135.69 -70.78 0.47 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.252 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 32.6 p-10 -96.52 -27.91 14.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.731 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -105.78 151.17 39.87 Favored Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.586 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.512 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.3 Cg_exo -55.21 128.62 31.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 121.688 1.592 . . . . 0.0 111.323 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.6 Cg_endo -67.27 120.59 3.52 Favored 'Cis proline' 0 C--O 1.214 -0.722 0 C-N-CA 124.169 -1.18 . . . . 0.0 111.881 -1.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 44' ' ' ASP . 3.5 t -81.01 116.57 25.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.218 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.7 82.74 1.09 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 17.1 t -148.82 -36.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.718 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -110.33 148.21 32.4 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.532 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 18' ' ' PRO . 6.1 pt -140.6 149.67 21.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.372 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG13 HG21 ' A' ' 38' ' ' ILE . 8.3 mt -137.65 144.52 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.834 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' GLY . 2.0 mm-40 -78.22 107.22 10.66 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -44.92 -26.13 0.38 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.826 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.45 -67.88 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.214 -0.995 . . . . 0.0 112.361 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 59' ' ' TRP . 19.1 p -79.51 9.17 5.16 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.422 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.84 16.69 0.05 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 m95 -60.33 118.22 6.16 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.015 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -85.99 115.24 23.47 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.218 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.8 mtmm -123.7 155.62 37.49 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.607 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 21' ' ' LEU . 2.7 m -117.47 141.6 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.883 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 24.3 p -91.3 -29.36 17.19 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.962 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 8.3 mt-30 -122.93 140.57 33.63 Favored Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.514 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.2 Cg_endo -62.8 167.66 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 121.336 1.358 . . . . 0.0 110.835 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.674 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -91.89 162.97 14.2 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.588 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -135.73 93.53 2.96 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.19 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -25.69 15.06 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -74.45 -28.03 60.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.974 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.56 -51.62 4.67 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 52.3 mt -140.98 117.0 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.72 -1.51 58.02 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 119.33 2.37 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.28 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 6.0 m-85 -99.88 139.24 35.83 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 75' ' ' ILE . 32.4 mt -104.1 127.07 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.128 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' HA ' HD12 ' A' ' 76' ' ' LEU . 2.9 tp -126.59 154.69 43.59 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.048 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -120.94 119.65 33.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 p -105.48 159.4 15.96 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.373 -0.931 . . . . 0.0 113.17 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 39' ' ' THR . 25.9 m-70 -139.58 150.45 45.04 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.978 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -124.61 142.65 51.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.512 -0.875 . . . . 0.0 112.083 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -136.7 150.04 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.542 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 84' ' ' ASN . 18.6 p -82.78 137.07 34.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.372 -1.331 . . . . 0.0 110.572 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -59.49 13.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.928 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 82' ' ' SER . 1.7 p-10 -119.88 1.77 11.0 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.291 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.69 2.47 46.55 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.531 -1.319 . . . . 0.0 112.06 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 88' ' ' VAL . 71.2 mm-40 -99.27 109.97 22.55 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -64.05 129.56 40.48 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.063 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.5 m -136.58 29.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.304 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.626 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -79.58 169.98 17.22 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.864 0.84 . . . . 0.0 112.931 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -160.1 138.9 7.79 Favored Pre-proline 0 C--N 1.298 -1.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.445 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -54.2 93.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 120.968 1.112 . . . . 0.0 111.779 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mmt -113.59 121.35 43.92 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.086 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.8 116.49 28.97 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.171 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.47 127.03 47.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.406 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -99.44 110.61 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 9' ' ' CYS . 6.1 mt -106.21 114.34 45.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.37 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -92.64 149.49 21.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.17 146.83 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.096 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.66 142.85 46.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.48 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -61.54 -162.83 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.291 -0.963 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -138.11 179.81 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.666 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -145.69 6.12 1.06 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.461 ' HB2' HE22 ' A' ' 101' ' ' GLN . 3.9 t0 -86.05 -174.54 5.14 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.307 -1.265 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.541 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 2.3 p-10 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 121.068 0.461 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.633 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 16.4 m0 -78.9 100.17 7.11 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.025 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' TRP . 42.2 t -150.61 86.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.19 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.789 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -162.62 88.46 1.36 Allowed Pre-proline 0 C--N 1.308 -1.196 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.549 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.8 Cg_exo -60.7 -42.43 39.14 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 121.388 1.392 . . . . 0.0 114.007 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.6 Cg_endo -70.53 137.65 33.65 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.446 1.431 . . . . 0.0 112.358 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.734 HG22 ' N ' ' A' ' 8' ' ' SER . 9.7 mm -142.79 171.98 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.734 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -136.4 147.99 47.57 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.952 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -139.18 127.16 13.42 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.332 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.72 148.97 91.86 Favored 'Trans proline' 0 C--N 1.333 -0.269 0 C-N-CA 121.473 1.449 . . . . 0.0 113.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 30.9 tt0 -103.99 147.92 26.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 50.16 27.53 2.62 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.908 -1.117 . . . . 0.0 110.379 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 3.2 tp10 -41.28 146.36 0.2 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.352 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.99 170.98 8.91 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.55 -151.58 17.41 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.627 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.94 148.09 48.55 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 87.2 m-85 -103.54 152.29 38.81 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.578 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.7 Cg_endo -71.19 152.94 96.14 Favored 'Cis proline' 0 C--O 1.216 -0.606 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.298 0.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -136.69 142.04 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 1.5 m120 -74.45 157.7 35.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.345 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 21' ' ' LEU . 25.5 mt -132.95 -66.67 0.66 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.577 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 23' ' ' GLN . 14.9 p -150.61 160.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.134 -1.027 . . . . 0.0 111.145 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.507 ' N ' HG22 ' A' ' 22' ' ' VAL . 2.0 tt0 -81.59 165.9 20.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG21 ' CD2' ' A' ' 36' ' ' TYR . 2.4 mm -105.7 155.95 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.941 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 9.0 mttm -141.62 126.14 17.8 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.623 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 41.2 t -107.09 -121.75 0.24 Allowed 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 18.4 m120 -154.44 -51.98 0.09 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.0 mmt180 -47.63 -15.22 0.05 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.139 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 27' ' ' ASN . 4.5 p-10 -58.17 7.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.956 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.641 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.4 mtpm? -88.97 -1.95 58.35 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.144 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -121.46 -39.57 2.65 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.715 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.1 t -160.77 159.6 30.25 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.102 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -51.92 116.29 2.09 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.3 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.637 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.6 p -106.63 144.89 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 119.412 -0.915 . . . . 0.0 113.398 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 5.3 m-30 -98.42 160.53 14.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.633 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 38.7 m-85 -116.11 174.34 6.1 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.58 147.1 15.37 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.721 -2.036 . . . . 0.0 107.334 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -131.8 150.09 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.919 -1.113 . . . . 0.0 112.825 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 t -158.99 158.79 33.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.924 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.7 -169.38 13.03 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -54.32 110.06 0.57 Allowed 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.053 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.99 -16.94 6.37 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 38' ' ' ILE . . . -128.08 -67.37 0.81 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.753 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 32.3 p-10 -102.95 -30.57 10.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.988 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -100.14 147.03 32.95 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.524 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.9 Cg_exo -57.21 132.03 48.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 121.463 1.442 . . . . 0.0 111.222 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HB2' HG21 ' A' ' 50' ' ' VAL . 2.1 Cg_endo -68.33 118.78 3.1 Favored 'Cis proline' 0 C--O 1.212 -0.779 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.649 -1.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.543 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -81.09 150.9 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.12 81.54 0.07 OUTLIER Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.731 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 47' ' ' PRO . 75.9 t -147.03 -48.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.432 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 50' ' ' VAL . 70.7 m-85 -107.57 139.99 41.25 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 pt -137.88 115.62 12.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.954 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 53' ' ' ILE . 1.6 pp -105.6 150.49 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.511 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -84.49 99.0 10.43 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.516 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 1.7 ttp85 -47.35 -11.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.608 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' OE1' ' CE2' ' A' ' 35' ' ' PHE . 56.5 mm-40 -97.2 -70.72 0.71 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.498 -0.881 . . . . 0.0 112.074 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -82.46 3.35 28.6 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.035 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.11 21.69 56.74 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.676 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.34 117.02 16.69 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.383 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.7 OUTLIER -83.83 117.7 23.46 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.577 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.597 ' N ' HD23 ' A' ' 60' ' ' LEU . 21.9 mttt -126.37 161.99 26.58 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.965 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.58 150.69 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.205 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 p -91.66 -26.41 18.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -133.36 137.77 29.89 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 3.4 Cg_endo -63.57 174.34 3.68 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.294 1.329 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.004 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.22 170.31 10.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.814 -1.155 . . . . 0.0 109.939 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 55.5 t0 -140.23 96.2 3.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.282 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.651 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.4 OUTLIER -59.6 -26.56 65.56 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.808 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.84 -18.57 56.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.778 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.64 -41.77 2.91 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 73' ' ' LYS . 6.8 mt -144.26 120.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.533 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.49 0.77 56.65 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 71' ' ' ILE . 23.8 ttpp -160.1 121.74 3.19 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.793 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 6.4 m-85 -100.51 138.61 37.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.948 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.22 109.69 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 76' ' ' LEU . 4.0 tp -110.16 137.58 47.71 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.95 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -99.32 148.32 24.29 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.5 p -138.17 159.37 42.21 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 118.352 -1.339 . . . . 0.0 113.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.656 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -127.56 151.55 48.75 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 113.939 -1.482 . . . . 0.0 108.465 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.42 145.67 51.38 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.39 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -139.6 131.01 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.12 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 84' ' ' ASN . 91.9 p -59.42 132.75 54.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.894 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.461 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -56.78 2.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.534 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.852 HD22 ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -98.57 -22.37 16.01 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.422 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.852 ' N ' HD22 ' A' ' 84' ' ' ASN . . . 122.46 7.87 7.32 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.909 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.827 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 10.4 mm-40 -100.27 132.6 45.56 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.35 122.22 19.17 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.769 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 m -137.16 25.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.584 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -79.18 160.26 27.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.43 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 92' ' ' MET . 6.9 m-20 -160.39 146.59 11.69 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.116 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.72 86.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 120.951 1.101 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.473 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.76 125.17 50.05 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.295 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.71 109.89 21.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.578 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.51 125.79 42.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.542 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 7' ' ' ILE . 29.6 t -99.58 123.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.249 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG21 ' SG ' ' A' ' 9' ' ' CYS . 51.7 mt -122.3 122.62 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.033 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.4 t -94.59 145.17 25.01 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.004 HG22 HD23 ' A' ' 66' ' ' LEU . 37.1 t -95.1 141.19 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -112.49 136.81 51.56 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 7.2 t70 -58.0 162.61 3.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.089 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.6 OUTLIER -177.69 178.37 1.01 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.755 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -44.17 98.88 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 101' ' ' GLN . 33.4 t70 -90.37 147.74 23.27 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.719 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.544 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.36 0 CA-C-O 116.277 -1.82 . . . . 0.0 110.674 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.923 0.392 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.617 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.7 m0 -85.47 88.7 7.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.205 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.8 OUTLIER -160.74 88.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.822 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.5 tp -160.79 89.2 1.68 Allowed Pre-proline 0 N--CA 1.487 1.402 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.089 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.6 Cg_exo -59.72 -42.39 46.8 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 121.398 1.399 . . . . 0.0 113.31 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.4 Cg_endo -71.57 137.13 29.76 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.781 1.654 . . . . 0.0 112.063 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.688 HG22 ' N ' ' A' ' 8' ' ' SER . 11.3 mm -138.9 170.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.69 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.688 ' N ' HG22 ' A' ' 7' ' ' ILE . 13.6 t -133.91 145.91 50.04 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.541 -0.863 . . . . 0.0 111.213 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 21' ' ' LEU . 1.3 m -140.24 123.04 10.06 Favored Pre-proline 0 N--CA 1.493 1.683 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.625 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.42 164.98 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.268 1.312 . . . . 0.0 112.313 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 12' ' ' ASN . 9.8 pt-20 -116.43 165.33 13.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.785 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 0.7 OUTLIER 38.23 37.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.835 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 46.6 mt-10 -49.71 169.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -140.94 165.71 26.77 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.381 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.95 -151.24 16.86 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.746 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.65 141.13 34.98 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.061 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.94 158.39 31.84 Favored Pre-proline 0 N--CA 1.49 1.547 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.11 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -73.63 160.23 96.26 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.158 -1.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -114.28 125.42 53.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.517 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.718 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.6 m-20 -75.28 139.19 42.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.948 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.718 HD12 ' C ' ' A' ' 20' ' ' ASN . 9.3 mp -113.11 -60.54 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.306 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -160.38 160.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 118.926 -1.11 . . . . 0.0 111.307 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HG2' ' CD2' ' A' ' 59' ' ' TRP . 12.0 mt-30 -83.79 153.78 23.9 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.971 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 25' ' ' LYS . 5.7 mm -89.65 159.95 2.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.518 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 24' ' ' ILE . 27.9 mttp -142.18 127.91 19.25 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.765 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 43.4 t -115.96 -173.08 2.28 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.521 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' N ' ' OG ' ' A' ' 26' ' ' SER . 81.4 m-20 -101.69 -48.54 4.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.938 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 16.5 mmt180 -50.64 -12.65 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.405 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.3 p-10 -62.98 15.61 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 6.6 mmtm -100.76 -10.54 20.7 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.122 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.93 -39.62 5.26 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.2 t -159.3 154.27 24.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.695 -1.202 . . . . 0.0 111.802 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -50.49 110.13 0.38 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.473 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.76 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 2.2 p -99.98 142.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.219 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.1 m-30 -98.4 162.19 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.231 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 33.2 m-85 -115.98 176.62 5.01 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.62 155.85 30.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.115 -1.857 . . . . 0.0 107.954 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.651 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -135.91 148.38 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 118.966 -1.093 . . . . 0.0 112.414 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.486 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -160.59 160.82 32.21 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.144 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.85 -169.01 12.94 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 1.2 pt20 -54.79 120.84 7.39 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 112.55 -15.36 24.6 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.565 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.5 -71.85 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.727 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 48' ' ' VAL . 6.5 p-10 -99.95 -21.91 15.48 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.825 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -104.97 150.87 39.21 Favored Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 119.771 -0.771 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -53.57 127.57 25.91 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 121.636 1.557 . . . . 0.0 111.249 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -65.17 123.8 4.22 Favored 'Cis proline' 0 C--O 1.214 -0.709 0 C-N-CA 124.22 -1.159 . . . . 0.0 111.69 -1.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 48' ' ' VAL . 2.1 t -80.9 108.02 13.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.667 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.85 77.72 1.24 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.421 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 3.7 m -141.6 -42.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.169 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -102.85 141.62 35.36 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.707 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.9 pt -139.68 151.91 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.299 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.7 mt -137.83 149.91 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.329 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' GLU . 2.0 mm-40 -89.1 100.26 13.07 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.436 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -44.82 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.257 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 28.2 mt-10 -93.28 -70.66 0.69 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.604 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.478 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.0 p -83.52 11.93 6.37 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 49.69 14.1 0.63 Allowed Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.044 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.478 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.7 m95 -58.57 115.73 3.22 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -91.58 114.89 27.54 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 pttp -126.95 159.9 32.65 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -132.74 146.66 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.288 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.63 ' OG1' ' NE2' ' A' ' 64' ' ' GLN . 31.5 p -92.44 -44.8 8.48 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.512 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.63 ' NE2' ' OG1' ' A' ' 63' ' ' THR . 2.8 mp0 -102.9 128.75 27.12 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.314 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.3 Cg_endo -65.4 165.38 22.66 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.411 1.407 . . . . 0.0 111.938 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 66' ' ' LEU . 5.0 mt -93.2 171.14 9.12 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.361 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 58.3 t0 -136.94 93.14 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.209 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.9 ttt85 -48.42 -25.31 1.57 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.972 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -69.57 -34.55 74.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.15 -42.15 9.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.562 ' O ' HG21 ' A' ' 98' ' ' VAL . 94.1 mt -141.16 118.8 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.21 -4.36 57.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 ttpp -158.85 120.08 3.37 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.31 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 12.8 m-85 -99.72 135.34 41.28 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.376 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.0 mt -102.89 142.93 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.134 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.2 tp -140.34 160.24 40.42 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.597 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -122.06 122.87 40.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.527 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 84.3 p -116.72 159.97 21.46 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 119.234 -0.986 . . . . 0.0 113.581 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.527 ' CD2' ' C ' ' A' ' 78' ' ' SER . 9.9 m-70 -137.76 151.31 48.03 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.037 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -129.58 144.79 51.43 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.009 -1.076 . . . . 0.0 113.486 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.95 131.44 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.692 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' ASN . 90.9 p -57.11 131.96 51.5 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.393 -1.323 . . . . 0.0 111.071 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' PHE . 10.1 t -57.0 3.44 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.013 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' SER . 11.6 p30 -96.17 -28.53 14.52 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 127.38 3.81 6.03 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 84' ' ' ASN . 52.7 mt-10 -99.63 135.28 41.28 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.744 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.79 123.02 20.97 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.115 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.63 25.76 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.95 152.15 31.24 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.498 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 92' ' ' MET . 1.3 m-20 -141.88 124.27 9.25 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.769 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.24 83.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 120.607 0.872 . . . . 0.0 110.784 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -101.62 138.79 38.14 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.392 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.46 117.47 31.78 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.462 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.13 127.34 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.29 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 95' ' ' VAL . 4.5 t -100.14 109.52 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.804 -0.759 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 6.4 mt -107.87 116.54 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.342 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t -93.41 150.05 20.76 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.303 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 71' ' ' ILE . 89.2 t -89.87 150.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.841 -1.144 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.28 149.93 51.75 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.816 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.41 ' CG ' ' N ' ' A' ' 101' ' ' GLN . 1.0 OUTLIER -45.07 158.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.723 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.41 ' N ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -86.52 -167.34 1.84 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.043 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -103.56 40.07 1.49 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -65.4 -52.59 52.4 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' CG ' ' O ' ' A' ' 104' ' ' ASN . 5.6 t-20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 116.327 -1.796 . . . . 0.0 110.711 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.63 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.7 m0 -79.67 101.89 8.64 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.64 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.197 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.0 tt -154.77 85.38 3.65 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.975 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.4 Cg_exo -66.17 -42.76 9.96 Favored 'Trans proline' 0 CA--C 1.554 1.51 0 C-N-CA 121.53 1.487 . . . . 0.0 113.971 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 5.2 Cg_endo -74.19 146.17 35.92 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 C-N-CA 121.714 1.609 . . . . 0.0 112.702 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 8' ' ' SER . 13.1 mm -143.79 169.94 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.623 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.6 t -140.62 148.0 40.22 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.337 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 66' ' ' LEU . 42.1 t -140.71 141.97 26.81 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.254 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -68.29 151.88 76.15 Favored 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 121.903 1.735 . . . . 0.0 113.272 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 9.0 tt0 -110.36 159.27 17.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.571 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 42.45 31.0 0.24 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.309 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.76 147.38 49.97 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.824 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.58 135.79 20.23 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.53 -119.23 0.89 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.487 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -108.73 150.14 28.01 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 46.5 m-85 -137.94 152.34 71.97 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.049 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 3.9 Cg_endo -72.87 167.45 78.39 Favored 'Cis proline' 0 C--N 1.324 -0.736 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.054 -1.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -131.44 127.23 37.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.739 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -75.09 150.65 38.77 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.849 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 21' ' ' LEU . 36.5 mt -124.97 -55.65 1.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.369 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 23' ' ' GLN . 9.6 p -160.55 159.7 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.768 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 22' ' ' VAL . 20.3 mt-30 -86.56 160.5 18.93 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.291 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -102.34 156.64 4.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.58 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 21.8 mttp -140.81 127.83 20.7 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.403 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.642 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 44.9 t -101.98 -125.98 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.132 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' N ' ' OG ' ' A' ' 26' ' ' SER . 19.6 t-20 -154.52 -49.84 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.8 mmt-85 -53.9 -11.79 0.47 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.053 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' N ' ' C ' ' A' ' 27' ' ' ASN . 1.5 p-10 -64.0 14.38 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.728 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' ARG . 51.8 mtpt -97.81 -15.5 20.24 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.096 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 32' ' ' THR . 1.9 pt-20 -107.49 -36.15 6.56 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.402 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 3.3 t -158.32 149.81 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 ttpt -47.5 144.93 2.79 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.862 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.58 140.1 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.766 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 16.3 m-30 -99.03 160.53 14.19 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.218 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 26' ' ' SER . 58.1 m-85 -110.11 174.01 6.06 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.54 148.21 16.09 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.433 -1.712 . . . . 0.0 107.379 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.667 HD11 HD13 ' A' ' 76' ' ' LEU . 19.5 tt -140.53 150.08 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 118.306 -1.358 . . . . 0.0 113.246 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -159.19 144.66 16.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.414 -1.267 . . . . 0.0 109.655 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.8 -175.87 20.78 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 1.5 pt20 -50.33 120.47 4.58 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.64 -24.52 12.04 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.45 -68.54 0.92 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.2 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 42.1 p-10 -107.32 -23.62 12.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.995 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 17.5 mttt -99.57 150.61 36.94 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.771 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.2 Cg_endo -59.45 130.82 37.38 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 121.505 1.47 . . . . 0.0 111.395 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.94 118.51 3.2 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 124.15 -1.188 . . . . 0.0 111.145 -2.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.0 p -80.59 144.83 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.55 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.35 77.15 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.546 -1.312 . . . . 0.0 111.478 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 64' ' ' GLN . 98.2 t -147.56 -41.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -121.89 134.42 54.86 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.723 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -140.58 153.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.463 HG12 ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -140.52 148.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.442 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -81.39 97.33 7.68 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.471 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -44.56 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.644 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.2 mt-10 -90.91 -67.89 0.82 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.277 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.3 p -82.28 6.71 15.96 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.373 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.37 18.53 3.55 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.196 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CD2' ' HG2' ' A' ' 23' ' ' GLN . 4.5 m95 -71.2 118.98 14.68 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.206 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -94.07 120.21 34.0 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.063 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' N ' HD23 ' A' ' 60' ' ' LEU . 15.3 ptmt -131.65 157.57 43.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.544 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.5 150.68 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.928 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.465 HG23 ' CD1' ' A' ' 52' ' ' ILE . 15.8 p -103.65 -21.36 13.73 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.073 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.689 ' HB2' HG13 ' A' ' 50' ' ' VAL . 5.0 mt-30 -127.16 128.52 24.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.278 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.79 170.14 7.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.262 1.308 . . . . 0.0 110.971 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.702 HD12 HG22 ' A' ' 98' ' ' VAL . 8.5 mt -98.71 170.16 8.97 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.18 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 13.3 t0 -139.78 102.81 4.52 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.575 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.651 HH21 ' H ' ' A' ' 100' ' ' ASP . 15.0 mtt180 -50.42 -34.92 26.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.08 -33.9 67.75 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.613 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.05 -51.96 4.42 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.769 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 73' ' ' LYS . 76.0 mt -145.76 126.42 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.03 -0.64 50.21 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.532 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 71' ' ' ILE . 18.8 tttt -157.64 118.29 3.49 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.529 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CE1' HD13 ' A' ' 66' ' ' LEU . 6.4 m-85 -99.72 143.91 29.4 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.28 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.2 mt -126.45 124.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.828 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 38' ' ' ILE . 4.1 mt -122.25 155.15 36.48 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.446 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.36 124.53 49.36 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 94' ' ' ILE . 20.0 p -110.4 156.27 21.03 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.405 -0.918 . . . . 0.0 113.082 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.444 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 67.3 m-70 -128.35 150.74 49.96 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.067 -1.424 . . . . 0.0 108.966 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.6 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -125.37 141.78 51.87 Favored 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.388 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.93 138.12 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.107 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 84' ' ' ASN . 46.8 p -78.66 127.37 32.0 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.222 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t -55.04 1.29 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.369 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' SER . 5.3 p30 -89.16 -31.07 18.13 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.642 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 127.07 28.41 0.94 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.626 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' HD21 ' A' ' 84' ' ' ASN . 26.1 mm-40 -130.59 127.89 39.94 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.494 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.06 112.7 6.63 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.95 29.76 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.6 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 2.0 pp20? -79.98 146.94 31.77 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.511 -0.876 . . . . 0.0 112.706 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 8.4 m-20 -141.62 145.0 35.48 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.32 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.19 89.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 120.744 0.963 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -108.39 119.37 39.31 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.32 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.92 113.53 25.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.61 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 78' ' ' SER . 5.0 mt -89.07 125.43 42.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.925 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.0 126.07 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.114 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.5 mt -123.52 112.83 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.141 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 t -89.3 145.74 25.18 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.957 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 HD12 ' A' ' 66' ' ' LEU . 21.2 t -99.14 141.59 16.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.55 126.73 53.26 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.651 ' H ' HH21 ' A' ' 68' ' ' ARG . 10.2 p-10 -57.64 162.74 2.85 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.463 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -138.72 -133.78 0.12 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.43 -85.12 0.19 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.793 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -44.95 116.99 1.2 Allowed 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.783 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.744 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.971 0.415 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.66 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -78.75 88.93 4.61 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.946 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 2' ' ' TRP . 96.4 t -159.62 89.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.414 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.8 tt -144.44 86.63 8.04 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.234 -0.987 . . . . 0.0 110.874 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -64.47 -42.59 16.26 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 121.553 1.502 . . . . 0.0 113.749 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.8 Cg_endo -70.85 134.34 25.47 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 C-N-CA 121.563 1.508 . . . . 0.0 112.18 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 8' ' ' SER . 12.9 mm -139.19 166.28 22.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.4 p -130.86 134.7 47.03 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.168 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 96' ' ' ILE . 53.3 m -140.3 115.11 7.62 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.556 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 170.31 10.74 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.275 1.316 . . . . 0.0 113.268 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.36 156.47 23.37 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.203 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 72.3 m-80 43.22 70.94 0.26 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.254 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 1.4 mm-40 -85.97 -164.83 1.09 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.636 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.541 ' HZ3' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -145.69 147.3 31.82 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.881 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.67 -174.73 17.14 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -87.83 117.33 26.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.838 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 47.9 m-85 -73.73 154.21 89.32 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.713 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.622 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 Cg_endo -72.48 145.11 82.67 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 123.559 -1.434 . . . . 0.0 111.852 -1.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -101.86 129.63 48.13 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.756 ' H ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -65.66 157.86 28.88 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.69 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 9' ' ' CYS . 74.1 mt -130.48 -67.4 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.212 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.63 159.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 118.801 -1.16 . . . . 0.0 111.392 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -83.97 143.81 29.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.558 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.685 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.6 mt -99.8 169.77 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.082 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.685 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 50.9 mttm -129.63 131.97 46.6 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.415 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.653 ' N ' ' CE3' ' A' ' 2' ' ' TRP . 4.7 t -97.79 -129.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.843 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 29' ' ' ASP . 1.7 t-20 -153.18 -48.46 0.1 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.608 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 30' ' ' LYS . 5.3 mmp_? -72.07 8.66 1.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.855 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 1.5 p-10 -65.54 18.87 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.096 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' ARG . 2.0 mmmt -112.44 -7.71 13.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.494 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.14 -41.92 5.93 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.793 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.3 t -160.61 161.53 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.294 -0.963 . . . . 0.0 110.893 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' THR . 5.2 tttp -47.71 110.14 0.29 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.997 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.0 p -99.12 133.5 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 83' ' ' SER . 5.3 m-30 -99.44 155.83 17.34 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.164 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.66 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 39.2 m-85 -99.57 166.78 10.98 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.6 m -160.8 135.3 7.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.011 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD12 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -134.44 150.48 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 118.991 -1.084 . . . . 0.0 112.378 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -156.77 159.38 38.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.071 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.42 -173.24 19.16 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.305 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 107.7 0.25 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.613 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 129.78 -25.05 4.49 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.91 -61.53 1.72 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.43 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 22.4 p30 -115.72 -22.89 8.94 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.755 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -99.9 150.61 37.0 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.394 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 2.4 Cg_endo -58.98 127.37 24.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 121.339 1.359 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.57 120.03 3.43 Favored 'Cis proline' 0 C--O 1.214 -0.717 0 C-N-CA 124.126 -1.197 . . . . 0.0 111.609 -1.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -81.12 132.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.273 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 50' ' ' VAL . . . 76.45 86.0 0.38 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.539 -1.315 . . . . 0.0 111.16 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' GLY . 60.1 t -156.11 -35.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.575 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.401 ' CD2' HG12 ' A' ' 62' ' ' VAL . 81.8 m-85 -120.7 136.58 54.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.622 HD11 ' CB ' ' A' ' 18' ' ' PRO . 3.5 pt -140.62 127.41 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.092 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.474 ' CD1' HD12 ' A' ' 24' ' ' ILE . 10.6 tt -104.61 148.02 9.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.171 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.59 ' HB3' ' H ' ' A' ' 59' ' ' TRP . 20.0 tp10 -78.17 96.48 5.2 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 119.256 -0.977 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -45.02 -22.68 0.1 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.332 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 -68.44 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.952 -1.099 . . . . 0.0 113.209 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 57.7 p -79.6 -24.88 41.7 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.468 -0.893 . . . . 0.0 112.506 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.11 15.19 54.7 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 118.975 -1.584 . . . . 0.0 109.886 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 11.5 m95 -71.84 114.84 10.36 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.305 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.97 121.07 25.01 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.592 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HE2' ' ND2' ' A' ' 20' ' ' ASN . 3.4 mtpt -123.92 160.64 27.08 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.398 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.7 m -125.07 141.21 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.647 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -19.89 25.26 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.138 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -144.93 137.37 13.41 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.589 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 2.1 Cg_endo -59.84 163.35 13.82 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.289 1.326 . . . . 0.0 111.376 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 98' ' ' VAL . 5.2 mt -89.23 170.34 10.68 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.639 -1.225 . . . . 0.0 109.797 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 58.2 t0 -148.09 108.8 4.19 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.679 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.5 mtm105 -55.63 -36.53 67.1 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.45 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -49.6 -28.68 6.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.177 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.18 -51.25 3.28 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.598 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 73' ' ' LYS . 51.3 mt -150.19 134.47 9.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.88 -5.54 37.91 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.554 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.571 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.7 OUTLIER -154.26 121.55 5.72 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.557 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.5 m-85 -100.01 135.4 41.49 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.597 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.53 ' C ' HD22 ' A' ' 76' ' ' LEU . 7.9 mm -105.72 109.41 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.872 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 75' ' ' ILE . 4.4 mm? -109.81 163.77 13.2 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.727 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -122.83 128.79 50.87 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.443 ' C ' ' CD2' ' A' ' 79' ' ' HIS . 37.6 p -110.33 156.62 20.49 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.199 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.532 ' NE2' ' CG2' ' A' ' 39' ' ' THR . 10.7 m-70 -140.8 147.38 38.96 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.579 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -113.24 143.31 44.63 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.971 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -139.4 135.94 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.509 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.636 ' OG ' ' ND2' ' A' ' 84' ' ' ASN . 59.7 p -65.13 138.86 58.56 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.296 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.523 ' CB ' ' CE1' ' A' ' 35' ' ' PHE . 31.5 p -56.77 4.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.972 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -106.5 -19.45 13.67 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.84 10.74 6.78 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.65 -1.262 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HB2' HD21 ' A' ' 84' ' ' ASN . 67.6 mm-40 -99.4 132.91 44.4 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.393 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 124.33 23.83 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.205 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -140.85 25.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -79.45 150.61 31.21 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.354 -1.294 . . . . 0.0 113.522 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -137.8 135.85 19.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.784 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -52.92 103.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.15 1.233 . . . . 0.0 111.704 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.3 mmt -127.14 116.55 20.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.748 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 114.38 23.49 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.026 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.9 mt -95.09 126.83 47.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.07 121.02 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.483 HD12 HD23 ' A' ' 76' ' ' LEU . 9.8 mt -116.48 113.68 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 t -89.91 149.12 22.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.536 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.626 HG22 HD12 ' A' ' 66' ' ' LEU . 39.1 t -105.99 134.45 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.684 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.18 148.35 22.42 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.717 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 32.5 p-10 -90.19 137.57 32.24 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.505 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -102.65 -85.07 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.0 80.81 0.85 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.58 178.92 3.27 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.957 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.846 179.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.941 0.4 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.632 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.2 m0 -88.65 88.56 7.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.623 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 2' ' ' TRP . 92.7 t -157.67 88.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.711 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 4' ' ' ILE . 18.3 tt -161.68 87.8 1.56 Allowed Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.924 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -62.27 -42.14 30.28 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.712 1.608 . . . . 0.0 114.188 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -70.21 141.5 43.57 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 C-N-CA 121.593 1.529 . . . . 0.0 112.339 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 8' ' ' SER . 8.4 mm -142.41 167.39 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 7' ' ' ILE . 2.2 t -127.82 144.25 51.1 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' ' CG2' ' A' ' 96' ' ' ILE . 3.9 p -140.64 116.08 7.54 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.25 156.71 63.64 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.162 1.242 . . . . 0.0 111.764 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -114.08 166.23 11.83 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 46.83 13.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.359 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.3 OUTLIER -58.6 134.91 57.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.667 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -92.3 163.73 13.78 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.6 168.84 11.43 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -82.32 110.8 17.8 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.748 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 55.7 m-85 -83.13 153.74 66.58 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.435 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.4 Cg_endo -71.58 163.54 86.18 Favored 'Cis proline' 0 C--N 1.323 -0.779 0 C-N-CA 123.604 -1.415 . . . . 0.0 112.146 -1.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -139.79 145.6 38.4 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.631 -0.827 . . . . 0.0 111.141 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.736 ' N ' HD22 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.33 152.47 38.15 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.013 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 21' ' ' LEU . 20.2 mt -124.25 -66.65 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 23' ' ' GLN . 13.2 p -155.77 159.57 2.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.187 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 25' ' ' LYS . 19.4 mt-30 -85.45 153.2 22.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.442 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 2.8 mt -93.11 167.23 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.815 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.63 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 7.7 mmtm -139.17 126.14 21.05 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.755 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.659 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 15.4 t -100.79 -114.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.566 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.614 ' N ' ' OG ' ' A' ' 26' ' ' SER . 14.5 p-10 -168.91 -53.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.231 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 4.7 mtt180 -64.94 -0.19 1.45 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.327 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.2 p-10 -66.31 19.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 8.4 mmtt -113.19 -7.68 13.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.472 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 32' ' ' THR . 9.3 pt-20 -112.86 -31.85 6.58 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.675 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 2.2 t -160.99 152.36 19.11 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.422 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -47.1 128.68 11.75 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 4.2 p -124.97 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.875 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -98.78 160.14 14.47 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.643 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.659 ' OH ' ' N ' ' A' ' 26' ' ' SER . 43.1 m-85 -110.74 169.78 8.53 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 154.94 37.1 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.797 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.42 150.65 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 C-N-CA 119.329 -0.948 . . . . 0.0 113.188 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -160.44 138.43 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.191 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 130.18 -177.27 18.33 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 119.496 -1.335 . . . . 0.0 112.041 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 1.8 pt20 -49.9 141.03 11.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.04 -23.19 35.63 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.237 -1.459 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -116.94 -77.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.778 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 1.3 p30 -97.17 -27.96 14.31 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 11.4 mmtm -102.7 151.12 38.25 Favored Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -54.37 132.22 49.62 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 121.734 1.622 . . . . 0.0 111.675 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB2' HG21 ' A' ' 50' ' ' VAL . 1.8 Cg_endo -67.53 120.57 3.66 Favored 'Cis proline' 0 C--O 1.213 -0.76 0 C-N-CA 124.114 -1.203 . . . . 0.0 111.241 -2.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 6.9 p -80.76 142.35 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.517 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.05 77.8 0.24 Allowed Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.745 -1.217 . . . . 0.0 111.691 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG21 ' HB2' ' A' ' 47' ' ' PRO . 52.9 t -144.21 -40.22 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.911 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 50' ' ' VAL . 21.3 m-85 -120.25 147.26 45.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.845 0.716 . . . . 0.0 110.524 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 pt -140.47 147.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 ' HB ' ' A' ' 38' ' ' ILE . 84.8 mt -128.52 150.56 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.677 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -88.97 102.12 14.76 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.055 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -44.44 -27.68 0.48 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.784 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -94.25 -67.38 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.452 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.5 p -79.32 8.74 5.55 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.694 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 43.45 28.64 1.0 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.693 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -74.5 127.04 32.09 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.206 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.36 114.03 26.01 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -123.28 159.99 27.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 21' ' ' LEU . 20.8 m -128.76 145.88 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.1 -1.04 . . . . 0.0 112.055 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -22.57 22.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.639 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -139.1 142.03 31.77 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.497 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.5 Cg_endo -61.34 -178.85 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.254 1.303 . . . . 0.0 110.61 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' A' ' 74' ' ' TYR . 3.4 mm? -90.52 154.85 19.32 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.019 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 52.2 t0 -118.2 89.51 3.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -18.41 57.67 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -75.17 -14.46 60.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.093 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.52 -44.72 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.165 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 6.9 mm -135.76 133.82 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.07 -6.17 20.2 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.139 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' H ' HG22 ' A' ' 71' ' ' ILE . 6.6 ttpt -160.57 121.19 2.9 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.882 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' CE1' HD12 ' A' ' 66' ' ' LEU . 5.9 m-85 -99.72 147.28 25.6 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.142 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 mt -111.56 136.53 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.067 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 38' ' ' ILE . 2.8 tp -138.26 134.76 34.79 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 118.888 -1.125 . . . . 0.0 112.423 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.69 129.94 45.17 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 p -119.55 155.41 32.25 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.385 -0.926 . . . . 0.0 113.13 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -132.92 150.88 52.12 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.818 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -128.54 140.72 51.66 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.791 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -131.55 133.44 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.375 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.574 ' C ' ' H ' ' A' ' 84' ' ' ASN . 82.9 p -68.97 125.96 28.28 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 t -61.27 7.58 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 82' ' ' SER . 27.3 p30 -94.83 -17.03 22.46 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.421 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.459 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 112.62 33.03 2.15 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -139.09 131.62 28.72 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.42 126.89 30.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.484 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.88 22.83 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.618 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.51 154.28 28.96 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.503 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' ' SD ' ' A' ' 92' ' ' MET . 5.8 m-20 -149.47 142.93 16.34 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.269 -1.332 . . . . 0.0 108.519 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' C ' ' SD ' ' A' ' 92' ' ' MET . 5.7 Cg_exo -51.78 89.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 120.679 0.919 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.612 ' SD ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -109.57 116.01 30.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.563 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -89.58 139.23 30.75 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.618 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.46 124.72 70.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.957 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 t -101.07 108.85 24.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.471 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.698 ' CG2' ' SG ' ' A' ' 9' ' ' CYS . 11.0 mt -104.92 110.64 31.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.307 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.7 145.87 24.56 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.225 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 9' ' ' CYS . 10.6 t -99.1 136.58 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.861 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.63 109.05 19.18 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -47.53 161.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.788 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' OE1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -103.94 -15.52 15.61 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.874 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.453 ' N ' ' OE1' ' A' ' 101' ' ' GLN . 3.5 t-20 52.28 90.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -167.75 37.51 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.768 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.637 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.0 m0 -78.99 88.38 4.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 2' ' ' TRP . 87.1 t -160.04 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.634 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.2 tt -159.47 88.14 2.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.724 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.5 Cg_exo -63.91 -42.1 20.82 Favored 'Trans proline' 0 CA--C 1.553 1.473 0 C-N-CA 121.43 1.42 . . . . 0.0 113.721 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' O ' HD13 ' A' ' 7' ' ' ILE . 7.4 Cg_endo -75.54 135.73 18.48 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.748 1.632 . . . . 0.0 112.307 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 6' ' ' PRO . 7.3 mm -145.48 170.63 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.553 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.584 ' H ' HG22 ' A' ' 7' ' ' ILE . 57.3 p -136.66 137.79 40.41 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.632 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 96' ' ' ILE . 37.7 m -140.15 127.61 12.59 Favored Pre-proline 0 N--CA 1.493 1.714 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.278 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -66.92 167.94 18.41 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 121.614 1.543 . . . . 0.0 113.535 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.78 167.19 12.76 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 58.98 28.35 17.55 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.724 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 mt-10 -74.17 102.69 4.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.755 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.72 162.72 14.78 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.26 -166.95 24.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -80.59 125.91 30.59 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.721 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 94.9 m-85 -96.68 153.56 38.7 Favored Pre-proline 0 C--N 1.304 -1.386 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.832 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -75.52 -177.85 21.93 Favored 'Cis proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.565 -3.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.42 135.95 32.56 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' N ' HD22 ' A' ' 20' ' ' ASN . 2.2 m120 -74.58 148.12 41.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.357 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 62' ' ' VAL . 12.9 mt -121.76 -65.35 1.13 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.101 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.18 160.02 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.0 154.23 33.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.301 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 25' ' ' LYS . 3.7 mm -89.11 166.68 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' N ' HG22 ' A' ' 24' ' ' ILE . 39.9 mttt -140.49 114.59 9.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.992 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.597 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 32.8 t -99.18 -115.88 0.15 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 9.7 p-10 -165.86 -48.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.608 ' C ' ' H ' ' A' ' 30' ' ' LYS . 27.9 mmt180 -70.63 6.42 1.45 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.764 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 2' ' ' TRP . 0.4 OUTLIER -68.25 22.68 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.983 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.5 mmmp? -124.56 0.95 8.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.08 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -117.23 -37.15 3.59 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 t -160.1 150.42 18.52 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.674 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -46.59 111.71 0.41 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.664 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.662 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -100.56 136.89 30.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.352 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 5.1 m-30 -98.41 159.81 14.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 16.1 m-85 -110.67 160.49 16.64 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.83 150.86 39.14 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.876 -1.511 . . . . 0.0 108.466 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -137.97 146.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.303 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -159.89 153.21 22.18 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.073 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.16 176.56 14.72 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.197 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.99 132.14 22.98 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.124 -1.031 . . . . 0.0 110.619 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 103.38 -20.85 41.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.84 -77.7 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.103 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 8.1 p-10 -102.95 -22.77 13.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 16.6 mtpt -100.31 149.81 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.568 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.4 Cg_exo -59.12 129.79 33.35 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 121.455 1.436 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.1 Cg_endo -68.39 119.35 3.4 Favored 'Cis proline' 0 C--O 1.212 -0.775 0 C-N-CA 124.196 -1.168 . . . . 0.0 111.708 -1.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 48' ' ' VAL . 12.6 p -81.08 124.68 39.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 50' ' ' VAL . . . 93.42 83.75 1.56 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.263 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLY . 58.0 t -153.65 -43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -121.43 142.14 50.31 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.11 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -139.9 145.13 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.741 HD12 ' HB ' ' A' ' 38' ' ' ILE . 48.0 mt -123.52 145.31 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.855 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -72.92 106.24 4.75 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.479 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -52.74 -19.49 2.47 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.53 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -96.28 -69.19 0.77 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.538 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.3 p -79.24 -21.97 45.45 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.804 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 54' ' ' GLU . . . 83.32 20.52 60.31 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 118.924 -1.608 . . . . 0.0 110.369 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.4 ' H ' ' HB2' ' A' ' 54' ' ' GLU . 6.1 m95 -70.18 118.59 13.2 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.08 109.87 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.055 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -115.18 161.75 18.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.845 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -129.75 146.46 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.334 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.05 -22.36 17.96 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 62' ' ' VAL . 17.7 mt-30 -134.0 140.52 36.54 Favored Pre-proline 0 N--CA 1.496 1.858 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 3.4 Cg_endo -64.65 164.89 22.33 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.416 1.41 . . . . 0.0 110.733 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 5.9 mt -90.27 162.0 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.309 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -151.2 112.28 4.31 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.496 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -53.49 -27.09 23.5 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.349 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.34 -34.45 77.73 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.54 -51.49 4.52 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 74' ' ' TYR . 68.3 mt -146.65 133.57 14.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 98' ' ' VAL . . . -90.59 -25.87 19.96 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.755 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -144.39 125.22 14.26 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 71' ' ' ILE . 13.5 m-85 -99.51 146.16 26.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.691 -0.803 . . . . 0.0 111.953 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' HD12 ' A' ' 76' ' ' LEU . 34.1 mt -113.12 138.73 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.841 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 75' ' ' ILE . 1.3 tp -140.38 128.08 21.7 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.108 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -98.71 129.57 45.17 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 p -118.68 159.49 23.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.815 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -140.16 146.26 38.55 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.662 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -116.22 143.82 45.0 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.527 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -141.0 132.41 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.541 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 84' ' ' ASN . 80.6 p -63.38 134.22 55.36 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.878 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.8 t -60.99 6.19 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.127 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.801 ' ND2' ' H ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -96.78 -18.88 19.31 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.233 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.537 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 116.53 2.62 19.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.801 ' H ' ' ND2' ' A' ' 84' ' ' ASN . 28.1 mt-10 -98.13 129.82 44.92 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.75 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.65 128.64 36.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.707 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -137.5 23.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -79.92 168.62 19.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.852 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 92' ' ' MET . 7.5 m-20 -159.14 141.82 10.32 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.81 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.72 90.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 120.782 0.988 . . . . 0.0 110.763 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -105.9 116.39 31.85 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.328 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 109.67 22.06 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.454 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.6 mt -93.35 127.05 45.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.676 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.6 t -102.59 125.54 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 ' SG ' ' A' ' 9' ' ' CYS . 18.6 mt -123.39 113.61 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.266 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 t -91.61 150.1 21.33 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.555 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 72' ' ' ALA . 42.1 t -91.23 147.79 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.279 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.28 145.42 43.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.167 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 5.0 p30 -69.79 72.99 0.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 100' ' ' ASP . 4.7 tt0 37.21 -141.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.514 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -143.72 -1.92 0.97 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.485 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.468 ' CG ' ' N ' ' A' ' 104' ' ' ASN . 25.6 t70 -78.5 174.87 10.87 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.971 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.468 ' N ' ' CG ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.375 -1.774 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.127 0.489 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.667 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 4.1 m0 -79.49 88.83 5.04 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.194 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -160.9 88.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.497 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.683 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -161.39 93.45 1.42 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.831 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.55 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.7 Cg_exo -61.0 -44.0 27.09 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 121.361 1.374 . . . . 0.0 114.262 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -60.29 136.29 67.36 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.234 1.289 . . . . 0.0 112.708 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.696 HG22 ' N ' ' A' ' 8' ' ' SER . 7.0 mm -141.34 170.42 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.85 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.696 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 t -137.29 140.58 41.66 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.099 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.59 115.25 7.44 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.251 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.03 166.79 13.56 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.283 1.322 . . . . 0.0 112.927 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 6.1 pt-20 -110.99 170.19 8.27 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.774 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 50.81 16.96 0.36 Allowed 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.816 -0.754 . . . . 0.0 112.08 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 31.6 mt-10 -46.31 133.74 9.36 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.282 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -135.01 161.71 34.51 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.203 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.597 ' HA3' ' HZ2' ' A' ' 19' ' ' LYS . . . 138.79 -110.53 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.697 ' H ' ' NZ ' ' A' ' 19' ' ' LYS . 24.9 mt-10 -128.02 116.34 19.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.445 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 47.9 m-85 -91.65 148.09 36.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 5.3 Cg_endo -72.19 168.87 73.09 Favored 'Cis proline' 0 C--O 1.215 -0.644 0 C-N-CA 123.451 -1.479 . . . . 0.0 110.897 -2.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.697 ' NZ ' ' H ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -134.97 137.68 43.29 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.214 -0.995 . . . . 0.0 111.729 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.465 HD21 ' HD3' ' A' ' 61' ' ' LYS . 1.4 m-80 -75.11 161.45 29.4 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD12 ' CG1' ' A' ' 62' ' ' VAL . 20.6 mt -138.95 -57.56 0.61 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.203 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.0 154.32 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.172 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 153.52 27.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.191 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 3.3 mm -92.62 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.953 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 25.9 mttm -141.28 125.48 17.4 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.026 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.654 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 27.7 t -99.44 -110.32 0.19 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 29' ' ' ASP . 29.4 t30 -173.37 -51.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.574 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.642 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.28 4.9 1.45 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.828 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 1.1 p-10 -64.14 16.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.574 -0.851 . . . . 0.0 110.985 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.642 ' H ' ' C ' ' A' ' 28' ' ' ARG . 1.2 mtpm? -102.88 -20.71 14.17 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.851 -0.739 . . . . 0.0 111.021 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.6 pt-20 -94.7 -40.47 9.77 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 4.3 t -159.43 151.93 21.36 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.088 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -49.43 113.98 0.94 Allowed 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.626 -1.23 . . . . 0.0 108.859 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 14.7 p -99.39 140.32 19.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.323 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 5.4 m-30 -98.6 154.88 17.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.848 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.667 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 53.4 m-85 -103.98 173.07 6.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -159.49 127.1 4.8 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.538 -1.665 . . . . 0.0 107.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.742 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -110.65 150.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.414 -0.915 . . . . 0.0 112.93 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.542 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -161.1 158.08 27.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.784 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 44' ' ' ASP . . . 107.83 -170.68 15.5 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.231 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -49.69 131.58 21.66 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.222 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.3 -22.37 40.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.79 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.55 -78.58 0.58 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.525 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 39.4 p30 -96.15 -21.55 17.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.691 -0.803 . . . . 0.0 110.896 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.1 mtpm? -102.62 149.56 36.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.7 Cg_exo -53.97 134.13 58.17 Favored 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 121.818 1.679 . . . . 0.0 111.849 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.1 Cg_endo -68.55 124.55 7.03 Favored 'Cis proline' 0 C--O 1.214 -0.678 0 C-N-CA 123.816 -1.327 . . . . 0.0 110.515 -2.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 2.6 t -73.83 140.93 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.59 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.9 82.69 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.304 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 64' ' ' GLN . 4.8 t -140.05 -49.38 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.198 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.76 144.4 41.11 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.17 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pt -140.58 120.19 12.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.246 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.496 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -107.3 150.31 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 57' ' ' THR . 13.8 tp10 -79.75 111.19 15.82 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -54.65 -25.44 26.86 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.931 -0.707 . . . . 0.0 111.607 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -90.28 -64.91 1.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.67 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.503 ' H ' ' HG3' ' A' ' 54' ' ' GLU . 40.6 p -79.3 -26.1 42.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.185 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.65 12.28 69.58 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 118.935 -1.602 . . . . 0.0 109.725 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.478 ' H ' ' HB3' ' A' ' 54' ' ' GLU . 7.0 m95 -65.22 117.83 8.37 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.556 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -83.6 118.41 23.8 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.764 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 60' ' ' LEU . 10.7 mttt -127.88 161.68 28.48 Favored 'General case' 0 C--O 1.205 -1.238 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 21' ' ' LEU . 1.9 m -135.95 150.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.327 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.3 -22.17 15.2 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.031 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.628 ' HB2' HG13 ' A' ' 50' ' ' VAL . 35.2 mt-30 -121.84 127.61 25.92 Favored Pre-proline 0 N--CA 1.495 1.795 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.659 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HB3' ' N ' ' A' ' 13' ' ' GLU . 1.6 Cg_endo -63.98 161.89 31.4 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.222 1.281 . . . . 0.0 110.83 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.7 mt -90.57 170.13 10.43 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 118.553 -1.259 . . . . 0.0 110.143 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 43.1 t0 -149.18 103.76 3.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.364 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -52.94 -33.84 52.7 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -56.55 -32.41 65.12 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.291 -0.963 . . . . 0.0 110.638 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.7 -53.67 3.23 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.628 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.4 mt -139.06 133.1 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.551 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.07 -5.85 32.97 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.031 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -160.03 128.78 4.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 8.2 m-85 -108.33 142.05 39.22 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.514 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.59 140.5 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.415 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -138.62 154.86 48.69 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.296 -0.962 . . . . 0.0 112.035 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -122.9 149.67 43.92 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 p -150.29 160.9 43.37 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.133 -1.427 . . . . 0.0 113.337 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -131.55 150.98 51.96 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.315 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -122.63 147.77 46.04 Favored 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.716 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -139.84 136.82 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 84' ' ' ASN . 89.4 p -58.41 121.67 11.43 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.193 -1.403 . . . . 0.0 110.034 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 84' ' ' ASN . 79.2 p 17.57 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 O-C-N 125.049 1.468 . . . . 0.0 113.039 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.751 ' N ' ' O ' ' A' ' 82' ' ' SER . 2.0 p-10 -169.85 50.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.831 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -144.17 -79.84 0.04 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.031 -1.556 . . . . 0.0 112.164 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' N ' ' OG ' ' A' ' 82' ' ' SER . 2.7 mp0 -101.99 136.58 41.57 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.204 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -72.2 133.32 45.04 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.026 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' VAL . 3.3 m -135.27 32.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -79.67 161.61 25.72 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.085 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' MET . 39.1 m-20 -157.15 147.52 15.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.713 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.33 86.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.72 0.947 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' ASP . 1.6 mtp -105.83 121.97 45.15 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 93' ' ' GLU . 0.7 OUTLIER -107.64 113.44 26.74 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.673 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.4 mt -89.6 134.54 28.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.33 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.37 111.83 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.32 123.48 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.382 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 t -104.94 149.82 25.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.286 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.22 149.97 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.68 149.68 48.27 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' HB3' HD21 ' A' ' 102' ' ' ASN . 6.0 m-20 -62.63 169.89 2.82 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.311 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' C ' ' CG ' ' A' ' 102' ' ' ASN . 8.2 tt0 -151.84 -59.15 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.622 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' CG ' ' C ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER 44.53 87.67 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.113 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -16.86 24.2 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.294 -1.812 . . . . 0.0 110.841 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 3.0 p30 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.097 0.475 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.663 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -78.49 93.88 4.85 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.026 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 2' ' ' TRP . 2.2 m -161.42 106.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.4 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -149.95 84.96 5.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.261 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 Cg_exo -67.93 -43.2 5.32 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 121.412 1.408 . . . . 0.0 114.358 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.3 Cg_endo -74.33 144.12 32.44 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.894 1.729 . . . . 0.0 113.328 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 8' ' ' SER . 17.2 mm -144.54 170.09 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.329 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.71 ' N ' HG22 ' A' ' 7' ' ' ILE . 3.3 p -134.08 139.84 46.23 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.614 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.9 m -135.95 127.57 17.26 Favored Pre-proline 0 N--CA 1.494 1.76 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.418 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.19 161.56 36.87 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.579 1.519 . . . . 0.0 112.269 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 13' ' ' GLU . 8.6 pt-20 -119.86 160.34 22.85 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 64.42 -19.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 11' ' ' GLU . 4.1 tp10 -42.92 109.41 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.626 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -131.75 143.1 50.0 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.581 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.09 -111.28 0.64 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.622 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' O ' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.4 147.74 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.197 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 16' ' ' GLU . 15.9 m-85 -150.1 159.86 34.55 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.965 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -75.06 -174.17 13.67 Favored 'Cis proline' 0 C--N 1.319 -0.997 0 C-N-CA 123.545 -1.439 . . . . 0.0 112.412 -1.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HZ1' ' HG ' ' A' ' 21' ' ' LEU . 1.7 ttpm? -131.53 122.44 26.14 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -69.65 148.06 49.8 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.451 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 62' ' ' VAL . 5.3 mt -118.55 -71.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 23' ' ' GLN . 5.8 p -161.31 161.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.849 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.601 HE21 ' C ' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -73.79 155.7 38.58 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.473 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -110.0 164.82 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.713 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 4.7 mptt -140.45 137.02 33.6 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.36 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.661 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 29.8 t -98.69 -101.93 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.428 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -179.99 -55.11 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.226 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.1 mpp_? -62.11 -2.76 1.02 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD2' ' CG ' ' A' ' 2' ' ' TRP . 5.1 p-10 -63.5 11.45 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' H ' ' C ' ' A' ' 28' ' ' ARG . 17.0 mtpp -93.29 -12.56 29.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 32' ' ' THR . 2.1 pt-20 -113.0 -38.48 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 2.4 t -155.03 138.72 16.11 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.846 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -48.29 120.4 3.59 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.779 -1.169 . . . . 0.0 109.52 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.8 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.5 p -108.09 145.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.429 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 12.4 m-30 -99.35 160.26 14.41 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.489 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 26' ' ' SER . 95.6 m-85 -109.46 170.98 7.71 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.09 110.48 1.64 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.422 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.846 HD11 HD13 ' A' ' 76' ' ' LEU . 16.4 tt -98.66 145.71 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.985 -1.086 . . . . 0.0 113.658 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.424 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 4.5 t -161.28 153.02 19.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.59 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.588 ' N ' ' OD2' ' A' ' 44' ' ' ASP . . . 132.56 -165.32 23.8 Favored Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.457 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -57.77 102.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.689 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 125.61 -9.81 7.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.0 -59.63 1.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.807 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.588 ' OD2' ' N ' ' A' ' 40' ' ' GLY . 0.9 OUTLIER -112.72 -23.22 10.3 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.274 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -101.92 148.88 35.95 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.172 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -56.0 128.31 29.72 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.743 1.629 . . . . 0.0 111.765 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 5.8 Cg_endo -68.23 124.34 6.65 Favored 'Cis proline' 0 C--O 1.215 -0.638 0 C-N-CA 123.966 -1.264 . . . . 0.0 110.766 -1.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 48' ' ' VAL . 1.2 p -78.55 129.77 37.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.241 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.16 85.98 0.49 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 64' ' ' GLN . 2.5 t -144.01 -37.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -121.5 150.6 41.35 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 52' ' ' ILE . 4.3 pt -137.56 150.24 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.803 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.68 142.64 30.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.644 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.9 OUTLIER -79.9 101.95 8.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.199 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 -46.52 -22.48 0.28 Allowed 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.668 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -94.7 -66.59 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.256 -0.977 . . . . 0.0 112.123 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.406 ' O ' ' NE2' ' A' ' 23' ' ' GLN . 20.0 p -79.25 8.56 5.79 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.249 -0.98 . . . . 0.0 111.551 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.601 ' C ' HE21 ' A' ' 23' ' ' GLN . . . 45.58 26.33 1.68 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.426 -1.369 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.27 115.01 14.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.959 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -86.93 117.93 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.911 -1.115 . . . . 0.0 111.241 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.67 151.76 41.19 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.913 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -112.16 149.22 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.614 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 29.8 p -104.2 -29.14 11.02 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HB2' HG13 ' A' ' 50' ' ' VAL . 40.5 mt-30 -125.11 143.73 45.1 Favored Pre-proline 0 N--CA 1.503 2.201 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.632 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -66.94 165.3 26.57 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 121.74 1.627 . . . . 0.0 111.187 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 74' ' ' TYR . 14.4 mt -107.15 152.84 23.51 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.455 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -110.51 95.26 5.46 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.457 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.34 -17.5 59.02 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.582 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -74.99 -15.16 60.67 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.221 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.87 -53.87 1.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.437 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 73' ' ' LYS . 27.7 mt -125.21 143.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.043 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.25 8.17 9.71 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.6 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.1 tttt -160.41 118.6 2.58 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.403 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 20.1 m-85 -101.84 149.36 24.26 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.391 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.23 139.58 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.302 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.846 HD13 HD11 ' A' ' 38' ' ' ILE . 39.3 mt -140.09 170.23 16.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 93' ' ' GLU . 38.5 m-85 -131.09 132.98 45.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.5 p -116.75 159.61 22.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.915 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -128.93 149.19 50.89 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.496 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.8 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -120.03 140.96 50.19 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.96 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -138.64 135.59 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.548 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.595 ' C ' ' H ' ' A' ' 84' ' ' ASN . 74.1 p -64.83 123.97 20.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.654 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.527 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 33.7 t -51.71 -2.85 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.3 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.739 ' ND2' ' N ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -85.7 -36.14 20.41 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.43 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' N ' ' ND2' ' A' ' 84' ' ' ASN . . . 136.25 10.56 1.28 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 84' ' ' ASN . 43.2 mt-10 -109.83 134.21 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.896 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.73 126.32 29.26 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.909 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.0 m -139.52 32.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.005 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.572 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -78.76 165.95 23.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.652 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 92' ' ' MET . 13.4 m-20 -152.3 138.21 11.59 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.579 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -54.22 86.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 120.657 0.904 . . . . 0.0 110.789 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.496 ' N ' ' O ' ' A' ' 90' ' ' ASP . 56.6 mmm -106.23 118.09 35.74 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.561 -0.855 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 1.2 pm0 -92.52 117.83 30.35 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.456 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.3 mt -89.59 128.02 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.367 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.435 HG13 ' HE3' ' A' ' 73' ' ' LYS . 79.5 t -102.91 113.5 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.09 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 76' ' ' LEU . 14.7 mt -103.5 119.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.919 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 t -96.11 150.51 20.43 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.016 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.86 149.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.368 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 m -146.72 149.05 32.67 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.97 150.03 5.93 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.444 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 103' ' ' ASP . 2.3 pt20 -56.02 -94.49 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.931 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -172.42 53.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.716 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' HE21 ' A' ' 101' ' ' GLN . 11.0 t0 -93.8 105.74 17.75 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 17.4 t30 . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.85 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.536 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 9.5 m0 -80.03 101.14 8.51 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.006 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 ' C ' ' A' ' 2' ' ' TRP . 93.4 t -154.58 85.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.084 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 4' ' ' ILE . 14.6 tt -163.94 88.82 1.15 Allowed Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -60.53 -42.05 43.4 Favored 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 121.46 1.44 . . . . 0.0 113.921 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.4 Cg_endo -72.47 145.11 41.9 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.605 1.537 . . . . 0.0 112.264 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.67 HG22 ' N ' ' A' ' 8' ' ' SER . 8.8 mm -139.13 171.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.183 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.67 ' N ' HG22 ' A' ' 7' ' ' ILE . 10.3 t -130.8 136.66 48.91 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.543 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD22 ' A' ' 66' ' ' LEU . 2.0 m -140.36 108.95 6.78 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.511 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -66.93 164.76 28.53 Favored 'Trans proline' 0 C--N 1.331 -0.376 0 C-N-CA 121.311 1.34 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -106.62 153.28 22.59 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.146 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.555 ' H ' ' HB2' ' A' ' 65' ' ' PRO . 29.5 m-80 46.54 66.04 1.06 Allowed 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.704 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 50.7 mt-10 -75.35 -173.99 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' H ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.33 170.54 8.1 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.474 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.47 174.77 46.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.04 110.75 23.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.214 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 98.7 m-85 -56.88 154.71 17.56 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.293 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 2.0 Cg_endo -70.48 157.96 93.62 Favored 'Cis proline' 0 N--CA 1.48 0.692 0 C-N-CA 124.168 -1.18 . . . . 0.0 112.388 0.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -140.47 146.05 37.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.338 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' ND2' ' HE2' ' A' ' 61' ' ' LYS . 4.2 m120 -75.7 153.16 37.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' OE1' ' A' ' 13' ' ' GLU . 27.4 mt -123.89 -66.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.99 159.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -81.85 156.3 24.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG22 ' CZ ' ' A' ' 36' ' ' TYR . 18.4 mt -90.63 154.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 2' ' ' TRP . 28.4 mttt -141.67 123.85 15.56 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.439 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.643 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 10.1 t -126.85 -177.18 3.93 Favored 'General case' 0 N--CA 1.502 2.174 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.549 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.643 ' N ' ' OG ' ' A' ' 26' ' ' SER . 2.1 t-20 -86.1 -49.32 7.87 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 30' ' ' LYS . 14.6 mmm180 -35.92 -28.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.222 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' ASN . 1.7 p-10 -62.98 11.32 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.994 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 28' ' ' ARG . 15.3 mtpp -100.34 2.29 42.33 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.051 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' OE1' ' NH1' ' A' ' 28' ' ' ARG . 2.5 pt-20 -136.61 -30.66 0.9 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.793 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.5 t -160.73 145.32 14.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.854 -1.138 . . . . 0.0 111.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -49.08 112.92 0.69 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 118.503 -1.279 . . . . 0.0 108.683 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.572 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -99.01 142.58 14.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 83' ' ' SER . 5.4 m-30 -99.57 148.61 24.11 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.906 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.563 ' OH ' ' N ' ' A' ' 26' ' ' SER . 26.7 m-85 -105.96 168.8 8.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -160.75 147.99 15.61 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.162 -1.836 . . . . 0.0 107.884 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 76' ' ' LEU . 21.3 tt -139.32 150.13 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 112.579 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 79' ' ' HIS . 12.1 t -153.74 138.38 16.94 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.078 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 143.2 -172.1 24.78 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.801 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.35 126.74 20.06 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.027 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.07 -26.59 23.9 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.12 -83.76 0.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.979 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 45' ' ' LYS . 7.1 p-10 -98.91 -22.27 15.87 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.016 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 12.7 mttp -100.15 150.79 37.2 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 119.609 -0.836 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 5.8 Cg_exo -55.05 130.12 39.02 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.585 1.523 . . . . 0.0 111.445 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.02 116.76 2.37 Favored 'Cis proline' 0 C--O 1.212 -0.801 0 C-N-CA 124.088 -1.213 . . . . 0.0 111.652 -2.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.553 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 9.7 p -81.04 129.09 38.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.817 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.56 72.26 1.28 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.245 -1.455 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 51' ' ' PHE . 76.8 t -145.82 -37.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.427 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 62' ' ' VAL . 75.7 m-85 -121.64 115.65 23.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.005 0.815 . . . . 0.0 111.337 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -110.29 154.08 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.113 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.454 HD12 ' C ' ' A' ' 53' ' ' ILE . 2.0 pp -143.57 148.55 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.003 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.02 101.46 13.8 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -51.04 -7.03 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.001 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' GLU . 39.6 mt-10 -95.93 -73.54 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.067 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -80.53 -10.99 59.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.498 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.44 13.55 82.51 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.258 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -61.61 113.37 2.67 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.717 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -88.82 113.64 24.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.852 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -118.58 160.58 21.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.575 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 51' ' ' PHE . 33.5 m -133.73 147.22 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -21.54 21.98 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.22 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -141.43 140.36 20.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.227 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.555 ' HB2' ' H ' ' A' ' 12' ' ' ASN . 4.3 Cg_endo -63.47 170.88 7.5 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 121.46 1.44 . . . . 0.0 112.084 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD23 HG22 ' A' ' 98' ' ' VAL . 7.2 mp -91.83 170.28 10.01 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.782 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -145.67 107.31 4.26 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.854 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 98' ' ' VAL . 5.1 mtp85 -54.91 -32.27 60.95 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.432 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.5 -32.33 68.71 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.15 -55.6 3.02 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 73' ' ' LYS . 55.2 mt -141.29 125.74 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.634 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.37 -2.08 57.95 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.413 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' H ' HG22 ' A' ' 71' ' ' ILE . 17.9 tttt -160.4 120.45 2.84 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.221 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.56 147.23 25.56 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.479 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.21 125.03 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -129.13 154.72 46.44 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.984 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 93' ' ' GLU . 44.4 m-85 -99.78 132.71 44.95 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 p -118.89 154.48 32.88 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.174 -1.01 . . . . 0.0 113.692 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.45 ' NE2' HG22 ' A' ' 39' ' ' THR . 9.1 m-70 -130.07 150.83 51.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.965 -1.47 . . . . 0.0 107.938 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB1' ' CG2' ' A' ' 34' ' ' VAL . . . -134.97 146.65 49.3 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 118.802 -1.159 . . . . 0.0 113.148 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.29 143.69 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.701 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 84' ' ' ASN . 22.5 p -74.47 133.86 42.33 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.187 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -61.14 14.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.521 -179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.582 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.5 p-10 -124.55 3.68 8.31 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.639 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.18 1.75 44.79 Favored Glycine 0 N--CA 1.507 3.43 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.389 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 39.1 mm-40 -98.75 112.05 24.24 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.375 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.87 128.84 37.44 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.837 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.27 25.52 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 1.9 pp20? -78.52 147.08 33.98 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.073 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.8 m-20 -154.63 150.47 21.82 Favored Pre-proline 0 C--N 1.292 -1.894 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.685 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -54.41 85.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 120.752 0.968 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -103.22 119.36 38.72 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.349 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 77' ' ' TYR . 53.2 mp0 -89.83 115.04 26.86 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.78 117.39 32.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 73' ' ' LYS . 71.9 t -99.67 128.37 51.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.736 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 76' ' ' LEU . 7.3 mt -129.12 112.91 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.941 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 t -89.26 145.3 25.48 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.429 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' NH2' ' A' ' 68' ' ' ARG . 90.8 t -89.36 133.36 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.647 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.42 150.01 23.79 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.546 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.51 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.951 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -172.62 -155.43 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.79 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.78 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 10.5 m-20 -66.75 -117.6 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.017 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 104' ' ' ASN . 38.0 t0 49.61 -157.45 0.08 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.659 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.678 HD22 ' H ' ' A' ' 104' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.797 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 2' ' ' TRP . 37.9 t70 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.563 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 7.7 m0 -79.16 87.35 4.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG23 ' C ' ' A' ' 2' ' ' TRP . 19.9 t -156.38 87.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.382 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.8 tt -161.25 88.22 1.62 Allowed Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.155 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.574 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 4.9 Cg_exo -61.72 -43.33 26.89 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 121.601 1.534 . . . . 0.0 114.319 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 3.2 Cg_endo -71.27 139.69 35.63 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.507 1.471 . . . . 0.0 112.429 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' N ' ' A' ' 8' ' ' SER . 6.6 mm -142.45 165.37 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.47 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.628 ' N ' HG22 ' A' ' 7' ' ' ILE . 60.0 p -136.35 148.09 47.71 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.607 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.6 m -140.15 124.04 10.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.35 165.23 25.41 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.355 1.37 . . . . 0.0 112.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -111.7 150.19 30.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 12' ' ' ASN . 1.4 m-20 58.92 31.99 21.83 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.221 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 86.4 mt-10 -55.01 134.1 48.86 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.876 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.8 154.01 17.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.87 174.4 13.79 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.407 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -79.88 142.38 35.25 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.432 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 54.5 m-85 -101.53 153.24 38.0 Favored Pre-proline 0 N--CA 1.489 1.476 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.778 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 52' ' ' ILE . 4.9 Cg_endo -73.7 157.72 99.05 Favored 'Cis proline' 0 C--O 1.215 -0.64 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.304 -0.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -115.73 134.66 54.81 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.435 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.515 HD21 ' HE2' ' A' ' 61' ' ' LYS . 5.4 m-80 -73.31 152.17 41.04 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.349 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 21' ' ' LEU . 28.4 mt -125.04 -65.31 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.508 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -160.5 159.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.82 157.88 34.39 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.196 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.67 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.9 mm -90.21 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.918 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.67 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.4 OUTLIER -127.48 119.72 26.73 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.212 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.694 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 6.9 t -105.66 -103.89 0.32 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.306 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -179.46 -50.52 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -74.31 12.2 0.8 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.651 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 27' ' ' ASN . 1.6 p30 -66.9 20.67 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' H ' ' C ' ' A' ' 28' ' ' ARG . 54.1 mttm -118.08 -14.11 9.95 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -100.54 -40.95 7.17 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.393 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.527 HG21 ' HB2' ' A' ' 82' ' ' SER . 7.4 t -158.14 158.54 34.84 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.371 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -51.17 115.41 1.54 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.809 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.4 p -99.64 135.64 34.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.386 -0.926 . . . . 0.0 113.085 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 83' ' ' SER . 4.8 m-30 -97.15 161.56 13.76 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.695 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.694 ' OH ' ' N ' ' A' ' 26' ' ' SER . 42.3 m-85 -124.56 178.96 5.15 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 m -161.2 136.42 7.64 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.201 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' ILE . 19.4 tt -124.27 150.37 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.353 -0.939 . . . . 0.0 112.25 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.446 ' OG1' ' OD2' ' A' ' 44' ' ' ASP . 11.8 t -158.31 156.73 31.13 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.439 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.36 -170.89 18.93 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.433 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 5.5 pt20 -52.22 132.07 33.27 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.547 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 50' ' ' VAL . . . 98.46 -20.49 50.23 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.168 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.83 -79.5 0.58 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.628 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' OG1' ' A' ' 39' ' ' THR . 3.9 p30 -102.24 -19.3 15.11 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 119.946 -0.701 . . . . 0.0 110.157 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -100.27 150.34 36.84 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.379 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 3.0 Cg_exo -58.29 129.98 35.48 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 121.503 1.469 . . . . 0.0 111.332 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.0 OUTLIER -67.74 122.4 4.92 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 C-N-CA 124.01 -1.246 . . . . 0.0 111.317 -1.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.501 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -79.87 119.09 28.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.375 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.13 81.91 1.54 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.09 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 51' ' ' PHE . 82.9 t -151.57 -36.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 50' ' ' VAL . 81.5 m-85 -124.14 132.86 53.67 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.946 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' CB ' ' A' ' 18' ' ' PRO . 2.3 pt -137.39 136.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.198 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.513 HG22 HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -115.24 148.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.761 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' HG12 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.61 99.41 10.17 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.48 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -46.1 -15.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.591 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' GLU . 90.4 mt-10 -90.9 -70.13 0.7 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.219 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.3 p -82.02 2.39 31.18 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.504 -0.878 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.3 58.09 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.082 -1.533 . . . . 0.0 110.395 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -75.4 113.16 12.47 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.809 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -79.55 117.05 20.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.538 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.557 ' N ' HD23 ' A' ' 60' ' ' LEU . 9.1 mttt -119.89 161.09 21.44 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.519 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 51' ' ' PHE . 1.3 m -122.17 140.99 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.208 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.32 -26.14 21.26 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.615 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.455 HE21 HG22 ' A' ' 50' ' ' VAL . 23.0 mt-30 -138.78 144.49 41.96 Favored Pre-proline 0 N--CA 1.487 1.391 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.602 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.508 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 4.1 Cg_endo -64.84 167.63 15.27 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.215 1.277 . . . . 0.0 110.469 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.6 mt -89.54 165.46 14.27 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.489 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -140.06 104.01 4.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.215 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -57.83 -28.0 63.68 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.724 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.52 -23.4 66.23 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.695 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.52 -57.46 2.03 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' LYS . 66.3 mt -139.35 133.44 39.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.344 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.83 0.28 32.42 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.437 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' H ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -160.64 132.53 5.94 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.191 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 4.9 m-85 -119.93 129.92 54.56 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' C ' HD22 ' A' ' 76' ' ' LEU . 37.4 mt -101.88 104.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.749 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.6 mm? -101.85 156.61 17.41 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.02 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -120.85 147.72 45.01 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.1 p -139.7 159.17 42.77 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.7 -1.2 . . . . 0.0 113.058 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 3.4 m-70 -134.14 150.67 51.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.289 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -120.26 146.86 45.66 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 119.593 -0.843 . . . . 0.0 113.091 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.75 150.45 20.68 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.905 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.607 ' C ' ' H ' ' A' ' 84' ' ' ASN . 67.0 p -86.91 129.94 34.67 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 35' ' ' PHE . 4.6 t -55.93 2.76 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.157 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 82' ' ' SER . 19.3 p30 -94.03 -24.39 17.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 123.64 9.62 5.77 Favored Glycine 0 N--CA 1.499 2.873 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.913 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 38.3 mt-10 -109.52 127.5 54.5 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.725 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 127.6 33.53 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 88' ' ' VAL . 2.4 m -135.49 32.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.225 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 9.5 pt-20 -79.14 162.27 25.91 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.981 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -155.98 147.01 16.48 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.51 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.18 94.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 120.964 1.109 . . . . 0.0 111.477 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mmt -113.05 118.02 33.63 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.586 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.728 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -104.27 110.54 22.8 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.912 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.528 HD11 ' CD1' ' A' ' 24' ' ' ILE . 23.4 mt -90.45 132.0 36.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.18 113.96 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 ' SG ' ' A' ' 9' ' ' CYS . 44.0 mt -108.24 109.06 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.29 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -92.03 150.14 21.14 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.325 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.52 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.496 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 149.18 49.72 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.475 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.56 174.41 0.44 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.021 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.644 ' NE2' ' H ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -91.48 -138.63 0.16 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.418 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.644 ' H ' ' NE2' ' A' ' 101' ' ' GLN . 4.1 t-20 -122.46 17.77 10.51 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -52.27 97.76 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.631 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 p30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.239 -1.839 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.631 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 m0 -82.4 91.75 6.89 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.52 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.2 OUTLIER -160.22 88.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 118.941 -1.103 . . . . 0.0 111.458 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 4' ' ' ILE . 15.6 tt -161.74 87.16 1.57 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.6 Cg_exo -62.96 -42.17 25.42 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 121.369 1.379 . . . . 0.0 113.549 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 6.9 Cg_endo -75.74 141.36 24.49 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.698 1.599 . . . . 0.0 112.231 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.63 ' CG2' ' N ' ' A' ' 8' ' ' SER . 3.6 mt -150.85 168.58 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.514 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.63 ' N ' ' CG2' ' A' ' 7' ' ' ILE . 2.5 p -125.43 145.31 50.12 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.321 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 96' ' ' ILE . 1.2 m -128.26 143.2 47.17 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 21' ' ' LEU . 5.7 Cg_endo -65.86 142.53 69.74 Favored 'Trans proline' 0 C--N 1.329 -0.493 0 C-N-CA 121.517 1.478 . . . . 0.0 113.356 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' CD ' ' ND2' ' A' ' 12' ' ' ASN . 2.8 tt0 -105.27 151.81 23.66 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.247 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' ND2' ' CD ' ' A' ' 11' ' ' GLU . 62.3 m-20 48.31 12.8 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.924 -1.111 . . . . 0.0 110.797 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -44.73 146.01 0.83 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.616 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -137.69 154.93 49.6 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.849 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.33 -138.56 8.86 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -106.8 140.7 39.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.254 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CZ ' ' HD3' ' A' ' 65' ' ' PRO . 40.9 m-85 -115.26 152.94 47.35 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.254 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.8 Cg_endo -74.03 168.64 76.05 Favored 'Cis proline' 0 C--N 1.322 -0.859 0 C-N-CA 123.524 -1.448 . . . . 0.0 111.625 -1.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -135.27 130.89 35.85 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -74.13 138.98 44.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.392 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD13 ' HD2' ' A' ' 10' ' ' PRO . 13.8 mt -111.8 -61.73 1.67 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.35 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.49 161.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 118.892 -1.123 . . . . 0.0 111.724 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -84.62 146.33 27.55 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -89.05 159.69 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.813 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 31.3 mttp -140.67 136.89 33.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.241 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.641 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 40.0 t -108.29 -118.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.721 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.52 ' ND2' ' CD ' ' A' ' 28' ' ' ARG . 3.1 p-10 -161.23 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.102 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.2 mmm180 -58.98 -6.13 0.75 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.447 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -63.66 10.55 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.916 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 28' ' ' ARG . 10.2 mttt -102.18 -23.69 14.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.908 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -100.38 -33.95 10.16 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 t -159.72 142.06 13.49 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.29 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -45.68 128.95 8.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.124 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.51 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 5.2 p -122.65 136.15 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.347 -0.941 . . . . 0.0 113.095 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -98.59 160.33 14.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.109 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.641 ' OH ' ' N ' ' A' ' 26' ' ' SER . 51.1 m-85 -110.83 175.42 5.43 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.31 147.4 22.22 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.393 -1.731 . . . . 0.0 107.541 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -132.08 147.26 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 118.987 -1.085 . . . . 0.0 112.86 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.537 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 2.2 t -161.01 143.14 12.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.91 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 131.56 -176.41 19.18 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.657 -1.258 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -49.56 139.22 12.66 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.605 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.27 -16.96 60.14 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.268 -1.444 . . . . 0.0 109.631 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.37 0.64 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 3.6 p-10 -98.26 -28.74 13.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.8 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -98.82 150.07 36.34 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.43 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.0 Cg_exo -54.91 131.74 48.04 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 121.583 1.522 . . . . 0.0 111.615 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 2.4 Cg_endo -68.71 121.73 5.05 Favored 'Cis proline' 0 C--O 1.215 -0.656 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.184 -2.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 48' ' ' VAL . 7.0 p -78.26 117.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.764 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.77 81.68 1.52 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.253 -1.451 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -146.46 -37.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.263 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CD1' HG12 ' A' ' 62' ' ' VAL . 65.8 m-85 -118.86 145.56 45.59 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 123.903 0.752 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.72 135.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 HG22 ' CG2' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -131.32 151.27 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.649 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.2 OUTLIER -91.61 105.74 17.97 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.328 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -50.04 -14.9 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.821 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -93.39 -69.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.369 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.45 ' C ' ' N ' ' A' ' 59' ' ' TRP . 44.6 p -84.32 10.51 10.36 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.048 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 47.74 16.54 0.41 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' N ' ' C ' ' A' ' 57' ' ' THR . 1.3 m95 -62.23 119.01 8.19 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.222 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.568 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -95.41 122.42 38.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.285 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -125.22 160.91 28.09 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.128 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 51' ' ' PHE . 5.0 m -122.3 149.87 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.78 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 p -105.99 -26.58 11.61 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.319 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -134.0 137.67 28.88 Favored Pre-proline 0 N--CA 1.495 1.786 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.601 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.474 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 2.1 Cg_endo -60.64 163.26 16.01 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.364 1.376 . . . . 0.0 111.047 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 66' ' ' LEU . 3.9 mt -90.29 170.14 10.51 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 5.1 t0 -136.07 97.73 3.69 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.682 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -18.07 58.98 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.266 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 27.0 mm-40 -75.72 -16.62 60.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.708 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . -113.69 -47.55 2.98 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.0 mt -140.79 117.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.25 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.2 54.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.764 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -160.3 122.14 3.19 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.05 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 66' ' ' LEU . 24.5 m-85 -99.45 134.21 42.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 mm -103.65 134.74 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.174 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -134.22 133.94 41.46 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.92 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -99.69 136.68 39.25 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -133.37 160.51 37.14 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.808 -1.157 . . . . 0.0 113.311 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.583 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 2.5 m-70 -126.15 150.89 47.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 113.965 -1.471 . . . . 0.0 108.825 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' A' ' 89' ' ' GLU . . . -124.44 144.2 50.2 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 119.339 -0.945 . . . . 0.0 112.646 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.08 130.93 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 84' ' ' ASN . 23.1 p -62.74 128.62 36.79 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.282 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 6.23 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.256 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 82' ' ' SER . 20.1 p30 -97.54 -9.38 27.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.44 2.11 27.69 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.523 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 71.3 mm-40 -104.27 124.28 48.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.75 127.23 31.94 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.736 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 81' ' ' VAL . 33.9 m -131.24 33.26 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.569 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -80.02 146.35 32.03 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.982 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 92' ' ' MET . 10.2 m-20 -145.4 149.27 40.4 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.184 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.83 86.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.585 0.857 . . . . 0.0 110.668 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.6 mmt -103.73 120.99 42.07 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.895 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.86 110.96 23.54 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -88.22 127.28 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.007 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.2 t -101.49 118.52 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.05 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.452 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.1 mt -115.87 113.86 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.891 -0.723 . . . . 0.0 110.624 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -89.5 150.9 22.25 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.536 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 71' ' ' ILE . 93.0 t -88.7 138.56 18.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.02 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.5 m -120.23 123.98 44.54 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.499 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.78 159.75 5.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.747 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -136.17 -17.18 1.6 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.966 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -130.66 74.32 1.59 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.805 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -167.46 -27.47 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.3 m120 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 110.839 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 27.2 p-10 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.162 0.506 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.525 ' CZ3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -78.55 103.18 8.32 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.628 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.3 m -160.06 100.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.036 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.5 tt -157.72 85.97 2.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.056 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.7 Cg_exo -69.14 -44.67 2.34 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 121.781 1.654 . . . . 0.0 115.384 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 7.6 Cg_endo -74.46 139.85 26.33 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 121.569 1.513 . . . . 0.0 113.412 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.761 HG22 ' N ' ' A' ' 8' ' ' SER . 23.3 mm -150.23 171.5 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.012 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.761 ' N ' HG22 ' A' ' 7' ' ' ILE . 42.9 t -138.27 148.13 44.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.571 ' SG ' HD13 ' A' ' 21' ' ' LEU . 13.5 m -140.33 132.35 14.45 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 119.756 -0.777 . . . . 0.0 111.158 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -66.42 159.97 47.83 Favored 'Trans proline' 0 N--CA 1.472 0.224 0 C-N-CA 121.644 1.563 . . . . 0.0 113.293 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -113.28 141.57 46.85 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.477 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 46.49 70.1 0.42 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.682 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 4.5 pm0 -102.38 139.44 37.98 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.496 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -90.33 169.48 11.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.049 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.94 -139.14 10.88 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.266 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -146.48 109.84 4.78 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.988 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' THR . 94.0 m-85 -67.14 158.36 81.73 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -67.66 163.2 75.62 Favored 'Cis proline' 0 N--CA 1.486 1.042 0 C-N-CA 124.882 -0.883 . . . . 0.0 113.277 1.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -138.75 121.45 16.37 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.584 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 61' ' ' LYS . 1.6 m120 -68.51 157.32 36.19 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.036 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' SG ' ' A' ' 9' ' ' CYS . 23.2 mt -133.82 -72.98 0.49 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.45 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 23' ' ' GLN . 4.0 t -150.53 159.96 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.052 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.49 ' N ' ' CG1' ' A' ' 22' ' ' VAL . 13.3 mt-30 -85.49 155.15 21.34 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.173 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.458 HG22 ' CE2' ' A' ' 36' ' ' TYR . 2.7 mt -104.86 154.79 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.334 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' HG22 ' A' ' 4' ' ' ILE . 61.2 mttp -143.19 136.32 28.02 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.965 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.58 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -126.09 -172.87 2.71 Favored 'General case' 0 N--CA 1.518 2.926 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 29' ' ' ASP . 35.6 m120 -95.8 -48.77 5.62 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.632 ' C ' ' H ' ' A' ' 30' ' ' LYS . 15.8 mmm180 -41.07 -19.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.98 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -60.49 12.23 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.063 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 28' ' ' ARG . 30.3 mtmm -94.87 -12.54 26.73 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' HH11 ' A' ' 28' ' ' ARG . 1.9 pt-20 -109.42 -44.46 3.9 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.478 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -155.56 154.5 31.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.19 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -50.68 109.17 0.29 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 118.724 -1.191 . . . . 0.0 108.737 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.708 HG21 ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -99.49 139.47 21.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.491 -0.884 . . . . 0.0 113.153 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.505 ' CE2' ' HG2' ' A' ' 56' ' ' GLU . 5.2 m-30 -98.81 162.26 13.2 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.394 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' OH ' ' CB ' ' A' ' 26' ' ' SER . 25.9 m-85 -121.04 178.04 4.89 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 118.664 -1.214 . . . . 0.0 114.11 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 36' ' ' TYR . 14.9 m -160.64 155.58 24.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.239 -1.8 . . . . 0.0 107.691 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 39' ' ' THR . 8.5 tt -125.01 150.68 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 C-N-CA 119.034 -1.067 . . . . 0.0 112.987 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 38' ' ' ILE . 2.9 t -160.09 155.62 25.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' A' ' 44' ' ' ASP . . . 114.43 -170.97 13.5 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' N ' ' HB2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -51.52 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.041 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 50' ' ' VAL . . . 144.89 -12.07 1.9 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.56 -59.97 0.52 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.76 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 40' ' ' GLY . 9.7 p-10 -100.86 -30.59 11.59 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.26 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HB2' ' N ' ' A' ' 41' ' ' GLN . 52.7 mttt -104.8 151.06 39.29 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 4.1 Cg_exo -55.01 126.6 23.12 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 121.564 1.509 . . . . 0.0 111.241 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 3.4 Cg_endo -68.41 118.1 2.92 Favored 'Cis proline' 0 C--O 1.214 -0.689 0 C-N-CA 124.204 -1.165 . . . . 0.0 111.213 -0.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.535 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -80.91 111.3 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.389 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 87.94 81.14 1.25 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.879 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 9.1 m -152.98 -37.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.31 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -108.64 140.86 41.44 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.181 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -140.53 147.82 22.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 53' ' ' ILE . 7.7 pt -132.91 150.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 119.414 -0.915 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -82.55 104.04 12.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.125 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -48.17 -17.57 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HG2' ' CE2' ' A' ' 35' ' ' PHE . 36.5 mt-10 -92.15 -70.85 0.67 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.477 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.41 ' C ' ' N ' ' A' ' 59' ' ' TRP . 63.4 p -84.72 13.46 5.73 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.081 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.19 23.79 1.29 Allowed Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.166 -1.493 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.41 ' N ' ' C ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -67.78 111.63 4.4 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.483 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -81.71 119.61 24.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.309 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' N ' HD23 ' A' ' 60' ' ' LEU . 11.7 mtmm -130.7 156.6 44.65 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.587 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.41 HG13 HD12 ' A' ' 21' ' ' LEU . 18.8 m -125.28 146.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.594 -0.842 . . . . 0.0 111.446 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 17' ' ' PHE . 81.4 p -93.37 -26.54 17.21 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.602 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -128.67 148.23 67.59 Favored Pre-proline 0 N--CA 1.495 1.778 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.379 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 17' ' ' PHE . 1.6 Cg_endo -66.71 168.37 16.94 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.245 1.297 . . . . 0.0 110.454 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 98' ' ' VAL . 7.1 mp -89.17 166.95 13.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.371 -1.332 . . . . 0.0 109.988 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 65.6 t0 -130.37 95.0 3.78 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.657 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -56.36 -26.82 54.04 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.009 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.24 -29.88 69.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.09 -44.91 8.15 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.538 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 73' ' ' LYS . 70.9 mt -148.43 134.48 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.307 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.81 -14.21 37.53 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.209 -0.997 . . . . 0.0 110.663 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 71' ' ' ILE . 3.2 ttpp -151.63 126.44 9.64 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.179 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.407 ' CE1' ' HB ' ' A' ' 71' ' ' ILE . 4.6 m-85 -99.64 132.78 44.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.671 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.512 ' C ' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -115.41 106.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 76' ' ' LEU . 3.8 mm? -98.74 170.75 8.56 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.662 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -131.58 124.71 30.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.2 p -114.94 159.72 20.39 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.276 -0.97 . . . . 0.0 113.069 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.481 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 12.7 m-70 -127.97 139.91 52.29 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -105.88 145.76 30.83 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.681 -0.808 . . . . 0.0 112.857 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -140.22 130.81 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.601 ' C ' ' H ' ' A' ' 84' ' ' ASN . 60.0 p -60.17 134.03 56.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.805 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 44.8 p -57.49 2.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 82' ' ' SER . 16.5 p30 -95.24 -22.36 17.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.996 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 84' ' ' ASN . . . 120.55 5.59 10.08 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.182 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 84' ' ' ASN . 14.8 mt-10 -103.13 137.28 41.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 81' ' ' VAL . . . -70.76 123.03 20.96 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.113 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.8 m -134.74 29.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.984 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HA ' ' H ' ' A' ' 80' ' ' ALA . 7.5 pt-20 -79.79 167.27 20.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 92' ' ' MET . 4.9 m-20 -158.6 147.26 14.22 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 113.921 -1.49 . . . . 0.0 108.183 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.01 88.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 120.673 0.915 . . . . 0.0 111.245 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASP . 8.3 mmt -109.65 109.18 19.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.576 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.681 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -88.79 129.14 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.237 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.29 129.37 51.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.345 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -99.72 128.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.54 HG21 ' SG ' ' A' ' 9' ' ' CYS . 15.5 mt -132.82 119.71 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -90.3 149.29 22.4 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 66' ' ' LEU . 47.8 t -109.55 150.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.33 122.72 28.43 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.676 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -146.31 33.34 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.549 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 101' ' ' GLN . 7.0 t-20 74.35 24.4 1.85 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.443 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -76.7 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.794 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.977 0.418 . . . . 0.0 111.407 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.672 ' CZ3' ' OH ' ' A' ' 36' ' ' TYR . 1.1 m0 -79.29 88.84 4.93 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.667 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -162.01 93.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 118.864 -1.134 . . . . 0.0 112.26 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.77 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.5 tp -159.07 87.56 2.17 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.523 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.6 Cg_exo -64.26 -41.34 21.78 Favored 'Trans proline' 0 CA--C 1.553 1.467 0 C-N-CA 121.878 1.718 . . . . 0.0 114.358 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 5' ' ' PRO . 1.2 Cg_endo -68.23 133.71 29.33 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.656 1.571 . . . . 0.0 112.664 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 8' ' ' SER . 10.3 mm -138.59 170.83 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.618 ' N ' HG22 ' A' ' 7' ' ' ILE . 5.8 p -133.42 143.88 49.16 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.493 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 1.7 m -136.46 119.51 12.08 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.637 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -62.33 155.34 57.77 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 121.358 1.372 . . . . 0.0 113.292 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.7 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.7 tt0 -103.61 154.32 19.64 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.572 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.434 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 86.9 m-20 44.0 66.89 0.75 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.183 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' H ' ' HB3' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -88.1 113.78 24.07 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.887 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -90.6 145.52 24.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.462 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.94 -136.39 8.12 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.617 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -118.2 139.55 51.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.719 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.425 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 41.1 m-85 -109.77 156.39 39.87 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.385 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 17' ' ' PHE . 4.3 Cg_endo -72.68 162.52 90.83 Favored 'Cis proline' 0 C--O 1.217 -0.567 0 C-N-CA 123.765 -1.348 . . . . 0.0 112.135 -0.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -115.55 127.46 55.28 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.832 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.824 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.81 157.75 37.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD11 HG11 ' A' ' 62' ' ' VAL . 25.6 mt -127.54 -70.27 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.2 p -161.24 159.55 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 118.752 -1.179 . . . . 0.0 111.487 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -72.68 145.64 47.07 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.622 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 1.2 mm -89.29 166.51 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.769 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.622 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 22.4 mmtp -136.42 131.1 33.68 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.363 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.635 ' N ' ' OH ' ' A' ' 36' ' ' TYR . 4.6 t -99.17 -126.71 0.17 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.223 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER -159.27 -49.09 0.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.473 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -75.87 14.82 0.61 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.781 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' HB3' ' CE3' ' A' ' 2' ' ' TRP . 0.6 OUTLIER -64.46 17.92 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.118 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.628 ' H ' ' C ' ' A' ' 28' ' ' ARG . 7.0 mtmp? -109.87 -17.8 13.55 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.264 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 32' ' ' THR . 1.1 pt-20 -91.33 -45.58 8.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.538 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 82' ' ' SER . 6.8 t -160.22 158.87 30.77 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.991 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -48.15 108.7 0.18 Allowed 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.588 -1.245 . . . . 0.0 108.673 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 ' HB1' ' A' ' 80' ' ' ALA . 13.3 p -99.24 132.33 44.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.347 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.515 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 6.2 m-30 -97.17 160.37 14.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.749 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.672 ' OH ' ' CZ3' ' A' ' 2' ' ' TRP . 64.2 m-85 -104.72 166.37 10.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.69 147.03 25.63 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.79 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.781 ' CD1' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -133.54 143.65 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.008 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 1.5 t -161.32 160.6 29.88 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.121 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.76 -172.53 17.52 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.187 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -51.44 104.12 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.745 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 50' ' ' VAL . . . 135.16 -16.66 4.15 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.04 -56.21 1.04 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.995 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -109.63 -26.32 9.96 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.65 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -102.86 148.7 35.95 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HA ' ' N ' ' A' ' 48' ' ' VAL . 6.2 Cg_exo -55.17 124.58 16.66 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 121.934 1.756 . . . . 0.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 46' ' ' PRO . 1.6 Cg_endo -66.31 117.54 2.11 Favored 'Cis proline' 0 C--O 1.215 -0.671 0 C-N-CA 124.288 -1.13 . . . . 0.0 111.556 -0.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' N ' ' HA ' ' A' ' 46' ' ' PRO . 0.5 OUTLIER -81.5 111.81 18.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.983 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.21 77.05 1.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 42' ' ' GLY . 1.1 p -142.34 -33.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.615 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.592 ' HE1' ' HG ' ' A' ' 9' ' ' CYS . 74.5 m-85 -118.83 136.54 53.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.401 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.97 138.9 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.812 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.633 HG22 ' HG ' ' A' ' 60' ' ' LEU . 1.9 pp -120.19 149.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' OE1' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -79.63 108.6 13.3 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.907 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 48.9 ttp180 -44.74 -26.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.308 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' A' ' 35' ' ' PHE . 36.6 mm-40 -97.78 -69.4 0.76 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.348 -0.941 . . . . 0.0 112.485 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' TRP . 50.7 p -78.75 10.84 2.96 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.696 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 46.64 16.08 0.18 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 118.866 -1.635 . . . . 0.0 110.062 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -59.08 107.98 0.61 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.045 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -82.02 123.61 29.06 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.518 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.718 ' N ' HD23 ' A' ' 60' ' ' LEU . 4.4 mtpt -132.67 160.36 36.95 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.577 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG11 HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -124.22 138.09 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.7 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -90.34 -21.93 21.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.718 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -130.85 132.1 23.69 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.444 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' HB3' ' H ' ' A' ' 13' ' ' GLU . 1.8 Cg_endo -60.63 163.94 14.52 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.174 1.249 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 66' ' ' LEU . 7.7 mp -94.73 170.44 9.45 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.974 -1.091 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 67' ' ' ASP . 62.7 t0 -134.26 89.51 2.57 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.313 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.7 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -56.04 -21.06 19.5 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.851 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -75.11 -29.25 60.52 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.771 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.01 -52.34 4.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.035 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.03 HG22 ' H ' ' A' ' 72' ' ' ALA . 8.4 mm -120.46 -171.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.686 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.03 ' H ' HG22 ' A' ' 71' ' ' ILE . . . -151.08 -13.27 0.22 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.46 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' H ' HG22 ' A' ' 71' ' ' ILE . 4.9 ttpm? -160.79 125.48 3.66 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 10.9 m-85 -100.84 143.12 31.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.549 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 mt -103.98 132.09 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.958 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 38' ' ' ILE . 4.0 tp -138.83 135.76 34.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.606 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -99.27 131.43 45.3 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.531 -0.868 . . . . 0.0 108.899 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.403 ' HB3' HD12 ' A' ' 94' ' ' ILE . 18.1 p -117.7 160.42 21.35 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.206 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.571 ' HD1' ' CD ' ' A' ' 89' ' ' GLU . 44.4 m-70 -139.51 151.32 46.05 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.953 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.781 ' H ' ' CB ' ' A' ' 89' ' ' GLU . . . -118.32 121.26 39.97 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.227 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -118.79 151.02 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.742 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.531 ' HB2' HG21 ' A' ' 32' ' ' THR . 84.1 p -81.27 147.71 29.8 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.687 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -61.29 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.746 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' ND2' ' CG ' ' A' ' 86' ' ' GLU . 1.1 p-10 -115.76 -7.86 12.05 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.4 10.52 27.24 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.878 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' CG ' ' ND2' ' A' ' 84' ' ' ASN . 8.0 mm-40 -98.43 116.26 30.27 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.891 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.35 115.04 5.86 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.884 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -123.72 20.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.781 ' CB ' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -78.98 170.46 16.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.875 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 92' ' ' MET . 34.7 m-20 -150.52 139.9 13.44 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.146 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -52.4 90.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.63 0.887 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 90' ' ' ASP . 3.9 tmm? -109.18 112.95 25.4 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.302 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.93 107.67 16.45 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 118.909 -1.116 . . . . 0.0 110.601 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 78' ' ' SER . 4.0 mt -87.75 134.91 26.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.594 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 95' ' ' VAL . 10.5 p -111.27 128.47 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 9' ' ' CYS . 5.2 mt -117.74 120.38 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.6 t -92.45 150.66 20.65 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.605 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 66' ' ' LEU . 93.2 t -89.18 150.32 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.23 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.01 147.96 36.1 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.465 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.75 149.94 41.46 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 12' ' ' ASN . 1.6 tt0 -168.78 50.25 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.184 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.58 102.95 0.78 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.673 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 103' ' ' ASP . 50.8 t0 -172.19 -56.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.915 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.515 ' ND2' ' C ' ' A' ' 104' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.75 179.934 . . . . . . . . 2 2 . 1 stop_ save_